Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
COQ7	positive	POLI	ENSG00000101751	COQ7	1	COQ7	1	0.000700022436971648					GO:0005634;GO:0016607;GO:0046872;GO:0016740;GO:0003677;GO:0003684;GO:0006281;GO:0005515;GO:0006974;GO:0016779;GO:0003887;GO:0006260;GO:0036464;GO:0071897;GO:0005654;GO:0019985;GO:0005622;GO:0042276	DNA repair;damaged DNA binding;nucleus;nuclear speck;metal ion binding;transferase activity;DNA binding;protein binding;cellular response to DNA damage stimulus;nucleotidyltransferase activity;DNA-directed DNA polymerase activity;DNA replication;cytoplasmic ribonucleoprotein granule;DNA biosynthetic process;nucleoplasm;translesion synthesis;intracellular;error-prone translesion synthesis	3D-structure;DNA damage;DNA repair;DNA replication;DNA synthesis;DNA-binding;DNA-directed DNA polymerase;Magnesium;Manganese;Metal-binding;Mutator protein;Nucleotidyltransferase;Nucleus;Polymorphism;Reference proteome;Schiff base;Transferase;Ubl conjugation	R-HSA-73894;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5656121	DNA Repair;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Translesion synthesis by POLI
COQ7	positive	METTL4	ENSG00000101574	COQ7	1	COQ7	1	0.00152875498067917	WBGene00015939	WBGene00015939(0)			GO:0003676;GO:0008168;GO:0032259;GO:0016740;GO:0006325;GO:0005634;GO:0009007;GO:0032775	nucleic acid binding;methyltransferase activity;methylation;nucleus;transferase activity;chromatin organization;RNA methylation;regulation of RNA splicing;regulation of chromatin organization;RNA methyltransferase activity;snRNA (adenine-N6)-methylation;site-specific DNA-methyltransferase (adenine-specific) activity;DNA methylation on adenine	Chromatin regulator;Methyltransferase;Nucleus;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase		
COQ7	positive	PFAS	ENSG00000178921	COQ7	1	COQ7	1	0.00152875498067917	WBGene00008654	WBGene00008654(0)			GO:0005737;GO:0046872;GO:0000166;GO:0005524;GO:0016874;GO:0006164;GO:0006541;GO:0006189;GO:0005829;GO:0070062;GO:0004642;GO:0009156;GO:0009168;GO:0042493;GO:0097065	'de novo' IMP biosynthetic process;phosphoribosylformylglycinamidine synthase activity;cytoplasm;metal ion binding;nucleotide binding;ATP binding;ligase activity;purine nucleotide biosynthetic process;glutamine metabolic process;cytosol;extracellular exosome;purine nucleobase biosynthetic process;ribonucleoside monophosphate biosynthetic process;purine ribonucleoside monophosphate biosynthetic process;response to drug;anterior head development	ATP-binding;Cytoplasm;Glutamine amidotransferase;Ligase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Purine biosynthesis;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-73817;R-HSA-8956320	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
COQ7	positive	PNPLA4	ENSG00000006757	COQ7	1	COQ7	1	0.00221692672730212	WBGene00008370;WBGene00015241	WBGene00008370(1)			GO:0016787;GO:0005739;GO:0006629;GO:0016042;GO:0042572;GO:0004806;GO:0050253;GO:0005737;GO:0016020;GO:0005829;GO:0008150;GO:0019433;GO:0055088;GO:0005811	hydrolase activity;lipid metabolic process;lipid catabolic process;triglyceride lipase activity;retinyl-palmitate esterase activity;mitochondrion;retinol metabolic process;cytoplasm;membrane;cytosol;biological_process;triglyceride catabolic process;lipid homeostasis;lipid droplet	Alternative splicing;Hydrolase;Lipid degradation;Lipid metabolism;Mitochondrion;Polymorphism;Primary mitochondrial disease;Reference proteome	R-HSA-1430728;R-HSA-556833;R-HSA-163560;R-HSA-8979227	Metabolism;Metabolism of lipids;Triglyceride catabolism;Triglyceride metabolism
COQ7	positive	GTF3C3	ENSG00000119041	COQ7	1	COQ7	1	0.00221692672730212	WBGene00014114	WBGene00014114(0)			GO:0005634;GO:0005730;GO:0003677;GO:0031965;GO:0005515;GO:0006383;GO:0001004;GO:0070898;GO:0005654;GO:0000995;GO:0042791;GO:0042797;GO:0000127;GO:0016020;GO:0016021	protein binding;transcription by RNA polymerase III;RNA polymerase III transcription regulator recruiting activity;nucleus;nucleoplasm;nucleolus;DNA binding;nuclear membrane;5S class rRNA transcription by RNA polymerase III;tRNA transcription by RNA polymerase III;transcription factor TFIIIC complex;membrane;integral component of membrane	Acetylation;Alternative splicing;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;TPR repeat;Transcription	R-HSA-74160;R-HSA-74158;R-HSA-749476;R-HSA-76046;R-HSA-76061;R-HSA-76066	Gene expression (Transcription);RNA Polymerase III Transcription;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter
COQ7	positive	POLR3C	ENSG00000186141	COQ7	1	COQ7	1	0.00221692672730212	WBGene00016750	WBGene00016750(0)			GO:0005654;GO:0003677;GO:0006351;GO:0003899;GO:0003697;GO:0005666;GO:0005634;GO:0005515;GO:0002376;GO:0045087;GO:0051607;GO:0005829;GO:0032728;GO:0045089;GO:0001056;GO:0006383;GO:0032481;GO:0006359	DNA binding;DNA-directed 5'-3' RNA polymerase activity;transcription, DNA-templated;single-stranded DNA binding;RNA polymerase III complex;nucleus;nucleoplasm;protein binding;immune system process;innate immune response;defense response to virus;cytosol;positive regulation of interferon-beta production;positive regulation of innate immune response;positive regulation of type I interferon production;regulation of transcription by RNA polymerase III	3D-structure;Antiviral defense;DNA-binding;DNA-directed RNA polymerase;Immunity;Innate immunity;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription	R-HSA-168249;R-HSA-168256;R-HSA-74160;R-HSA-74158;R-HSA-749476;R-HSA-76046;R-HSA-76061;R-HSA-76066;R-HSA-76071;R-HSA-73980;R-HSA-1834949;R-HSA-73780	Innate Immune System;Immune System;Gene expression (Transcription);RNA Polymerase III Transcription;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Termination;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation
COQ7	positive	SRBD1	ENSG00000068784	COQ7	1	COQ7	1	0.00317488795120502	WBGene00022830	WBGene00022830(0)			GO:0003676;GO:0003723;GO:0006139;GO:0003735;GO:0003729;GO:0006412	nucleic acid binding;nucleobase-containing compound metabolic process;RNA binding;structural constituent of ribosome;mRNA binding;translation	Alternative splicing;Coiled coil;Isopeptide bond;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Ubl conjugation		
COQ7	positive	FH	ENSG00000091483	COQ7	1	COQ7	1	0.00317488795120502	WBGene00001503	WBGene00001503(1)		Fumaric aciduria;HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER;Hereditary pheochromocytoma-paraganglioma;FUMARASE DEFICIENCY;FUMARASE DEFICIENCY;HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	GO:0005634;GO:0005737;GO:0006099;GO:0005739;GO:0003824;GO:0016829;GO:0005694;GO:0005829;GO:0005515;GO:0006281;GO:0006974;GO:0004333;GO:0006106;GO:0048873;GO:0120162;GO:0045239;GO:0070062;GO:0005759;GO:0006108	catalytic activity;lyase activity;tricarboxylic acid cycle;fumarate hydratase activity;fumarate metabolic process;tricarboxylic acid cycle enzyme complex;nucleus;cytoplasm;mitochondrion;chromosome;cytosol;protein binding;DNA repair;cellular response to DNA damage stimulus;malate metabolic process;homeostasis of number of cells within a tissue;positive regulation of cold-induced thermogenesis;extracellular exosome;mitochondrial matrix	3D-structure;Acetylation;Alternative initiation;Chromosome;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Lyase;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transit peptide;Tricarboxylic acid cycle;Tumor suppressor	R-HSA-1430728;R-HSA-1428517;R-HSA-71406;R-HSA-71403	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Citric acid cycle (TCA cycle)
COQ7	positive	C17orf75	ENSG00000108666	COQ7	1	COQ7	1	0.00317488795120502					GO:0006886;GO:0005794;GO:0031410;GO:0005515;GO:0003674;GO:0005802;GO:0099041	cell;intracellular protein transport;Golgi apparatus;cytoplasmic vesicle;protein binding;molecular_function;trans-Golgi network;vesicle tethering to Golgi	Cytoplasmic vesicle;Golgi apparatus;Phosphoprotein;Reference proteome		
COQ7	positive	QRSL1	ENSG00000130348	COQ7	1	COQ7	1	0.00317488795120502	WBGene00021508	WBGene00021508(1)			GO:0006412;GO:0000166;GO:0005524;GO:0005739;GO:0016874;GO:0005515;GO:0032543;GO:0016884;GO:0050567;GO:0070681;GO:0030956;GO:0004040;GO:0031647	translation;amidase activity;glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity;glutamyl-tRNA(Gln) amidotransferase complex;nucleotide binding;ATP binding;mitochondrion;ligase activity;protein binding;mitochondrial translation;carbon-nitrogen ligase activity, with glutamine as amido-N-donor;glutaminyl-tRNAGln biosynthesis via transamidation;regulation of protein stability	ATP-binding;Alternative splicing;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Polymorphism;Protein biosynthesis;Reference proteome		
COQ7	positive	ITGB3BP	ENSG00000142856	COQ7	1	COQ7	1	0.00317488795120502					GO:0005634;GO:0005737;GO:0005654;GO:0006355;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0006915;GO:0034080;GO:0000775;GO:0000776;GO:0000777;GO:0005829;GO:0007165;GO:0007155;GO:0016020;GO:0043065;GO:0008022	regulation of transcription, DNA-templated;CENP-A containing nucleosome assembly;nucleus;cytoplasm;nucleoplasm;cell division;chromosome;protein binding;cell cycle;apoptotic process;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;signal transduction;cell adhesion;membrane;positive regulation of apoptotic process;protein C-terminus binding	Activator;Alternative splicing;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Isopeptide bond;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-162582;R-HSA-194315;R-HSA-193704;R-HSA-204998;R-HSA-73887;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-205043	Signal Transduction;Signaling by Rho GTPases;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Death Receptor Signalling;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;NRIF signals cell death from the nucleus
COQ7	positive	SETDB1	ENSG00000143379	COQ7	1	COQ7	1	0.00317488795120502	WBGene00019883;WBGene00021515	WBGene00019883(0);WBGene00019584(0);WBGene00011729(0);WBGene00018023(0);WBGene00008527(0);WBGene00019690(0);WBGene00020919(0);WBGene00016603(0);WBGene00021282(0);WBGene00022431(0);WBGene00008062(0);WBGene00008206(0);WBGene00020006(0)			GO:0005634;GO:0043231;GO:0008270;GO:0016740;GO:0005829;GO:0005654;GO:0008168;GO:0032259;GO:0003677;GO:0005886;GO:0018024;GO:0034968;GO:0005515;GO:0005737;GO:0046872;GO:0006325;GO:0005694;GO:0007265;GO:0003682;GO:0046974;GO:1990841;GO:0090309;GO:0045869;GO:0051567;GO:0033273;GO:0045471	DNA binding;zinc ion binding;nucleus;protein binding;histone-lysine N-methyltransferase activity;histone lysine methylation;cytoplasm;intracellular membrane-bounded organelle;metal ion binding;transferase activity;nucleoplasm;methyltransferase activity;methylation;chromatin organization;chromosome;Ras protein signal transduction;chromatin binding;negative regulation of gene expression;histone methyltransferase activity (H3-K9 specific);promoter-specific chromatin binding;positive regulation of methylation-dependent chromatin silencing;negative regulation of single stranded viral RNA replication via double stranded DNA intermediate;response to vitamin;response to ethanol;histone H3-K9 methylation;heterochromatin organization	3D-structure;Alternative splicing;Chromatin regulator;Chromosome;Coiled coil;Cytoplasm;Isopeptide bond;Metal-binding;Methylation;Methyltransferase;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc	R-HSA-3247509;R-HSA-4839726;R-HSA-3214841	Chromatin modifying enzymes;Chromatin organization;PKMTs methylate histone lysines
COQ7	positive	CHEK2	ENSG00000183765	COQ7	1	COQ7	1	0.00317488795120502	WBGene00000499;WBGene00011612	WBGene00011612(1);WBGene00000499(1)		Familial prostate cancer;Hereditary breast and ovarian cancer syndrome;Li-Fraumeni syndrome;OSTEOSARCOMA;Breast Cancer;LI-FRAUMENI SYNDROME 2;OSTEOGENIC SARCOMA;Prostate Cancer	GO:0004672;GO:0005524;GO:0006468;GO:0005634;GO:0005794;GO:0046872;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0005654;GO:0051301;GO:0042803;GO:0005515;GO:0006281;GO:0006974;GO:0007049;GO:0006915;GO:0006302;GO:0045893;GO:0042802;GO:0042176;GO:0005737;GO:0006977;GO:0019901;GO:0050821;GO:0044257;GO:0031625;GO:0016605;GO:0090307;GO:0006355;GO:1901796;GO:0046777;GO:0090399;GO:0000781;GO:0000077;GO:0006975;GO:0000086;GO:0042770;GO:0001302;GO:0008630;GO:0044773;GO:0072428;GO:0001934;GO:0006978;GO:0010332;GO:0018105;GO:0035690;GO:0042771;GO:0071157;GO:0071480;GO:1903416;GO:1903926;GO:2000002;GO:2000210	ATP binding;protein phosphorylation;protein kinase activity;protein binding;nucleus;Golgi apparatus;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;cell division;protein homodimerization activity;DNA repair;cellular response to DNA damage stimulus;cell cycle;apoptotic process;double-strand break repair;positive regulation of transcription, DNA-templated;identical protein binding;regulation of protein catabolic process;cytoplasm;PML body;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;protein kinase binding;protein stabilization;cellular protein catabolic process;ubiquitin protein ligase binding;regulation of transcription, DNA-templated;mitotic spindle assembly;regulation of signal transduction by p53 class mediator;protein autophosphorylation;replicative senescence;chromosome, telomeric region;DNA damage checkpoint;DNA damage induced protein phosphorylation;G2/M transition of mitotic cell cycle;signal transduction in response to DNA damage;replicative cell aging;intrinsic apoptotic signaling pathway in response to DNA damage;mitotic DNA damage checkpoint;signal transduction involved in intra-S DNA damage checkpoint;positive regulation of protein phosphorylation;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;response to gamma radiation;peptidyl-serine phosphorylation;cellular response to drug;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;negative regulation of cell cycle arrest;cellular response to gamma radiation;response to glycoside;cellular response to bisphenol A;negative regulation of DNA damage checkpoint;positive regulation of anoikis	3D-structure;ATP-binding;Alternative splicing;Apoptosis;Cell cycle;Cell division;DNA damage;DNA repair;Disease mutation;Kinase;Li-Fraumeni syndrome;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Tumor suppressor;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5693532;R-HSA-73894;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-5633007;R-HSA-6804757;R-HSA-6806003;R-HSA-5693565;R-HSA-5693606;R-HSA-6804756;R-HSA-6804760;R-HSA-69473;R-HSA-75035	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;DNA Double-Strand Break Repair;DNA Repair;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity through Methylation;G2/M DNA damage checkpoint;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
COQ7	positive	SETD4	ENSG00000185917	COQ7	1	COQ7	1	0.00317488795120502	WBGene00022371	WBGene00022371(0)			GO:0005634;GO:0005737;GO:0016740;GO:0008168;GO:0032259;GO:0005829;GO:0016279;GO:0018026;GO:0005515	protein binding;nucleus;cytoplasm;transferase activity;methyltransferase activity;methylation;cytosol;protein-lysine N-methyltransferase activity;peptidyl-lysine monomethylation	Alternative splicing;Cytoplasm;Methyltransferase;Nucleus;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase		
COQ7	positive	TADA2A	ENSG00000276234	COQ7	1	COQ7	1	0.00317488795120502					GO:0005634;GO:0003713;GO:0003677;GO:0006357;GO:1903508;GO:0005515;GO:0000278;GO:0001932;GO:0031063;GO:0031647;GO:0035065;GO:0090043;GO:0005671;GO:0072686	DNA binding;protein binding;regulation of transcription by RNA polymerase II;transcription coactivator activity;regulation of histone acetylation;nucleus;positive regulation of nucleic acid-templated transcription;mitotic cell cycle;regulation of protein phosphorylation;regulation of histone deacetylation;regulation of protein stability;regulation of tubulin deacetylation;Ada2/Gcn5/Ada3 transcription activator complex;mitotic spindle			
COQ7	positive	LIG3	ENSG00000005156	COQ7	1	COQ7	1	0.0044904887391326	WBGene00002985;WBGene00010626	WBGene00022237(0);WBGene00010626(0)			GO:0005634;GO:0008270;GO:0046872;GO:0000166;GO:0005524;GO:0005654;GO:0003677;GO:0005739;GO:0051301;GO:0006281;GO:0016874;GO:0005515;GO:0006310;GO:0006974;GO:0007049;GO:0006260;GO:0003909;GO:0003910;GO:0051103;GO:0071897;GO:0005737;GO:0006283;GO:0000724;GO:0006288;GO:0006273;GO:0006297;GO:0006302;GO:0006266;GO:0043504;GO:0090298;GO:0097681;GO:0070421	DNA binding;zinc ion binding;ATP binding;DNA repair;DNA ligase (ATP) activity;DNA recombination;DNA biosynthetic process;DNA ligase activity;DNA ligation involved in DNA repair;nucleus;metal ion binding;nucleotide binding;nucleoplasm;mitochondrion;cell division;ligase activity;protein binding;cellular response to DNA damage stimulus;cell cycle;DNA replication;cytoplasm;transcription-coupled nucleotide-excision repair;double-strand break repair via homologous recombination;base-excision repair, DNA ligation;lagging strand elongation;nucleotide-excision repair, DNA gap filling;double-strand break repair;DNA ligation;mitochondrial DNA repair;negative regulation of mitochondrial DNA replication;double-strand break repair via alternative nonhomologous end joining;DNA ligase III-XRCC1 complex	3D-structure;ATP-binding;Alternative initiation;Alternative splicing;Cell cycle;Cell division;DNA damage;DNA recombination;DNA repair;DNA replication;Ligase;Magnesium;Metal-binding;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide;Zinc;Zinc-finger	R-HSA-5693532;R-HSA-5693538;R-HSA-73894;R-HSA-5696398;R-HSA-6781827;R-HSA-6782210;R-HSA-5649702;R-HSA-73884;R-HSA-73933;R-HSA-5685939;R-HSA-5696399;R-HSA-110381;R-HSA-5696397	DNA Double-Strand Break Repair;Homology Directed Repair;DNA Repair;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Gap-filling DNA repair synthesis and ligation in TC-NER;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through MMEJ (alt-NHEJ);Global Genome Nucleotide Excision Repair (GG-NER);Resolution of AP sites via the single-nucleotide replacement pathway;Gap-filling DNA repair synthesis and ligation in GG-NER
COQ7	positive	PEX3	ENSG00000034693	COQ7	1	COQ7	1	0.0044904887391326	WBGene00004193			Infantile Refsum disease;NEONATAL ADRENOLEUKODYSTROPHY;Zellweger Syndrome;PEROXISOME BIOGENESIS DISORDER COMPLEMENTATION GROUP 12;Zellweger Syndrome;PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER);PEROXISOME BIOGENESIS DISORDER 10B	GO:0005779;GO:0007031;GO:0016020;GO:0016021;GO:0005654;GO:0005783;GO:0005515;GO:0005777;GO:0008289;GO:0005778;GO:0055085;GO:0032991;GO:0030674;GO:0046983;GO:0045046;GO:0016557;GO:0005829;GO:0032994	peroxisome organization;integral component of peroxisomal membrane;membrane;integral component of membrane;nucleoplasm;endoplasmic reticulum;protein binding;peroxisome;lipid binding;peroxisomal membrane;transmembrane transport;protein-containing complex;protein binding, bridging;protein-lipid complex;protein import into peroxisome membrane;peroxisome membrane biogenesis;cytosol	3D-structure;Disease mutation;Membrane;Peroxisome;Peroxisome biogenesis;Peroxisome biogenesis disorder;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Zellweger syndrome	R-HSA-382551;R-HSA-382556;R-HSA-9609507;R-HSA-9603798;R-HSA-1369062	Transport of small molecules;ABC-family proteins mediated transport;Protein localization;Class I peroxisomal membrane protein import;ABC transporters in lipid homeostasis
COQ7	positive	TIPIN	ENSG00000075131	COQ7	1	COQ7	1	0.0044904887391326	WBGene00017738	WBGene00017738(0)			GO:0005634;GO:0005737;GO:0043231;GO:0051301;GO:0005515;GO:0006974;GO:0007049;GO:0003677;GO:0005654;GO:0000076;GO:0048478;GO:0006260;GO:0008284;GO:0044770;GO:0031298;GO:0043111;GO:0000077;GO:0009411;GO:0031573;GO:0033262;GO:0000790	nucleus;cellular response to DNA damage stimulus;replication fork protection;DNA replication checkpoint;cytoplasm;cell division;protein binding;cell cycle;DNA binding;nucleoplasm;DNA replication;positive regulation of cell population proliferation;cell cycle phase transition;replication fork protection complex;replication fork arrest;DNA damage checkpoint;response to UV;intra-S DNA damage checkpoint;regulation of nuclear cell cycle DNA replication;nuclear chromatin	Cell cycle;Cell division;Cytoplasm;DNA damage;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-5693607	DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Processing of DNA double-strand break ends
COQ7	positive	ALG6	ENSG00000088035	COQ7	1	COQ7	1	0.0044904887391326	WBGene00007435	WBGene00007435(1)		ALG6-CDG;ALG6-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ic	GO:0016020;GO:0016021;GO:0016740;GO:0005783;GO:0005789;GO:0016757;GO:0016758;GO:0006488;GO:0006486;GO:0042281;GO:0006487;GO:0006490;GO:0046527;GO:0004583	membrane;integral component of membrane;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;transferase activity, transferring glycosyl groups;transferase activity, transferring hexosyl groups;dolichol-linked oligosaccharide biosynthetic process;protein glycosylation;dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity;protein N-linked glycosylation;oligosaccharide-lipid intermediate biosynthetic process;glucosyltransferase activity;dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity	Congenital disorder of glycosylation;Disease mutation;Endoplasmic reticulum;Glycosyltransferase;Membrane;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-446193;R-HSA-446203;R-HSA-1643685;R-HSA-3781865;R-HSA-3781860;R-HSA-4724289	Metabolism of proteins;Post-translational protein modification;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Disease;Diseases of glycosylation;Diseases associated with N-glycosylation of proteins;Defective ALG6 causes ALG6-CDG (CDG-1c)
COQ7	positive	CIRBP	ENSG00000099622	COQ7	1	COQ7	1	0.0044904887391326	WBGene00004705;WBGene00011155;WBGene00011156				GO:0003676;GO:0003723;GO:0005634;GO:0005737;GO:0005730;GO:0005515;GO:0005654;GO:0045727;GO:0048026;GO:0005681;GO:1990904;GO:0010494;GO:0009411;GO:0003730;GO:0034063;GO:0030371;GO:0048255;GO:0009409;GO:0070181;GO:0017148	nucleic acid binding;RNA binding;nucleus;cytoplasm;nucleoplasm;protein binding;positive regulation of mRNA splicing, via spliceosome;regulation of RNA metabolic process;spliceosomal complex;ribonucleoprotein complex;cytoplasmic stress granule;response to UV;mRNA 3'-UTR binding;stress granule assembly;positive regulation of translation;translation repressor activity;mRNA stabilization;response to cold;small ribosomal subunit rRNA binding;negative regulation of translation	3D-structure;Activator;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Stress response		
COQ7	positive	ALG13	ENSG00000101901	COQ7	1	COQ7	1	0.0044904887391326	WBGene00011193			ALG13-CDG;X-linked non-syndromic intellectual disability;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Is;epileptic encephalopathies;Epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 36	GO:0016758;GO:0006488;GO:0003723;GO:0016740;GO:0005783;GO:0016787;GO:0016757;GO:0003824;GO:0008152;GO:0008233;GO:0008234;GO:0006508;GO:0036459;GO:0005789;GO:0004577	transferase activity, transferring hexosyl groups;dolichol-linked oligosaccharide biosynthetic process;RNA binding;transferase activity;endoplasmic reticulum;hydrolase activity;transferase activity, transferring glycosyl groups;catalytic activity;metabolic process;peptidase activity;cysteine-type peptidase activity;proteolysis;thiol-dependent ubiquitinyl hydrolase activity;endoplasmic reticulum membrane;N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity	Alternative splicing;Congenital disorder of glycosylation;Disease mutation;Endoplasmic reticulum;Epilepsy;Glycosyltransferase;Hydrolase;Multifunctional enzyme;Polymorphism;Protease;Reference proteome;Thiol protease;Transferase;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-446193;R-HSA-446203;R-HSA-1643685;R-HSA-3781865;R-HSA-3781860;R-HSA-5633231	Metabolism of proteins;Post-translational protein modification;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Disease;Diseases of glycosylation;Diseases associated with N-glycosylation of proteins;Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
COQ7	positive	NBN	ENSG00000104320	COQ7	1	COQ7	1	0.0044904887391326				Familial prostate cancer;Hereditary breast and ovarian cancer syndrome;NIJMEGEN BREAKAGE SYNDROME;NIJMEGEN BREAKAGE SYNDROME;APLASTIC ANEMIA APLASTIC ANEMIA SUSCEPTIBILITY TO INCLUDED;LEUKEMIA ACUTE LYMPHOBLASTIC;NIJMEGEN BREAKAGE SYNDROME	GO:0005634;GO:0005694;GO:0006281;GO:0005515;GO:0000723;GO:0006974;GO:0007049;GO:0006302;GO:0051321;GO:0030870;GO:0007095;GO:0007093;GO:0000781;GO:0005654;GO:0005829;GO:0007050;GO:0000784;GO:0035861;GO:0016605;GO:0032508;GO:0047485;GO:0008134;GO:1901796;GO:0006260;GO:0005730;GO:0030330;GO:0000724;GO:0003684;GO:0090656;GO:0090737;GO:0003678;GO:0000077;GO:0000729;GO:0001701;GO:0001832;GO:0006303;GO:0008283;GO:0016233;GO:0030174;GO:0031860;GO:0031954;GO:0032206;GO:0033674;GO:0042770;GO:0045190;GO:0050885;GO:0097193;GO:1904354;GO:0005657;GO:0042405	nucleus;protein binding;DNA repair;double-strand break repair;Mre11 complex;telomere maintenance;cellular response to DNA damage stimulus;mitotic cell cycle checkpoint;mitotic G2 DNA damage checkpoint;chromosome;cell cycle;meiotic cell cycle;chromosome, telomeric region;PML body;nucleoplasm;cytosol;cell cycle arrest;nuclear chromosome, telomeric region;site of double-strand break;viral process;protein N-terminus binding;transcription factor binding;regulation of signal transduction by p53 class mediator;DNA replication;nucleolus;DNA damage response, signal transduction by p53 class mediator;double-strand break repair via homologous recombination;damaged DNA binding;t-circle formation;telomere maintenance via telomere trimming;DNA helicase activity;DNA damage checkpoint;DNA double-strand break processing;in utero embryonic development;blastocyst growth;double-strand break repair via nonhomologous end joining;cell population proliferation;telomere capping;regulation of DNA-dependent DNA replication initiation;telomeric 3' overhang formation;positive regulation of protein autophosphorylation;positive regulation of telomere maintenance;DNA duplex unwinding;positive regulation of kinase activity;signal transduction in response to DNA damage;isotype switching;neuromuscular process controlling balance;intrinsic apoptotic signaling pathway;negative regulation of telomere capping;replication fork;nuclear inclusion body	3D-structure;Cell cycle;Chromosome;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Host-virus interaction;Isopeptide bond;Meiosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Telomere;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-2262752;R-HSA-69481;R-HSA-69620;R-HSA-8953897;R-HSA-5633007;R-HSA-5693565;R-HSA-5693606;R-HSA-2559583;R-HSA-6804756;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-912446;R-HSA-5685938;R-HSA-2559586;R-HSA-5693571;R-HSA-5685939;R-HSA-5693548	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Cellular responses to stress;G2/M Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Regulation of TP53 Activity;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Cellular Senescence;Regulation of TP53 Activity through Phosphorylation;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Meiotic recombination;HDR through Single Strand Annealing (SSA);DNA Damage/Telomere Stress Induced Senescence;Nonhomologous End-Joining (NHEJ);HDR through MMEJ (alt-NHEJ);Sensing of DNA Double Strand Breaks
COQ7	positive	EMC2	ENSG00000104412	COQ7	1	COQ7	1	0.0044904887391326	WBGene00021973	WBGene00021973(1)			GO:0005515;GO:0005634;GO:0005737;GO:0005783;GO:0072546	protein binding;nucleus;cytoplasm;endoplasmic reticulum;ER membrane protein complex	Acetylation;Cytoplasm;Nucleus;Reference proteome;Repeat;TPR repeat		
COQ7	positive	LANCL1	ENSG00000115365	COQ7	1	COQ7	1	0.0044904887391326					GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0008270;GO:0003824;GO:0005886;GO:0005515;GO:0004364;GO:0043295;GO:0017124;GO:0004930;GO:0007186;GO:0005887;GO:0050750;GO:0043523;GO:1903203	catalytic activity;cytoplasm;membrane;metal ion binding;transferase activity;zinc ion binding;plasma membrane;protein binding;glutathione transferase activity;glutathione binding;SH3 domain binding;G protein-coupled receptor activity;G protein-coupled receptor signaling pathway;integral component of plasma membrane;low-density lipoprotein particle receptor binding;regulation of neuron apoptotic process;regulation of oxidative stress-induced neuron death	3D-structure;Acetylation;Cell membrane;Cytoplasm;Direct protein sequencing;Membrane;Metal-binding;Reference proteome;Transferase;Zinc		
COQ7	positive	DARS2	ENSG00000117593	COQ7	1	COQ7	1	0.0044904887391326	WBGene00001095	WBGene00001095(1)		Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome;LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION;LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	GO:0003676;GO:0005737;GO:0005524;GO:0016874;GO:0000166;GO:0004812;GO:0006418;GO:0006412;GO:0005634;GO:0005739;GO:0005759;GO:0042803;GO:0005515;GO:0000049;GO:0004815;GO:0050560;GO:0043039;GO:0070145	ATP binding;cytoplasm;nucleic acid binding;aminoacyl-tRNA ligase activity;tRNA aminoacylation for protein translation;nucleotide binding;ligase activity;translation;nucleoplasm;mitochondrion;mitochondrial matrix;protein homodimerization activity;protein binding;tRNA binding;aspartate-tRNA ligase activity;aspartate-tRNA(Asn) ligase activity;tRNA aminoacylation;mitochondrial asparaginyl-tRNA aminoacylation	3D-structure;ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-379724;R-HSA-379726	Metabolism of proteins;Translation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation
COQ7	positive	UTP20	ENSG00000120800	COQ7	1	COQ7	1	0.0044904887391326	WBGene00007050	WBGene00007050(0)			GO:0003723;GO:0005634;GO:0005737;GO:0005730;GO:0005886;GO:0005515;GO:0005654;GO:0006364;GO:0032040;GO:0008285;GO:0030688;GO:0000447;GO:0000472;GO:0000480;GO:0030686	RNA binding;nucleus;cytoplasm;nucleolus;plasma membrane;protein binding;nucleoplasm;rRNA processing;small-subunit processome;negative regulation of cell population proliferation;preribosome, small subunit precursor;endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);90S preribosome	Coiled coil;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
COQ7	positive	MTX2	ENSG00000128654	COQ7	1	COQ7	1	0.0044904887391326	WBGene00022516	WBGene00022516(1)			GO:0016020;GO:0015031;GO:0005730;GO:0005739;GO:0005515;GO:0005741;GO:0001401;GO:0006839	SAM complex;membrane;protein transport;nucleolus;mitochondrion;protein binding;mitochondrial outer membrane;inner mitochondrial membrane organization;mitochondrial transport;MIB complex	Acetylation;Alternative splicing;Membrane;Mitochondrion;Mitochondrion outer membrane;Protein transport;Reference proteome;Transport	R-HSA-1852241;R-HSA-9609507;R-HSA-1592230;R-HSA-1268020;R-HSA-8949613	Organelle biogenesis and maintenance;Protein localization;Mitochondrial biogenesis;Mitochondrial protein import;Cristae formation
COQ7	positive	XPO4	ENSG00000132953	COQ7	1	COQ7	1	0.0044904887391326	WBGene00022087	WBGene00022087(1)			GO:0005634;GO:0005737;GO:0015031;GO:0005829;GO:0005654;GO:0005515;GO:0005643;GO:0005049;GO:0006611;GO:0046827;GO:0051168	nuclear export signal receptor activity;nucleus;cytoplasm;protein transport;nucleoplasm;cytosol;protein binding;nuclear pore;protein export from nucleus;positive regulation of protein export from nucleus;nuclear export	Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport		
COQ7	positive	CCDC90B	ENSG00000137500	COQ7	1	COQ7	1	0.0044904887391326					GO:0005739;GO:0016020;GO:0016021;GO:0031966;GO:0005515	membrane;integral component of membrane;mitochondrion;protein binding;mitochondrial membrane	3D-structure;Alternative splicing;Coiled coil;Membrane;Mitochondrion;Polymorphism;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix		
COQ7	positive	DLAT	ENSG00000150768	COQ7	1	COQ7	1	0.0044904887391326	WBGene00009082	WBGene00009082(1)		PYRUVATE DEHYDROGENASE E2 DEFICIENCY;PYRUVATE DEHYDROGENASE E2 DEFICIENCY;PYRUVATE DEHYDROGENASE E2 DEFICIENCY	GO:0016740;GO:0006099;GO:0005739;GO:0005759;GO:0016746;GO:0005515;GO:0005975;GO:0006090;GO:0042802;GO:0006006;GO:0004742;GO:0030523;GO:0045254;GO:0034604;GO:0006086;GO:0030431;GO:0005967	transferase activity, transferring acyl groups;pyruvate metabolic process;dihydrolipoyllysine-residue acetyltransferase activity;pyruvate dehydrogenase complex;transferase activity;tricarboxylic acid cycle;mitochondrion;mitochondrial matrix;protein binding;carbohydrate metabolic process;identical protein binding;glucose metabolic process;dihydrolipoamide S-acyltransferase activity;pyruvate dehydrogenase (NAD+) activity;acetyl-CoA biosynthetic process from pyruvate;sleep;mitochondrial pyruvate dehydrogenase complex	3D-structure;Acetylation;Acyltransferase;Carbohydrate metabolism;Glucose metabolism;Lipoyl;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transferase;Transit peptide;Tricarboxylic acid cycle	R-HSA-1430728;R-HSA-162582;R-HSA-71291;R-HSA-389661;R-HSA-9006931;R-HSA-1428517;R-HSA-204174;R-HSA-5362517;R-HSA-70268;R-HSA-71406	Metabolism;Signal Transduction;Metabolism of amino acids and derivatives;Glyoxylate metabolism and glycine degradation;Signaling by Nuclear Receptors;The citric acid (TCA) cycle and respiratory electron transport;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
COQ7	positive	OBI1	ENSG00000152193	COQ7	1	COQ7	1	0.0044904887391326					GO:0046872;GO:0016740;GO:0005694;GO:0005515;GO:0004842;GO:0051865;GO:0003682;GO:0000785;GO:0006275;GO:0006513	ubiquitin-protein transferase activity;regulation of DNA replication;protein monoubiquitination;metal ion binding;transferase activity;chromosome;protein binding;protein autoubiquitination;chromatin binding;chromatin	Chromosome;Coiled coil;Metal-binding;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger		
COQ7	positive	KAT5	ENSG00000172977	COQ7	1	COQ7	1	0.0044904887391326	WBGene00007029;WBGene00010537	WBGene00016200(0)	ERCC1		GO:0005634;GO:0005737;GO:0046872;GO:0016740;GO:0005654;GO:0006355;GO:0016746;GO:0006325;GO:0005515;GO:0048471;GO:0006302;GO:0004402;GO:0016573;GO:0035267;GO:0043967;GO:0003713;GO:0045893;GO:0005730;GO:0042393;GO:0000790;GO:0045944;GO:0010508;GO:0040008;GO:0016032;GO:0045892;GO:0000122;GO:1904837;GO:1901796;GO:0043161;GO:0006260;GO:1901985;GO:0030521;GO:0010485;GO:0050681;GO:0071392;GO:0000729;GO:0006303;GO:0010212;GO:0000123;GO:0032703;GO:0006978;GO:0070491;GO:0018394;GO:0016407;GO:0032777;GO:0061733;GO:0000812;GO:0006357;GO:0005667	regulation of transcription, DNA-templated;histone acetyltransferase activity;histone acetylation;NuA4 histone acetyltransferase complex;nucleus;cytoplasm;metal ion binding;transferase activity;nucleoplasm;transferase activity, transferring acyl groups;chromatin organization;protein binding;perinuclear region of cytoplasm;double-strand break repair;histone H4 acetylation;transcription coactivator activity;positive regulation of transcription, DNA-templated;nucleolus;histone binding;nuclear chromatin;positive regulation of transcription by RNA polymerase II;positive regulation of autophagy;regulation of growth;viral process;negative regulation of transcription, DNA-templated;negative regulation of transcription by RNA polymerase II;beta-catenin-TCF complex assembly;regulation of signal transduction by p53 class mediator;proteasome-mediated ubiquitin-dependent protein catabolic process;DNA replication;positive regulation of protein acetylation;androgen receptor signaling pathway;H4 histone acetyltransferase activity;androgen receptor binding;cellular response to estradiol stimulus;DNA double-strand break processing;double-strand break repair via nonhomologous end joining;response to ionizing radiation;histone acetyltransferase complex;negative regulation of interleukin-2 production;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;repressing transcription factor binding;peptidyl-lysine acetylation;acetyltransferase activity;Piccolo NuA4 histone acetyltransferase complex;peptide-lysine-N-acetyltransferase activity;Swr1 complex;regulation of transcription by RNA polymerase II;transcription factor complex	3D-structure;Acetylation;Activator;Acyltransferase;Alternative splicing;Chromatin regulator;Cytoplasm;Direct protein sequencing;Growth regulation;Host-virus interaction;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-195721;R-HSA-201681;R-HSA-2262752;R-HSA-69481;R-HSA-69620;R-HSA-8953897;R-HSA-8939211;R-HSA-9006931;R-HSA-5633007;R-HSA-5693565;R-HSA-5693606;R-HSA-201722;R-HSA-2559583;R-HSA-6804756;R-HSA-3247509;R-HSA-4839726;R-HSA-9018519;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-3214847;R-HSA-5693554;R-HSA-5685938;R-HSA-2559586;R-HSA-5693571;R-HSA-5693548	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Signaling by WNT;TCF dependent signaling in response to WNT;Cellular responses to stress;G2/M Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;ESR-mediated signaling;Signaling by Nuclear Receptors;Regulation of TP53 Activity;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Formation of the beta-catenin:TCF transactivating complex;Cellular Senescence;Regulation of TP53 Activity through Phosphorylation;Chromatin modifying enzymes;Chromatin organization;Estrogen-dependent gene expression;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;HATs acetylate histones;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Single Strand Annealing (SSA);DNA Damage/Telomere Stress Induced Senescence;Nonhomologous End-Joining (NHEJ);Sensing of DNA Double Strand Breaks
COQ7	positive	RMDN1	ENSG00000176623	COQ7	1	COQ7	1	0.0044904887391326	WBGene00009369	WBGene00009369(1)			GO:0005515;GO:0005737;GO:0005856;GO:0005874;GO:0000922;GO:0005819	protein binding;cytoplasm;cytoskeleton;microtubule;spindle pole;spindle	Alternative splicing;Cytoplasm;Cytoskeleton;Microtubule;Polymorphism;Reference proteome;Repeat;TPR repeat		
COQ7	positive	ERI2	ENSG00000196678	COQ7	1	COQ7	1	0.0044904887391326					GO:0003676;GO:0008270;GO:0046872;GO:0016787;GO:0090305;GO:0006259;GO:0004527;GO:0004518;GO:0090503;GO:0000175;GO:0008310	nucleic acid binding;zinc ion binding;metal ion binding;hydrolase activity;DNA metabolic process;nucleic acid phosphodiester bond hydrolysis;exonuclease activity;nuclease activity;RNA phosphodiester bond hydrolysis, exonucleolytic;3'-5'-exoribonuclease activity;single-stranded DNA 3'-5' exodeoxyribonuclease activity	Alternative splicing;Exonuclease;Hydrolase;Magnesium;Metal-binding;Nuclease;Polymorphism;Reference proteome;Zinc;Zinc-finger		
COQ7	positive	VPS50	ENSG00000004766	COQ7	1	COQ7	1	0.00627297185755882	WBGene00008078	WBGene00008078(1)			GO:0016020;GO:0015031;GO:0005829;GO:0032456;GO:0005515;GO:0005768;GO:0070062;GO:0055037;GO:1990745;GO:0000149;GO:0042147	retrograde transport, endosome to Golgi;endocytic recycling;EARP complex;membrane;protein transport;cytosol;endosome;protein binding;extracellular exosome;recycling endosome;SNARE binding	Acetylation;Alternative splicing;Coiled coil;Endosome;Isopeptide bond;Phosphoprotein;Protein transport;Reference proteome;Transport;Ubl conjugation		
COQ7	positive	COX10	ENSG00000006695	COQ7	1	COQ7	1	0.00627297185755882	WBGene00012895	WBGene00012895(1)		Isolated cytochrome C oxidase deficiency;Leigh syndrome;MITOCHONDRIAL COMPLEX IV DEFICIENCY;Leigh syndrome;MITOCHONDRIAL COMPLEX IV DEFICIENCY	GO:0005730;GO:0005829;GO:0005739;GO:0016020;GO:0016021;GO:0016740;GO:1902600;GO:0031966;GO:0016765;GO:0006783;GO:0005743;GO:0004129;GO:0004311;GO:0008495;GO:0000266;GO:0006123;GO:0006784;GO:0007005;GO:0008535;GO:0009060;GO:0017004;GO:0045333;GO:0048034;GO:0070069	membrane;integral component of membrane;transferase activity;nucleolus;cytosol;mitochondrion;proton transmembrane transport;mitochondrial membrane;transferase activity, transferring alkyl or aryl (other than methyl) groups;heme biosynthetic process;mitochondrial inner membrane;cytochrome-c oxidase activity;farnesyltranstransferase activity;protoheme IX farnesyltransferase activity;mitochondrial electron transport, cytochrome c to oxygen;heme a biosynthetic process;respiratory chain complex IV assembly;cellular respiration;heme O biosynthetic process;cytochrome complex;mitochondrial fission;mitochondrion organization;aerobic respiration;cytochrome complex assembly	Alternative splicing;Disease mutation;Heme biosynthesis;Leigh syndrome;Membrane;Mitochondrion;Polymorphism;Primary mitochondrial disease;Reference proteome;Transferase;Transit peptide;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-189445;R-HSA-189451	Metabolism;Metabolism of porphyrins;Heme biosynthesis
COQ7	positive	RRP15	ENSG00000067533	COQ7	1	COQ7	1	0.00627297185755882	WBGene00018762				GO:0006364;GO:0030687	rRNA processing;preribosome, large subunit precursor;maturation of 5.8S rRNA;maturation of LSU-rRNA	Acetylation;Citrullination;Coiled coil;Isopeptide bond;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation		
COQ7	positive	ING3	ENSG00000071243	COQ7	1	COQ7	1	0.00627297185755882	WBGene00013095;WBGene00021545				GO:0005634;GO:0046872;GO:0006325;GO:0004402;GO:0005654;GO:0040008;GO:0043065;GO:0043967;GO:0035064;GO:0035267;GO:0043968;GO:0000812;GO:0032777;GO:0005515	nucleus;metal ion binding;nucleoplasm;chromatin organization;histone acetyltransferase activity;regulation of growth;positive regulation of apoptotic process;histone H4 acetylation;methylated histone binding;NuA4 histone acetyltransferase complex;histone H2A acetylation;Swr1 complex;Piccolo NuA4 histone acetyltransferase complex;protein binding	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Direct protein sequencing;Disease mutation;Growth regulation;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
COQ7	positive	MSH2	ENSG00000095002	COQ7	1	COQ7	1	0.00627297185755882	WBGene00003418	WBGene00003418(1)		Constitutional mismatch repair deficiency syndrome;Lynch syndrome;Muir-Torre syndrome;Lynch syndrome I;MISMATCH REPAIR CANCER SYNDROME;Muir-Torre syndrome	GO:0005634;GO:0016020;GO:0000166;GO:0005524;GO:0003677;GO:0005694;GO:0005515;GO:0006281;GO:0006974;GO:0030983;GO:0006298;GO:0032300;GO:0032301;GO:0005654;GO:0019901;GO:0003682;GO:0000784;GO:0008022;GO:0045910;GO:0006301;GO:0019899;GO:0000400;GO:0008094;GO:0006310;GO:0071168;GO:0043524;GO:0030183;GO:0042803;GO:0003697;GO:0032405;GO:0016887;GO:0008584;GO:0032139;GO:0032142;GO:0032181;GO:0043570;GO:0051096;GO:0032302;GO:0032357;GO:0000287;GO:0003690;GO:0032137;GO:0032143;GO:0043531;GO:0000406;GO:0003684;GO:0019237;GO:0001701;GO:0002204;GO:0006119;GO:0006302;GO:0007050;GO:0007281;GO:0008340;GO:0008630;GO:0010165;GO:0010224;GO:0016446;GO:0016447;GO:0019724;GO:0031573;GO:0042771;GO:0045190;GO:0048298;GO:0048304	ATP binding;DNA binding;mismatched DNA binding;mismatch repair;mismatch repair complex;nucleus;membrane;nucleotide binding;chromosome;protein binding;DNA repair;cellular response to DNA damage stimulus;MutSalpha complex;nucleoplasm;protein kinase binding;chromatin binding;nuclear chromosome, telomeric region;protein C-terminus binding;postreplication repair;enzyme binding;four-way junction DNA binding;DNA-dependent ATPase activity;DNA recombination;protein localization to chromatin;negative regulation of neuron apoptotic process;B cell differentiation;negative regulation of DNA recombination;protein homodimerization activity;single-stranded DNA binding;MutLalpha complex binding;ATPase activity;male gonad development;dinucleotide insertion or deletion binding;single guanine insertion binding;dinucleotide repeat insertion binding;maintenance of DNA repeat elements;positive regulation of helicase activity;MutSbeta complex;magnesium ion binding;double-stranded DNA binding;guanine/thymine mispair binding;single thymine insertion binding;oxidized purine DNA binding;ADP binding;double-strand/single-strand DNA junction binding;damaged DNA binding;centromeric DNA binding;in utero embryonic development;somatic recombination of immunoglobulin genes involved in immune response;oxidative phosphorylation;double-strand break repair;cell cycle arrest;germ cell development;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;response to X-ray;response to UV-B;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;B cell mediated immunity;intra-S DNA damage checkpoint;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;isotype switching;positive regulation of isotype switching to IgA isotypes;positive regulation of isotype switching to IgG isotypes	3D-structure;ATP-binding;Acetylation;Alternative splicing;Chromosome;DNA damage;DNA repair;DNA-binding;Disease mutation;Hereditary nonpolyposis colorectal cancer;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Tumor suppressor;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-73894;R-HSA-6796648;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606;R-HSA-5423599;R-HSA-5632927;R-HSA-5632928;R-HSA-5632968	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;DNA Repair;TP53 Regulates Transcription of DNA Repair Genes;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Diseases of Mismatch Repair (MMR);Defective Mismatch Repair Associated With MSH3;Defective Mismatch Repair Associated With MSH2;Defective Mismatch Repair Associated With MSH6
COQ7	positive	DHX35	ENSG00000101452	COQ7	1	COQ7	1	0.00627297185755882	WBGene00022056	WBGene00022056(1);WBGene00022433(0)			GO:0000166;GO:0005524;GO:0016787;GO:0004386;GO:0006397;GO:0008380;GO:0005681;GO:0000398;GO:0071013;GO:0003724;GO:0003723;GO:0001701	helicase activity;nucleotide binding;ATP binding;hydrolase activity;mRNA processing;RNA splicing;spliceosomal complex;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;RNA helicase activity;RNA binding;in utero embryonic development	ATP-binding;Alternative splicing;Helicase;Hydrolase;Nucleotide-binding;Polymorphism;Reference proteome;Spliceosome;mRNA processing;mRNA splicing		
COQ7	positive	NUBP1	ENSG00000103274	COQ7	1	COQ7	1	0.00627297185755882	WBGene00008664	WBGene00008664(1)			GO:0005524;GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0005829;GO:0005886;GO:0005856;GO:0042995;GO:0051536;GO:0051539;GO:0006879;GO:0016226;GO:0005815;GO:0005515;GO:0005929;GO:0030030;GO:0005814;GO:0001558;GO:0010826;GO:0051642;GO:0072697	ATP binding;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;iron-sulfur cluster assembly;cell;nucleus;cytoplasm;metal ion binding;nucleotide binding;cytosol;plasma membrane;cytoskeleton;cell projection;cellular iron ion homeostasis;microtubule organizing center;protein binding;cilium;cell projection organization;centriole;regulation of cell growth;negative regulation of centrosome duplication;centrosome localization;protein localization to cell cortex	4Fe-4S;ATP-binding;Acetylation;Alternative splicing;Cell projection;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Iron;Iron-sulfur;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-2564830	Metabolism;Cytosolic iron-sulfur cluster assembly
COQ7	positive	INTS2	ENSG00000108506	COQ7	1	COQ7	1	0.00627297185755882	WBGene00013877	WBGene00013877(0)			GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0016180;GO:0032039;GO:0005515;GO:0005654;GO:0031965;GO:0042795;GO:0005622;GO:0034472	snRNA processing;integrator complex;nucleus;cytoplasm;membrane;integral component of membrane;protein binding;nucleoplasm;nuclear membrane;snRNA transcription by RNA polymerase II;intracellular;snRNA 3'-end processing	Cytoplasm;Membrane;Nucleus;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-73857;R-HSA-74160;R-HSA-6807505	RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes
COQ7	positive	SLC38A1	ENSG00000111371	COQ7	1	COQ7	1	0.00627297185755882	WBGene00021765	WBGene00006783(0);WBGene00012804(0);WBGene00020837(0);WBGene00019837(0);WBGene00012487(0);WBGene00012629(0);WBGene00010421(0)			GO:0016020;GO:0016021;GO:0015293;GO:0006811;GO:0005886;GO:0005515;GO:0006814;GO:0005887;GO:0070062;GO:0015171;GO:0003333;GO:0006865;GO:1902475;GO:0015175;GO:0015804;GO:0001504;GO:0005283;GO:0015179;GO:0015186;GO:0006868;GO:0007565;GO:0030424	neuronal cell body;membrane;integral component of membrane;symporter activity;ion transport;plasma membrane;protein binding;sodium ion transport;integral component of plasma membrane;extracellular exosome;amino acid transmembrane transporter activity;amino acid transmembrane transport;amino acid transport;external side of apical plasma membrane;neutral amino acid transmembrane transporter activity;neutral amino acid transport;neurotransmitter uptake;neutral amino acid:sodium symporter activity;amino acid:sodium symporter activity;L-amino acid transmembrane transporter activity;L-alpha-amino acid transmembrane transport;L-glutamine transmembrane transporter activity;glutamine transport;female pregnancy;axon	Amino-acid transport;Cell membrane;Disulfide bond;Glycoprotein;Ion transport;Membrane;Phosphoprotein;Reference proteome;Sodium;Sodium transport;Symport;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-425407;R-HSA-112315;R-HSA-112316;R-HSA-425393;R-HSA-352230;R-HSA-112313;R-HSA-210455	Transport of small molecules;SLC-mediated transmembrane transport;Transmission across Chemical Synapses;Neuronal System;Transport of inorganic cations/anions and amino acids/oligopeptides;Amino acid transport across the plasma membrane;Neurotransmitter uptake and metabolism In glial cells;Astrocytic Glutamate-Glutamine Uptake And Metabolism
COQ7	positive	UTP25	ENSG00000117597	COQ7	1	COQ7	1	0.00627297185755882	WBGene00012756	WBGene00012756(0)			GO:0005634;GO:0003723;GO:0005515;GO:0007275;GO:0005730;GO:0000462;GO:0032040;GO:0005654;GO:0031648;GO:0006364;GO:0030163;GO:0040019;GO:0034511;GO:0019843	nucleus;RNA binding;protein binding;multicellular organism development;nucleolus;rRNA binding;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);small-subunit processome;nucleoplasm;protein destabilization;rRNA processing;protein catabolic process;positive regulation of embryonic development;U3 snoRNA binding	Developmental protein;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
COQ7	positive	CYP20A1	ENSG00000119004	COQ7	1	COQ7	1	0.00627297185755882					GO:0016020;GO:0016021;GO:0046872;GO:0004497;GO:0016491;GO:0055114;GO:0005506;GO:0016705;GO:0020037	oxidation-reduction process;heme binding;iron ion binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;membrane;integral component of membrane;metal ion binding;monooxygenase activity;oxidoreductase activity	Alternative splicing;Heme;Iron;Membrane;Metal-binding;Monooxygenase;Oxidoreductase;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ7	positive	EXOSC8	ENSG00000120699	COQ7	1	COQ7	1	0.00627297185755882	WBGene00018305;WBGene00018154	WBGene00018305(0)		Pontocerebellar hypoplasia type 1;PONTOCEREBELLAR HYPOPLASIA TYPE 1C	GO:0003723;GO:0006396;GO:0005634;GO:0005737;GO:0005515;GO:0006401;GO:0005730;GO:0006364;GO:0042802;GO:0005654;GO:0005829;GO:0008150;GO:0000178;GO:0043488;GO:0043928;GO:0000467;GO:0016075;GO:0035925;GO:0071035;GO:0071038;GO:0000176;GO:0034427;GO:0034473;GO:0034475;GO:0034476;GO:0071028;GO:0071042;GO:0000177	RNA processing;RNA catabolic process;exosome (RNase complex);RNA binding;nucleus;cytoplasm;intracellular membrane-bounded organelle;nucleoplasm;cytosol;fibrillar center;protein binding;nucleolus;identical protein binding;rRNA processing;biological_process;regulation of mRNA stability;exonucleolytic catabolism of deadenylated mRNA;exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);AU-rich element binding;rRNA catabolic process;mRNA 3'-UTR AU-rich region binding;nuclear polyadenylation-dependent rRNA catabolic process;nuclear polyadenylation-dependent tRNA catabolic process;nuclear exosome (RNase complex);nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';U1 snRNA 3'-end processing;U4 snRNA 3'-end processing;U5 snRNA 3'-end processing;nuclear mRNA surveillance;nuclear polyadenylation-dependent mRNA catabolic process;cytoplasmic exosome (RNase complex)	3D-structure;Acetylation;Cytoplasm;Disease mutation;Exosome;Neurodegeneration;Nucleus;RNA-binding;Reference proteome;rRNA processing	R-HSA-392499;R-HSA-8953854;R-HSA-450531;R-HSA-429914;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-381119;R-HSA-380994;R-HSA-381042;R-HSA-450604;R-HSA-450513;R-HSA-450385;R-HSA-429958	Metabolism of proteins;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Deadenylation-dependent mRNA decay;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Unfolded Protein Response (UPR);ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;KSRP (KHSRP) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;mRNA decay by 3' to 5' exoribonuclease
COQ7	positive	STAMBPL1	ENSG00000138134	COQ7	1	COQ7	1	0.00627297185755882					GO:0016020;GO:0046872;GO:0016787;GO:0005515;GO:0008233;GO:0006508;GO:0008237;GO:0005829;GO:0016579;GO:0004843;GO:0005768;GO:0061578;GO:0070536	protein binding;membrane;metal ion binding;hydrolase activity;peptidase activity;proteolysis;metallopeptidase activity;cytosol;protein deubiquitination;thiol-dependent ubiquitin-specific protease activity;endosome;Lys63-specific deubiquitinase activity;protein K63-linked deubiquitination	3D-structure;Acetylation;Alternative splicing;Hydrolase;Metal-binding;Metalloprotease;Phosphoprotein;Polymorphism;Protease;Reference proteome;Ubl conjugation pathway;Zinc	R-HSA-392499;R-HSA-597592;R-HSA-5688426;R-HSA-5689901	Metabolism of proteins;Post-translational protein modification;Deubiquitination;Metalloprotease DUBs
COQ7	positive	DOP1B	ENSG00000142197	COQ7	1	COQ7	1	0.00627297185755882	WBGene00003905	WBGene00003905(0)			GO:0005829;GO:0006895;GO:0016020;GO:0015031;GO:0005794;GO:0000139;GO:0007275;GO:0070062;GO:0003674;GO:0005802;GO:0005768;GO:0050890;GO:0007029	Golgi to endosome transport;cytosol;membrane;protein transport;Golgi apparatus;multicellular organism development;Golgi membrane;extracellular exosome;molecular_function;trans-Golgi network;endosome;cognition;endoplasmic reticulum organization	Alternative splicing;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport		
COQ7	positive	GIN1	ENSG00000145723	COQ7	1	COQ7	1	0.00627297185755882					GO:0003676;GO:0015074	nucleic acid binding;DNA integration	Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome		
COQ7	positive	MINDY3	ENSG00000148481	COQ7	1	COQ7	1	0.00627297185755882					GO:0005634;GO:0005654;GO:0016787;GO:0031965;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0006915;GO:0036459;GO:1990380;GO:0016807;GO:0071108	nucleus;nucleoplasm;hydrolase activity;nuclear membrane;protein binding;peptidase activity;cysteine-type peptidase activity;proteolysis;apoptotic process;thiol-dependent ubiquitinyl hydrolase activity;Lys48-specific deubiquitinase activity;cysteine-type carboxypeptidase activity;protein K48-linked deubiquitination	Alternative splicing;Apoptosis;Hydrolase;Nucleus;Phosphoprotein;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway		
COQ7	positive	ALG8	ENSG00000159063	COQ7	1	COQ7	1	0.00627297185755882	WBGene00007464	WBGene00007464(1)		ALG8-CDG;ALG8-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ih;POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS	GO:0016020;GO:0016021;GO:0016740;GO:0005783;GO:0005789;GO:0016757;GO:0016758;GO:0042283;GO:0006486;GO:0006490;GO:0005515;GO:0097502;GO:0018279;GO:0006487;GO:0000033;GO:0006488;GO:0004583;GO:0042281	endoplasmic reticulum;transferase activity, transferring hexosyl groups;endoplasmic reticulum membrane;dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity;oligosaccharide-lipid intermediate biosynthetic process;membrane;integral component of membrane;transferase activity;transferase activity, transferring glycosyl groups;protein glycosylation;protein binding;mannosylation;protein N-linked glycosylation via asparagine;protein N-linked glycosylation;alpha-1,3-mannosyltransferase activity;dolichol-linked oligosaccharide biosynthetic process;dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity;dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity	Alternative splicing;Congenital disorder of glycosylation;Disease mutation;Endoplasmic reticulum;Glycosyltransferase;Membrane;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-446193;R-HSA-446203;R-HSA-1643685;R-HSA-3781865;R-HSA-3781860;R-HSA-4724325	Metabolism of proteins;Post-translational protein modification;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Disease;Diseases of glycosylation;Diseases associated with N-glycosylation of proteins;Defective ALG8 causes ALG8-CDG (CDG-1h)
COQ7	positive	NDUFV3	ENSG00000160194	COQ7	1	COQ7	1	0.00627297185755882					GO:0003723;GO:0016020;GO:0005654;GO:0055114;GO:0005739;GO:0005743;GO:0005515;GO:0005747;GO:0070469;GO:0008137;GO:0006120;GO:0032981;GO:0042775	mitochondrion;mitochondrial respiratory chain complex I;RNA binding;membrane;oxidation-reduction process;mitochondrial inner membrane;protein binding;respirasome;NADH dehydrogenase (ubiquinone) activity;mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly;mitochondrial ATP synthesis coupled electron transport	3D-structure;Alternative splicing;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Reference proteome;Respiratory chain;Transit peptide;Transport	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
COQ7	positive	TMEM65	ENSG00000164983	COQ7	1	COQ7	1	0.00627297185755882	WBGene00044325	WBGene00015386(0);WBGene00044325(1)			GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0005886;GO:0014704;GO:0003231;GO:1903779	membrane;integral component of membrane;mitochondrial inner membrane;mitochondrion;plasma membrane;intercalated disc;cardiac ventricle development;regulation of cardiac conduction	Cell membrane;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix		
COQ7	positive	PIGP	ENSG00000185808	COQ7	1	COQ7	1	0.00627297185755882				Early infantile epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 55	GO:0016020;GO:0016021;GO:0016740;GO:0016757;GO:0006506;GO:0017176;GO:0005789;GO:0016254;GO:0000506	GPI anchor biosynthetic process;phosphatidylinositol N-acetylglucosaminyltransferase activity;membrane;integral component of membrane;transferase activity;transferase activity, transferring glycosyl groups;endoplasmic reticulum membrane;preassembly of GPI anchor in ER membrane;glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex	Alternative splicing;Direct protein sequencing;Disease mutation;Epilepsy;GPI-anchor biosynthesis;Glycosyltransferase;Membrane;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-163125;R-HSA-162710	Metabolism of proteins;Post-translational protein modification;Post-translational modification: synthesis of GPI-anchored proteins;Synthesis of glycosylphosphatidylinositol (GPI)
COQ7	positive	GTF2F2	ENSG00000188342	COQ7	1	COQ7	1	0.00627297185755882	WBGene00012694	WBGene00012694(1)			GO:0005634;GO:0000166;GO:0005524;GO:0016787;GO:0003677;GO:0006366;GO:0015630;GO:0005515;GO:0032508;GO:0006367;GO:0003678;GO:0004386;GO:0005674;GO:0045944;GO:0005654;GO:0006368;GO:0006370;GO:0050434;GO:0042795;GO:0000398;GO:0008543;GO:0016070;GO:0097550;GO:0032968	transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;transcription factor TFIIF complex;nucleus;nucleotide binding;ATP binding;nucleoplasm;hydrolase activity;DNA binding;microtubule cytoskeleton;protein binding;DNA duplex unwinding;DNA helicase activity;helicase activity;positive regulation of transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;7-methylguanosine mRNA capping;positive regulation of viral transcription;snRNA transcription by RNA polymerase II;mRNA splicing, via spliceosome;fibroblast growth factor receptor signaling pathway;RNA metabolic process;transcriptional preinitiation complex;positive regulation of transcription elongation from RNA polymerase II promoter;positive regulation of transcription initiation from RNA polymerase II promoter	3D-structure;ATP-binding;Acetylation;DNA-binding;Direct protein sequencing;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-5663202;R-HSA-112382;R-HSA-167152;R-HSA-167169;R-HSA-167172;R-HSA-167200;R-HSA-167238;R-HSA-167243;R-HSA-167246;R-HSA-167287;R-HSA-167290;R-HSA-674695;R-HSA-6796648;R-HSA-75955;R-HSA-9006934;R-HSA-168254;R-HSA-168255;R-HSA-168273;R-HSA-168325;R-HSA-72203;R-HSA-8939211;R-HSA-9006931;R-HSA-113418;R-HSA-167158;R-HSA-167160;R-HSA-167242;R-HSA-6807505;R-HSA-72086;R-HSA-77075;R-HSA-167161;R-HSA-167162;R-HSA-73776;R-HSA-73779;R-HSA-75953;R-HSA-76042;R-HSA-9018519;R-HSA-72163;R-HSA-72172;R-HSA-1226099;R-HSA-1839126;R-HSA-190236;R-HSA-5654738;R-HSA-5655253;R-HSA-6803529;R-HSA-72165;R-HSA-8851708	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Diseases of signal transduction;Formation of RNA Pol II elongation complex ;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription Elongation;Signaling by Receptor Tyrosine Kinases;Influenza Infection;Influenza Life Cycle;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;Processing of Capped Intron-Containing Pre-mRNA;ESR-mediated signaling;Signaling by Nuclear Receptors;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;Abortive elongation of HIV-1 transcript in the absence of Tat;RNA polymerase II transcribes snRNA genes;mRNA Capping;RNA Pol II CTD phosphorylation and interaction with CE;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;Estrogen-dependent gene expression;mRNA Splicing - Major Pathway;mRNA Splicing;Signaling by FGFR in disease;FGFR2 mutant receptor activation;Signaling by FGFR;Signaling by FGFR2;Signaling by FGFR2 in disease;FGFR2 alternative splicing;mRNA Splicing - Minor Pathway;Signaling by FGFR2 IIIa TM
COQ7	positive	PIGN	ENSG00000197563	COQ7	1	COQ7	1	0.00627297185755882	WBGene00021840	WBGene00021840(1)		Fryns syndrome;MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME;MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME;MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1	GO:0016020;GO:0016021;GO:0003824;GO:0005789;GO:0016740;GO:0051377;GO:0006506;GO:0005829;GO:0005783;GO:0005886;GO:0016254;GO:0008484	catalytic activity;transferase activity;endoplasmic reticulum membrane;mannose-ethanolamine phosphotransferase activity;GPI anchor biosynthetic process;membrane;integral component of membrane;cytosol;plasma membrane;endoplasmic reticulum;preassembly of GPI anchor in ER membrane;sulfuric ester hydrolase activity	Disease mutation;Endoplasmic reticulum;Epilepsy;GPI-anchor biosynthesis;Glycoprotein;Membrane;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-163125;R-HSA-162710	Metabolism of proteins;Post-translational protein modification;Post-translational modification: synthesis of GPI-anchored proteins;Synthesis of glycosylphosphatidylinositol (GPI)
COQ7	positive	IRAK4	ENSG00000198001	COQ7	1	COQ7	1	0.00627297185755882	WBGene00004029			Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency;INVASIVE PNEUMOCOCCAL DISEASE RECURRENT ISOLATED 1;IRAK4 DEFICIENCY	GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0000287;GO:0007165;GO:0005515;GO:0002376;GO:0045087;GO:0005886;GO:0005634;GO:0035556;GO:0005829;GO:0010008;GO:0070498;GO:0002224;GO:0002755;GO:0043123;GO:0034162;GO:1990266;GO:0002446;GO:0005149;GO:0001816;GO:0007254;GO:0019221;GO:0048661;GO:0005615	ATP binding;magnesium ion binding;signal transduction;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;protein binding;immune system process;innate immune response;plasma membrane;nucleus;intracellular signal transduction;cytosol;endosome membrane;interleukin-1-mediated signaling pathway;toll-like receptor signaling pathway;MyD88-dependent toll-like receptor signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB signaling;toll-like receptor 9 signaling pathway;neutrophil migration;neutrophil mediated immunity;interleukin-1 receptor binding;cytokine production;JNK cascade;cytokine-mediated signaling pathway;positive regulation of smooth muscle cell proliferation;extracellular space	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Immunity;Innate immunity;Kinase;Magnesium;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-168249;R-HSA-168256;R-HSA-162582;R-HSA-1643685;R-HSA-1257604;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-9006925;R-HSA-9020702;R-HSA-166016;R-HSA-166058;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-5260271;R-HSA-5602358;R-HSA-5603041;R-HSA-975138;R-HSA-975155;R-HSA-199418;R-HSA-6811558;R-HSA-168142;R-HSA-168176;R-HSA-975871;R-HSA-5603037;R-HSA-975110	Innate Immune System;Immune System;Signal Transduction;Disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Intracellular signaling by second messengers;Interleukin-1 signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Diseases of Immune System;Diseases associated with the TLR signaling cascade;IRAK4 deficiency (TLR2/4);TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Negative regulation of the PI3K/AKT network;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;MyD88 cascade initiated on plasma membrane;IRAK4 deficiency (TLR5);TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
COQ7	positive	SCYL3	ENSG00000000457	COQ7	1	COQ7	1	0.00865557568115727					GO:0005737;GO:0005524;GO:0006468;GO:0005794;GO:0042995;GO:0005515;GO:0030027;GO:0016477;GO:0004672	ATP binding;protein phosphorylation;protein kinase activity;cytoplasm;Golgi apparatus;cell projection;protein binding;lamellipodium;cell migration;identical protein binding;inflammatory response;spinal cord motor neuron differentiation;cellular protein localization;neuron development;Golgi membrane	Alternative splicing;Cell projection;Cytoplasm;Golgi apparatus;Lipoprotein;Myristate;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ7	positive	KIF22	ENSG00000079616	COQ7	1	COQ7	1	0.00865557568115727				Spondyloepimetaphyseal dysplasia with multiple dislocations;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2	GO:0005634;GO:0005737;GO:0016607;GO:0000166;GO:0005524;GO:0005829;GO:0003677;GO:0003774;GO:0006281;GO:0003777;GO:0005856;GO:0008017;GO:0005874;GO:0007018;GO:0016887;GO:0005515;GO:0006890;GO:0072686;GO:0019886;GO:0005871;GO:0000278;GO:0051310;GO:0007080;GO:0007062;GO:0000776;GO:0000785;GO:0005819	DNA binding;ATP binding;DNA repair;microtubule binding;microtubule motor activity;microtubule-based movement;cell;nucleus;cytoplasm;nuclear speck;nucleotide binding;cytosol;motor activity;cytoskeleton;microtubule;protein binding;ATPase activity;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;mitotic spindle;antigen processing and presentation of exogenous peptide antigen via MHC class II;kinesin complex;mitotic cell cycle;metaphase plate congression;mitotic metaphase plate congression;sister chromatid cohesion;kinetochore;chromatin;spindle	3D-structure;ATP-binding;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;DNA-binding;Disease mutation;Dwarfism;Isopeptide bond;Microtubule;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2132295;R-HSA-983189;R-HSA-983231	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;MHC class II antigen presentation;Kinesins;Factors involved in megakaryocyte development and platelet production
COQ7	positive	IFT74	ENSG00000096872	COQ7	1	COQ7	1	0.00865557568115727	WBGene00016005	WBGene00016005(0)		BARDET-BIEDL SYNDROME 20	GO:0042073;GO:0060271;GO:0030992;GO:0048487;GO:0005929;GO:0042995;GO:0031410;GO:0005515;GO:0035735;GO:0097542;GO:0030030;GO:0005813;GO:0031514;GO:0003682;GO:0003334;GO:0007219;GO:0007368;GO:0007507;GO:0008544;GO:0033630;GO:0045944;GO:0050680;GO:1905515;GO:0005634	beta-tubulin binding;cilium assembly;intraciliary transport;intraciliary transport particle B;cilium;cell projection;cytoplasmic vesicle;protein binding;intraciliary transport involved in cilium assembly;ciliary tip;cell projection organization;centrosome;motile cilium;chromatin binding;keratinocyte development;Notch signaling pathway;determination of left/right symmetry;heart development;epidermis development;positive regulation of cell adhesion mediated by integrin;positive regulation of transcription by RNA polymerase II;negative regulation of epithelial cell proliferation;non-motile cilium assembly;nucleus	Alternative splicing;Bardet-Biedl syndrome;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Coiled coil;Cytoplasmic vesicle;Methylation;Obesity;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-5620924	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
COQ7	positive	FAM118A	ENSG00000100376	COQ7	1	COQ7	1	0.00865557568115727					GO:0016020;GO:0016021;GO:0005515;GO:0042802	membrane;integral component of membrane;protein binding;identical protein binding	Acetylation;Alternative splicing;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ7	positive	RBM23	ENSG00000100461	COQ7	1	COQ7	1	0.00865557568115727	WBGene00021921				GO:0005634;GO:0003676;GO:0003723;GO:0016020;GO:0005515;GO:0006397;GO:1990904	nucleus;RNA binding;nucleic acid binding;mRNA processing;membrane;protein binding;positive regulation of transcription, DNA-templated;regulation of RNA metabolic process;ribonucleoprotein complex;regulation of mRNA splicing, via spliceosome	3D-structure;Alternative splicing;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing		
COQ7	positive	CYB5B	ENSG00000103018	COQ7	1	COQ7	1	0.00865557568115727	WBGene00007848;WBGene00020931;WBGene00014300	WBGene00007848(0)			GO:0020037;GO:0046872;GO:0016020;GO:0016021;GO:0055114;GO:0005739;GO:0005515;GO:0005741;GO:0006805	heme binding;membrane;integral component of membrane;metal ion binding;oxidation-reduction process;mitochondrion;positive regulation of catalytic activity;protein binding;mitochondrial outer membrane;xenobiotic metabolic process;enzyme activator activity;intracellular membrane-bounded organelle	3D-structure;Acetylation;Electron transport;Heme;Iron;Membrane;Metal-binding;Methylation;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-211859;R-HSA-211945	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
COQ7	positive	CLUAP1	ENSG00000103351	COQ7	1	COQ7	1	0.00865557568115727	WBGene00001119	WBGene00001119(1)			GO:0005634;GO:0043231;GO:0005654;GO:0042995;GO:0005515;GO:0005929;GO:0035735;GO:0030992;GO:0097542;GO:0030030;GO:0060271;GO:0005813	nucleus;intracellular membrane-bounded organelle;nucleoplasm;cell projection;protein binding;cilium;intraciliary transport involved in cilium assembly;intraciliary transport particle B;ciliary tip;cell projection organization;cilium assembly;centrosome	Alternative splicing;Cell projection;Cilium;Cilium biogenesis/degradation;Coiled coil;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-5620924	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
COQ7	positive	SNX16	ENSG00000104497	COQ7	1	COQ7	1	0.00865557568115727					GO:0005737;GO:0016020;GO:0015031;GO:0005829;GO:0043231;GO:0035091;GO:0008289;GO:0005764;GO:0005768;GO:0005769;GO:0031902;GO:0008333;GO:0045022;GO:0031313;GO:0031901;GO:0042802;GO:0005770;GO:0006622	phosphatidylinositol binding;cytoplasm;membrane;protein transport;cytosol;intracellular membrane-bounded organelle;endosome;identical protein binding;lipid binding;lysosome;early endosome;late endosome membrane;endosome to lysosome transport;early endosome to late endosome transport;extrinsic component of endosome membrane;early endosome membrane;late endosome;protein targeting to lysosome	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Endosome;Lipid-binding;Lysosome;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport		
COQ7	positive	AGFG2	ENSG00000106351	COQ7	1	COQ7	1	0.00865557568115727	WBGene00012359				GO:0046872;GO:0005096;GO:0043547;GO:0016020;GO:0003674;GO:0008150	metal ion binding;GTPase activator activity;positive regulation of GTPase activity;membrane;molecular_function;biological_process	Acetylation;Alternative splicing;Metal-binding;Polymorphism;Reference proteome;Repeat;Zinc;Zinc-finger		
COQ7	positive	COA1	ENSG00000106603	COQ7	1	COQ7	1	0.00865557568115727	WBGene00195063				GO:0016020;GO:0016021;GO:0005829;GO:0005739;GO:0005743;GO:0031305;GO:0032981;GO:0033617	membrane;integral component of membrane;cytosol;mitochondrion;mitochondrial inner membrane;integral component of mitochondrial inner membrane;mitochondrial respiratory chain complex I assembly;mitochondrial respiratory chain complex IV assembly	Membrane;Mitochondrion;Mitochondrion inner membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ7	positive	C2CD5	ENSG00000111731	COQ7	1	COQ7	1	0.00865557568115727	WBGene00018719				GO:0005737;GO:0016020;GO:0015031;GO:0005829;GO:0005886;GO:0042995;GO:0005815;GO:0031410;GO:0030659;GO:0005544;GO:0005509;GO:0008289;GO:0005938;GO:0032587;GO:0090314;GO:0001726;GO:0032869;GO:0010828;GO:0031340;GO:0038028;GO:0065002;GO:0006906;GO:0046326;GO:0072659	calcium-dependent phospholipid binding;cytoplasm;membrane;protein transport;cytosol;plasma membrane;cell projection;centriolar satellite;cytoplasmic vesicle;cytoplasmic vesicle membrane;lipid binding;calcium ion binding;positive regulation of protein targeting to membrane;cell cortex;ruffle membrane;ruffle;cellular response to insulin stimulus;protein localization to plasma membrane;positive regulation of glucose transmembrane transport;positive regulation of vesicle fusion;insulin receptor signaling pathway via phosphatidylinositol 3-kinase;intracellular protein transmembrane transport;vesicle fusion;positive regulation of glucose import	Alternative splicing;Calcium;Cell membrane;Cell projection;Cytoplasm;Cytoplasmic vesicle;Lipid-binding;Membrane;Metal-binding;Phosphoprotein;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-199991;R-HSA-1445148	Vesicle-mediated transport;Membrane Trafficking;Translocation of SLC2A4 (GLUT4) to the plasma membrane
COQ7	positive	HDDC2	ENSG00000111906	COQ7	1	COQ7	1	0.00865557568115727	WBGene00018481	WBGene00018481(1)			GO:0016311;GO:0005515;GO:0002953	dephosphorylation;protein binding;cytoplasm;5'-deoxynucleotidase activity	3D-structure;Acetylation;Alternative splicing;Cobalt;Hydrolase;Magnesium;Manganese;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome		
COQ7	positive	SENP6	ENSG00000112701	COQ7	1	COQ7	1	0.00865557568115727	WBGene00006739;WBGene00006737	WBGene00006739(0)			GO:0005634;GO:0005829;GO:0005654;GO:0016787;GO:0008233;GO:0008234;GO:0006508;GO:0005737;GO:0016926;GO:0005515;GO:0016925;GO:0090169;GO:0090234;GO:0070139;GO:0070646	proteolysis;cysteine-type peptidase activity;nucleus;nucleoplasm;cytosol;hydrolase activity;peptidase activity;protein binding;cytoplasm;protein desumoylation;protein sumoylation;regulation of spindle assembly;regulation of kinetochore assembly;SUMO-specific endopeptidase activity;protein modification by small protein removal	Alternative splicing;Hydrolase;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Protease;Reference proteome;Thiol protease;Ubl conjugation;Ubl conjugation pathway		
COQ7	positive	RXYLT1	ENSG00000118600	COQ7	1	COQ7	1	0.00865557568115727				Walker-Warburg syndrome;Severe Cobblestone Lissencephaly;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 10	GO:0016020;GO:0016021;GO:0005794;GO:0016740;GO:0005654;GO:0005515;GO:0000139;GO:0006486;GO:0035269;GO:0005887;GO:0120053	membrane;integral component of membrane;Golgi apparatus;transferase activity;nucleoplasm;protein binding;protein glycosylation;Golgi membrane;protein O-linked mannosylation;integral component of plasma membrane;ribitol beta-1,4-xylosyltransferase activity	Congenital muscular dystrophy;Disease mutation;Dystroglycanopathy;Golgi apparatus;Lissencephaly;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix		
COQ7	positive	RBMX2	ENSG00000134597	COQ7	1	COQ7	1	0.00865557568115727	WBGene00016245	WBGene00016245(1)			GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005515;GO:0005681;GO:0000398;GO:0005686;GO:0071005;GO:0000384	nucleic acid binding;RNA binding;mRNA processing;RNA splicing;nucleus;protein binding;spliceosomal complex;mRNA splicing, via spliceosome;U2 snRNP;U2-type precatalytic spliceosome;precatalytic spliceosome	3D-structure;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing		
COQ7	positive	VPS45	ENSG00000136631	COQ7	1	COQ7	1	0.00865557568115727	WBGene00016643	WBGene00016643(0)		Congenital neutropenia-myelofibrosis-nephromegaly syndrome;NEUTROPENIA SEVERE CONGENITAL 5 AUTOSOMAL RECESSIVE	GO:0016192;GO:0006904;GO:0016020;GO:0006886;GO:0015031;GO:0005794;GO:0005515;GO:0000139;GO:0005768;GO:0003674;GO:0005575;GO:0010008;GO:0007596;GO:0016021;GO:0008021	vesicle-mediated transport;vesicle docking involved in exocytosis;membrane;intracellular protein transport;protein transport;endosome;Golgi apparatus;protein binding;Golgi membrane;molecular_function;cellular_component;endosome membrane;blood coagulation;integral component of membrane;synaptic vesicle	Alternative splicing;Disease mutation;Endosome;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport	R-HSA-109582;R-HSA-5653656;R-HSA-199991;R-HSA-6811442;R-HSA-983231;R-HSA-6811438	Hemostasis;Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Factors involved in megakaryocyte development and platelet production;Intra-Golgi traffic
COQ7	positive	CARF	ENSG00000138380	COQ7	1	COQ7	1	0.00865557568115727					GO:0005634;GO:0003677;GO:0003700;GO:0061400;GO:0001228;GO:0071277;GO:0035865;GO:0000978;GO:0045944;GO:0051090;GO:0001652	DNA-binding transcription factor activity;positive regulation of transcription from RNA polymerase II promoter in response to calcium ion;nucleus;DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;cellular response to calcium ion;cellular response to potassium ion;RNA polymerase II cis-regulatory region sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II;regulation of DNA-binding transcription factor activity;granular component	Activator;Alternative splicing;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation		
COQ7	positive	INTS7	ENSG00000143493	COQ7	1	COQ7	1	0.00865557568115727	WBGene00008361	WBGene00008361(0)			GO:0016180;GO:0032039;GO:0005634;GO:0005737;GO:0005694;GO:0005515;GO:0006974;GO:0016604;GO:0005654;GO:0042795;GO:0000077;GO:0071479;GO:0034472	snRNA processing;integrator complex;nucleus;cytoplasm;chromosome;protein binding;cellular response to DNA damage stimulus;nuclear body;nucleoplasm;snRNA transcription by RNA polymerase II;DNA damage checkpoint;cellular response to ionizing radiation;snRNA 3'-end processing	Alternative splicing;Chromosome;Cytoplasm;DNA damage;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-73857;R-HSA-74160;R-HSA-6807505	RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes
COQ7	positive	CDKAL1	ENSG00000145996	COQ7	1	COQ7	1	0.00865557568115727	WBGene00022363;WBGene00017776	WBGene00022363(1)			GO:0008150;GO:0016020;GO:0016021;GO:0046872;GO:0016740;GO:0008033;GO:0005783;GO:0005789;GO:0003824;GO:0005515;GO:0006400;GO:0051536;GO:0051539;GO:0035596;GO:0035598;GO:0061712;GO:0035600;GO:1990145;GO:0005791	catalytic activity;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;transferase activity;tRNA modification;N6-threonylcarbomyladenosine methylthiotransferase activity;tRNA methylthiolation;methylthiotransferase activity;biological_process;membrane;integral component of membrane;metal ion binding;tRNA processing;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase;maintenance of translational fidelity;rough endoplasmic reticulum	4Fe-4S;Alternative splicing;Diabetes mellitus;Endoplasmic reticulum;Iron;Iron-sulfur;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase;Transmembrane;Transmembrane helix;tRNA processing	R-HSA-6782315;R-HSA-72306;R-HSA-8953854	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
COQ7	positive	MRRF	ENSG00000148187	COQ7	1	COQ7	1	0.00865557568115727	WBGene00020625	WBGene00020625(0)			GO:0006412;GO:0005739;GO:0032790;GO:0043023;GO:0005759;GO:0070126	translation;mitochondrion;ribosome disassembly;ribosomal large subunit binding;mitochondrial matrix;mitochondrial translational termination	3D-structure;Alternative splicing;Mitochondrion;Polymorphism;Protein biosynthesis;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368287;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation;Mitochondrial translation termination
COQ7	positive	PDSS1	ENSG00000148459	COQ7	1	COQ7	1	0.00865557568115727	WBGene00000761	WBGene00000761(0)		Deafness-encephaloneuropathy-obesity-valvulopathy syndrome;COENZYME Q10 DEFICIENCY PRIMARY 2;COENZYME Q10 DEFICIENCY PRIMARY 2	GO:0046872;GO:0016740;GO:0005739;GO:0008299;GO:0006744;GO:0005759;GO:1990234;GO:0046982;GO:0000010;GO:0050347	isoprenoid biosynthetic process;metal ion binding;transferase activity;mitochondrion;ubiquinone biosynthetic process;mitochondrial matrix;protein binding;transferase complex;trans-hexaprenyltranstransferase activity;protein heterodimerization activity;trans-octaprenyltranstransferase activity	Alternative splicing;Disease mutation;Isoprene biosynthesis;Magnesium;Metal-binding;Mitochondrion;Primary mitochondrial disease;Reference proteome;Transferase;Ubiquinone biosynthesis	R-HSA-1430728;R-HSA-196854;R-HSA-2142789;R-HSA-8978934	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
COQ7	positive	IMPACT	ENSG00000154059	COQ7	1	COQ7	1	0.00865557568115727	WBGene00013122	WBGene00013122(1)			GO:0005737;GO:0003779;GO:0030154;GO:0007399;GO:0000122;GO:0003674;GO:0008150;GO:0005575;GO:0006417;GO:0001933;GO:0031333;GO:0070301;GO:0042149;GO:0060548;GO:0034198;GO:0005844;GO:0097201;GO:0045666;GO:0071468;GO:1990138;GO:1990253;GO:0031953;GO:0071494;GO:0060733;GO:0071264;GO:0043022;GO:0006446;GO:0072755;GO:0005515	protein binding;cytoplasm;actin binding;cell differentiation;nervous system development;negative regulation of transcription by RNA polymerase II;molecular_function;biological_process;cellular_component;regulation of translation;negative regulation of protein phosphorylation;negative regulation of protein-containing complex assembly;cellular response to hydrogen peroxide;cellular response to glucose starvation;negative regulation of cell death;cellular response to amino acid starvation;polysome;negative regulation of transcription from RNA polymerase II promoter in response to stress;positive regulation of neuron differentiation;cellular response to acidic pH;neuron projection extension;cellular response to leucine starvation;negative regulation of protein autophosphorylation;cellular response to UV-C;regulation of eIF2 alpha phosphorylation by amino acid starvation;positive regulation of translational initiation in response to starvation;ribosome binding;regulation of translational initiation;cellular response to benomyl	Actin-binding;Alternative splicing;Cytoplasm;Differentiation;Neurogenesis;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Stress response;Translation regulation		
COQ7	positive	RWDD2B	ENSG00000156253	COQ7	1	COQ7	1	0.00865557568115727					GO:0005515;GO:0003674;GO:0008150;GO:0005575	protein binding;molecular_function;biological_process;cellular_component	3D-structure;Phosphoprotein;Reference proteome		
COQ7	positive	TBC1D31	ENSG00000156787	COQ7	1	COQ7	1	0.00865557568115727					GO:0005515;GO:0005813	protein binding;centrosome	Alternative splicing;Coiled coil;Polymorphism;Reference proteome;Repeat;WD repeat		
COQ7	positive	OXR1	ENSG00000164830	COQ7	1	COQ7	1	0.00865557568115727	WBGene00018700				GO:0043231;GO:0005654;GO:0005739;GO:0055114;GO:0003674;GO:0006979;GO:0016491;GO:0007628;GO:0043524;GO:0051402;GO:0071447;GO:1900408;GO:1902083;GO:1903204;GO:0005730	mitochondrion;oxidation-reduction process;molecular_function;response to oxidative stress;oxidoreductase activity;adult walking behavior;negative regulation of neuron apoptotic process;neuron apoptotic process;cellular response to hydroperoxide;negative regulation of cellular response to oxidative stress;negative regulation of peptidyl-cysteine S-nitrosylation;negative regulation of oxidative stress-induced neuron death;nucleolus	Alternative splicing;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Stress response		
COQ7	positive	ZNF16	ENSG00000170631	COQ7	1	COQ7	1	0.00865557568115727	WBGene00021931;WBGene00001223				GO:0003676;GO:0005634;GO:0046872;GO:0043066;GO:0005730;GO:0003677;GO:0051301;GO:0005515;GO:0007049;GO:0006357;GO:0000981;GO:0051781;GO:0008284;GO:0045648;GO:0033674;GO:0045654;GO:0072707;GO:1901989	nucleic acid binding;nucleus;metal ion binding;negative regulation of apoptotic process;nucleoplasm;nucleolus;DNA binding;cell division;protein binding;cell cycle;positive regulation of cell division;positive regulation of cell population proliferation;positive regulation of erythrocyte differentiation;positive regulation of kinase activity;positive regulation of megakaryocyte differentiation;cellular response to sodium dodecyl sulfate;positive regulation of cell cycle phase transition	Acetylation;Activator;Cell cycle;Cell division;DNA-binding;Isopeptide bond;Metal-binding;Mitogen;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ7	positive	BCLAF3	ENSG00000173681	COQ7	1	COQ7	1	0.00865557568115727					GO:0005739	mitochondrion	Alternative splicing;Isopeptide bond;Mitochondrion;Phosphoprotein;Reference proteome;Ubl conjugation		
COQ7	positive	PAAF1	ENSG00000175575	COQ7	1	COQ7	1	0.00865557568115727	WBGene00021467	WBGene00021467(0)			GO:0005515;GO:0000502;GO:0016032;GO:0016020;GO:0016021	protein binding;proteasome complex;viral process;membrane;integral component of membrane	Acetylation;Alternative splicing;Host-virus interaction;Polymorphism;Proteasome;Reference proteome;Repeat;WD repeat		
COQ7	positive	CEP63	ENSG00000182923	COQ7	1	COQ7	1	0.00865557568115727				Autosomal recessive primary microcephaly;SECKEL SYNDROME 6;SECKEL SYNDROME 6	GO:0005737;GO:0051301;GO:0005856;GO:0005515;GO:0006974;GO:0007049;GO:0000922;GO:0005813;GO:0005815;GO:0005829;GO:0005814;GO:0000086;GO:0010389;GO:0097711;GO:0007099;GO:0000077;GO:0051225;GO:0042770;GO:0098535	cytoplasm;cytoskeleton;cell division;protein binding;cellular response to DNA damage stimulus;cell cycle;spindle pole;centrosome;microtubule organizing center;cytosol;centriole;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;centriole replication;DNA damage checkpoint;spindle assembly;signal transduction in response to DNA damage;de novo centriole assembly involved in multi-ciliated epithelial cell differentiation	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;DNA damage;Dwarfism;Mental retardation;Mitosis;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518	Organelle biogenesis and maintenance;Cilium Assembly;Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2
COQ7	positive	SMYD4	ENSG00000186532	COQ7	1	COQ7	1	0.00865557568115727		WBGene00044070(0)			GO:0046872;GO:0016740;GO:0008168;GO:0032259;GO:0005515	protein binding;metal ion binding;transferase activity;methyltransferase activity;methylation	Metal-binding;Methyltransferase;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase;Zinc;Zinc-finger		
COQ7	positive	ZSCAN25	ENSG00000197037	COQ7	1	COQ7	1	0.00865557568115727	WBGene00013970				GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0003700;GO:0005622	nucleic acid binding;nucleus;metal ion binding;regulation of transcription, DNA-templated;DNA binding;DNA-binding transcription factor activity	Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ7	positive	BBIP1	ENSG00000214413	COQ7	1	COQ7	1	0.00865557568115727				Bardet-Biedl syndrome;Bardet-Biedl syndrome 18	GO:0005737;GO:0015031;GO:0042995;GO:0005515;GO:0060271;GO:0034464;GO:0005929;GO:0005829;GO:0030030;GO:0097500	BBSome;cilium assembly;cytoplasm;protein transport;cell projection;protein binding;cilium;cytosol;cell projection organization;receptor localization to non-motile cilium	Alternative splicing;Bardet-Biedl syndrome;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Cytoplasm;Obesity;Protein transport;Reference proteome;Transport	R-HSA-1852241;R-HSA-5617833;R-HSA-5620920;R-HSA-5620922	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
COQ7	negative	ECM1	ENSG00000143369	COQ7	1	COQ7	1	7.09800392346693e-05				Lipoid proteinosis;LIPOID PROTEINOSIS OF URBACH AND WIETHE	GO:0005615;GO:0007165;GO:0005576;GO:0043236;GO:0005515;GO:0010466;GO:0070062;GO:0031214;GO:0062023;GO:0030500;GO:0008022;GO:0001525;GO:0043123;GO:0001503;GO:0019899;GO:0002576;GO:0002020;GO:0005201;GO:0031012;GO:0045766;GO:0001938;GO:0031089;GO:0030502;GO:0005134;GO:0001960;GO:0002063;GO:0002828;GO:0003416;GO:0006357;GO:0006954;GO:2000404	extracellular region;signal transduction;extracellular space;protein binding;laminin binding;negative regulation of peptidase activity;extracellular exosome;biomineral tissue development;collagen-containing extracellular matrix;regulation of bone mineralization;protein C-terminus binding;angiogenesis;positive regulation of I-kappaB kinase/NF-kappaB signaling;ossification;enzyme binding;platelet degranulation;protease binding;extracellular matrix structural constituent;extracellular matrix;positive regulation of angiogenesis;positive regulation of endothelial cell proliferation;platelet dense granule lumen;negative regulation of bone mineralization;interleukin-2 receptor binding;negative regulation of cytokine-mediated signaling pathway;chondrocyte development;regulation of type 2 immune response;endochondral bone growth;regulation of transcription by RNA polymerase II;inflammatory response;regulation of T cell migration	Alternative splicing;Angiogenesis;Biomineralization;Disease mutation;Extracellular matrix;Glycoprotein;Mineral balance;Osteogenesis;Polymorphism;Reference proteome;Repeat;Secreted;Signal	R-HSA-109582;R-HSA-76002;R-HSA-76005;R-HSA-114608	Hemostasis;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation 
COQ7	negative	IDS	ENSG00000010404	COQ7	1	COQ7	1	0.000199170372272017				Mucopolysaccharidosis type 2 attenuated form;Mucopolysaccharidosis type 2 severe form;MUCOPOLYSACCHARIDOSIS TYPE 2;MUCOPOLYSACCHARIDOSIS TYPE II	GO:0046872;GO:0016787;GO:0003824;GO:0008484;GO:0005764;GO:0004423;GO:0043202;GO:0006027;GO:0030207	catalytic activity;sulfuric ester hydrolase activity;iduronate-2-sulfatase activity;metal ion binding;hydrolase activity;calcium ion binding;lysosome;lysosomal lumen;glycosaminoglycan catabolic process;chondroitin sulfate catabolic process	3D-structure;Alternative splicing;Calcium;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Hydrolase;Lysosome;Metal-binding;Mucopolysaccharidosis;Reference proteome;Signal;Zymogen	R-HSA-1430728;R-HSA-1643685;R-HSA-71387;R-HSA-1630316;R-HSA-1638091;R-HSA-1793185;R-HSA-2024096;R-HSA-2024101;R-HSA-5668914;R-HSA-5663084;R-HSA-2206281;R-HSA-2206296	Metabolism;Disease;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;HS-GAG degradation;CS/DS degradation;Diseases of metabolism;Diseases of carbohydrate metabolism;Mucopolysaccharidoses;MPS II - Hunter syndrome
COQ7	negative	FXYD5	ENSG00000089327	COQ7	1	COQ7	1	0.000199170372272017					GO:0016020;GO:0006811;GO:0099106;GO:0043269;GO:0016021;GO:0003779;GO:0017080;GO:2000649;GO:0005515;GO:0045296;GO:0030033;GO:0046588	membrane;ion channel regulator activity;regulation of ion transport;ion transport;integral component of membrane;actin binding;sodium channel regulator activity;regulation of sodium ion transmembrane transporter activity;protein binding;cadherin binding;microvillus assembly;negative regulation of calcium-dependent cell-cell adhesion	Alternative splicing;Glycoprotein;Ion channel;Ion transport;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix;Transport		
COQ7	negative	EPS8L1	ENSG00000131037	COQ7	1	COQ7	1	0.000199170372272017	WBGene00001330	WBGene00001330(0)			GO:0005515;GO:0005737;GO:0005829;GO:0003779;GO:0005886;GO:0045296;GO:0070062;GO:0032587;GO:0032991;GO:0007266;GO:0005089;GO:0030676;GO:0042608;GO:0035023;GO:1900029;GO:0016301;GO:0016310	protein binding;cytoplasm;cytosol;actin binding;plasma membrane;cadherin binding;extracellular exosome;ruffle membrane;protein-containing complex;Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;Rac guanyl-nucleotide exchange factor activity;regulation of Rho protein signal transduction;T cell receptor binding;positive regulation of ruffle assembly;kinase activity;phosphorylation	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Phosphoprotein;Polymorphism;Reference proteome;SH3 domain		
COQ7	negative	CCDC85B	ENSG00000175602	COQ7	1	COQ7	1	0.000199170372272017	WBGene00017931	WBGene00017931(0)			GO:0005634;GO:0005737;GO:0005856;GO:0005515;GO:0030154;GO:0005813;GO:0005815;GO:0040008;GO:0030308;GO:0045892;GO:0045599	nucleus;cytoplasm;cytoskeleton;protein binding;cell junction;cell differentiation;centrosome;microtubule organizing center;regulation of growth;adherens junction;viral process;negative regulation of cell growth;negative regulation of transcription, DNA-templated;negative regulation of fat cell differentiation	Acetylation;Cell junction;Coiled coil;Cytoplasm;Cytoskeleton;Differentiation;Growth regulation;Host-virus interaction;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation		
COQ7	negative	CDR2L	ENSG00000109089	COQ7	1	COQ7	1	0.000325521408673035					GO:0005515	protein binding	Coiled coil;Phosphoprotein;Polymorphism;Reference proteome		
COQ7	negative	RALBP1	ENSG00000017797	COQ7	1	COQ7	1	0.000523406522363823	WBGene00011970	WBGene00011970(0)			GO:0016020;GO:0007165;GO:0007264;GO:0005096;GO:0005515;GO:0043547;GO:0017160;GO:0005829;GO:0051056;GO:0006897;GO:0006935;GO:0042910;GO:1990961;GO:0042626;GO:0055085;GO:0043087;GO:0048365;GO:0022857;GO:1900753	signal transduction;GTPase activator activity;small GTPase mediated signal transduction;Ral GTPase binding;membrane;protein binding;positive regulation of GTPase activity;cytosol;regulation of small GTPase mediated signal transduction;endocytosis;chemotaxis;xenobiotic transmembrane transporter activity;xenobiotic detoxification by transmembrane export across the plasma membrane;ATPase-coupled transmembrane transporter activity;transmembrane transport;regulation of GTPase activity;Rac GTPase binding;transmembrane transporter activity;doxorubicin transport	3D-structure;Acetylation;Direct protein sequencing;GTPase activation;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transport	R-HSA-162582;R-HSA-194315;R-HSA-194840	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
COQ7	negative	CD82	ENSG00000085117	COQ7	1	COQ7	1	0.000523406522363823	WBGene00006634;WBGene00006637				GO:0016020;GO:0016021;GO:0005886;GO:0005515;GO:0005887;GO:0070062	integral component of membrane;membrane;plasma membrane;protein binding;integral component of plasma membrane;extracellular exosome	Alternative splicing;Cell membrane;Glycoprotein;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ7	negative	IP6K1	ENSG00000176095	COQ7	1	COQ7	1	0.000523406522363823	WBGene00009262;WBGene00020631;WBGene00021260	WBGene00002979(0);WBGene00009262(0)			GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005829;GO:0001650;GO:0032958;GO:0005515;GO:0000832;GO:0052723;GO:0052724;GO:0005654;GO:0120163;GO:0043647;GO:0046854;GO:0000828	kinase activity;inositol phosphate biosynthetic process;nucleus;cytoplasm;nucleotide binding;ATP binding;transferase activity;phosphorylation;nucleoplasm;cytosol;fibrillar center;protein binding;inositol hexakisphosphate 5-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol hexakisphosphate 3-kinase activity;negative regulation of cold-induced thermogenesis;inositol phosphate metabolic process;phosphatidylinositol phosphorylation;inositol hexakisphosphate kinase activity	ATP-binding;Alternative splicing;Cytoplasm;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase	R-HSA-1430728;R-HSA-1483249;R-HSA-1855167;R-HSA-1855191	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol;Synthesis of IPs in the nucleus
COQ7	negative	SMTN	ENSG00000183963	COQ7	1	COQ7	1	0.000523406522363823	WBGene00020530				GO:0005623;GO:0032456;GO:0017137;GO:0005737;GO:0005856;GO:0005815;GO:0030036;GO:0031941;GO:0015629;GO:0003779;GO:0007517;GO:0008307;GO:0006939;GO:0005515;GO:0003085;GO:0060452	Rab GTPase binding;endocytic recycling;protein binding;cytoplasm;cytoskeleton;microtubule organizing center;actin cytoskeleton organization;filamentous actin;actin cytoskeleton;actin binding;muscle organ development;structural constituent of muscle;smooth muscle contraction;negative regulation of systemic arterial blood pressure;positive regulation of cardiac muscle contraction	3D-structure;Acetylation;Alternative promoter usage;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome		
COQ7	negative	BCR	ENSG00000186716	COQ7	1	COQ7	1	0.000523406522363823				Chronic myeloid leukemia;Distal 22q11.2 microdeletion syndrome;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia;LEUKEMIA ACUTE LYMPHOBLASTIC;LEUKEMIA CHRONIC MYELOID	GO:0016020;GO:0000166;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0035556;GO:0007165;GO:0005886;GO:0005085;GO:0005089;GO:0005096;GO:0035023;GO:0042995;GO:0005515;GO:0030054;GO:0045202;GO:0045211;GO:0043547;GO:0030424;GO:0005829;GO:0070062;GO:0051056;GO:0090630;GO:0014069;GO:0043197;GO:0032991;GO:0048041;GO:0030216;GO:0019899;GO:0002692;GO:0003014;GO:0007264;GO:0007420;GO:0030036;GO:0030336;GO:0032496;GO:0042472;GO:0043114;GO:0043314;GO:0046777;GO:0048008;GO:0048872;GO:0050728;GO:0050766;GO:0050804;GO:0050885;GO:0051171;GO:0051726;GO:0060216;GO:0060268;GO:0060313;GO:0065002;GO:0071222;GO:2000378;GO:0005737;GO:0098685;GO:0098978;GO:0099092	signal transduction;guanyl-nucleotide exchange factor activity;protein phosphorylation;GTPase activator activity;intracellular signal transduction;protein serine/threonine kinase activity;positive regulation of GTPase activity;membrane;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;cell projection;protein binding;cell junction;synapse;axon;cytosol;extracellular exosome;regulation of small GTPase mediated signal transduction;activation of GTPase activity;postsynaptic density;dendritic spine;protein-containing complex;focal adhesion assembly;keratinocyte differentiation;Rho guanyl-nucleotide exchange factor activity;regulation of Rho protein signal transduction;enzyme binding;negative regulation of cellular extravasation;renal system process;small GTPase mediated signal transduction;brain development;actin cytoskeleton organization;negative regulation of cell migration;response to lipopolysaccharide;inner ear morphogenesis;regulation of vascular permeability;negative regulation of neutrophil degranulation;protein autophosphorylation;platelet-derived growth factor receptor signaling pathway;homeostasis of number of cells;negative regulation of inflammatory response;positive regulation of phagocytosis;modulation of chemical synaptic transmission;neuromuscular process controlling balance;regulation of nitrogen compound metabolic process;regulation of cell cycle;definitive hemopoiesis;negative regulation of respiratory burst;negative regulation of blood vessel remodeling;intracellular protein transmembrane transport;cellular response to lipopolysaccharide;negative regulation of reactive oxygen species metabolic process;cytoplasm;plasma membrane;Schaffer collateral - CA1 synapse;glutamatergic synapse;postsynaptic density, intracellular component	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell junction;Cell projection;Chromosomal rearrangement;GTPase activation;Guanine-nucleotide releasing factor;Kinase;Methylation;Nucleotide-binding;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Serine/threonine-protein kinase;Synapse;Transferase	R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-1643685;R-HSA-5663202;R-HSA-1226099;R-HSA-1839117;R-HSA-1839124;R-HSA-5655302	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Disease;Diseases of signal transduction;Signaling by FGFR in disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease
COQ7	negative	R3HDM4	ENSG00000198858	COQ7	1	COQ7	1	0.000523406522363823	WBGene00012908	WBGene00012908(0)			GO:0003676;GO:0005634	nucleic acid binding;nucleus	Nucleus;Reference proteome		
COQ7	negative	AMPD2	ENSG00000116337	COQ7	1	COQ7	1	0.000827997489282084	WBGene00016415	WBGene00016415(0)		Autosomal recessive spastic paraplegia type 63;Pontocerebellar hypoplasia type 9;Pontocerebellar hypoplasia;PONTOCEREBELLAR HYPOPLASIA TYPE 9;Spastic paraplegia 63 autosomal recessive	GO:0003876;GO:0032264;GO:0046872;GO:0005829;GO:0016787;GO:0019239;GO:0009168;GO:0005515;GO:0009117;GO:0043101;GO:0006188;GO:0046033;GO:0052652;GO:0097009	AMP deaminase activity;IMP salvage;deaminase activity;purine ribonucleoside monophosphate biosynthetic process;metal ion binding;cytosol;hydrolase activity;protein binding;nucleotide metabolic process;purine-containing compound salvage;IMP biosynthetic process;AMP metabolic process;cyclic purine nucleotide metabolic process;energy homeostasis	3D-structure;Alternative splicing;Disease mutation;Hereditary spastic paraplegia;Hydrolase;Metal-binding;Methylation;Neurodegeneration;Nucleotide metabolism;Phosphoprotein;Polymorphism;Reference proteome;Zinc	R-HSA-1430728;R-HSA-15869;R-HSA-8956321;R-HSA-74217	Metabolism;Metabolism of nucleotides;Nucleotide salvage;Purine salvage
COQ7	negative	GAMT	ENSG00000130005	COQ7	1	COQ7	1	0.000827997489282084				GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY;GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY;CEREBRAL CREATINE DEFICIENCY SYNDROME 2	GO:0016740;GO:0008168;GO:0032259;GO:0005634;GO:0005737;GO:0030731;GO:0005829;GO:0006936;GO:0006600;GO:0008757;GO:0006601;GO:0007283;GO:0009887;GO:0040014	guanidinoacetate N-methyltransferase activity;transferase activity;methyltransferase activity;methylation;nucleus;cytoplasm;cytosol;muscle contraction;creatine metabolic process;S-adenosylmethionine-dependent methyltransferase activity;creatine biosynthetic process;spermatogenesis;animal organ morphogenesis;regulation of multicellular organism growth	3D-structure;Acetylation;Alternative splicing;Disease mutation;Methyltransferase;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-71291;R-HSA-8986944;R-HSA-71288	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of amino acids and derivatives;Transcriptional Regulation by MECP2;Creatine metabolism
COQ7	negative	NES	ENSG00000132688	COQ7	1	COQ7	1	0.000827997489282084					GO:0045111;GO:0005515;GO:0005882;GO:0007275;GO:0007399;GO:0003674;GO:2000179;GO:0019215;GO:0007420;GO:0032091;GO:0043086;GO:0007417;GO:0000086;GO:0072089;GO:0005737;GO:0031076;GO:0030844;GO:0043524;GO:0048858	intermediate filament binding;intermediate filament cytoskeleton;protein binding;intermediate filament;multicellular organism development;nervous system development;molecular_function;positive regulation of neural precursor cell proliferation;brain development;negative regulation of protein binding;negative regulation of catalytic activity;central nervous system development;G2/M transition of mitotic cell cycle;stem cell proliferation;cytoplasm;embryonic camera-type eye development;positive regulation of intermediate filament depolymerization	Acetylation;Coiled coil;Developmental protein;Intermediate filament;Isopeptide bond;Neurogenesis;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation		
COQ7	negative	CCS	ENSG00000173992	COQ7	1	COQ7	1	0.000827997489282084	WBGene00004930;WBGene00007036				GO:0005634;GO:0005737;GO:0046872;GO:0055114;GO:0005515;GO:0030001;GO:0005507;GO:0006801;GO:0005829;GO:0045296;GO:0015035;GO:0016532;GO:0015680;GO:0019430;GO:0034599;GO:0051353;GO:0004784	metal ion binding;oxidation-reduction process;metal ion transport;superoxide dismutase activity;superoxide metabolic process;nucleus;cytoplasm;protein binding;copper ion binding;cytosol;cadherin binding;protein disulfide oxidoreductase activity;superoxide dismutase copper chaperone activity;protein maturation by copper ion transfer;removal of superoxide radicals;cellular response to oxidative stress;positive regulation of oxidoreductase activity	3D-structure;Chaperone;Copper;Cytoplasm;Disulfide bond;Isopeptide bond;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc	R-HSA-2262752;R-HSA-8953897;R-HSA-3299685	Cellular responses to stress;Cellular responses to external stimuli;Detoxification of Reactive Oxygen Species
COQ7	negative	CTDNEP1	ENSG00000175826	COQ7	1	COQ7	1	0.000827997489282084	WBGene00018474	WBGene00018474(1)			GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0016787;GO:0004721;GO:0005515;GO:0005811;GO:0016791;GO:0005635;GO:0031965;GO:0006470;GO:0004722;GO:0006998;GO:0034504;GO:0007077;GO:0007276;GO:0007498;GO:0010867;GO:0090263;GO:0071595;GO:0016311	phosphatase activity;dephosphorylation;lipid droplet;nucleus;cytoplasm;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;hydrolase activity;phosphoprotein phosphatase activity;protein binding;nuclear envelope;nuclear membrane;protein dephosphorylation;protein serine/threonine phosphatase activity;nuclear envelope organization;protein localization to nucleus;mitotic nuclear envelope disassembly;gamete generation;mesoderm development;positive regulation of triglyceride biosynthetic process;positive regulation of canonical Wnt signaling pathway;Nem1-Spo7 phosphatase complex	Endoplasmic reticulum;Hydrolase;Membrane;Nucleus;Polymorphism;Protein phosphatase;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-2980766;R-HSA-68875;R-HSA-4419969	Cell Cycle;M Phase;Cell Cycle, Mitotic;Nuclear Envelope Breakdown;Mitotic Prophase;Depolymerisation of the Nuclear Lamina
COQ7	negative	RGCC	ENSG00000102760	COQ7	1	COQ7	1	0.00128877417972895					GO:0010628;GO:0043537;GO:2000353;GO:1900087;GO:0008285;GO:0001937;GO:0016525;GO:0051091;GO:0071158;GO:0010718;GO:0045944;GO:0005737;GO:0071456;GO:0005634;GO:0005730;GO:0005856;GO:0007049;GO:0051726;GO:0005815;GO:0032147;GO:0006977;GO:0005829;GO:0005515;GO:0019901;GO:0070412;GO:0051496;GO:0005813;GO:0050710;GO:0045840;GO:0045737;GO:0032967;GO:2000048;GO:0006956;GO:0050715;GO:0030295;GO:0071850;GO:1901203;GO:0001100;GO:0003331;GO:0072537;GO:0090272;GO:1901991;GO:2000573	regulation of cell cycle;positive regulation of gene expression;negative regulation of blood vessel endothelial cell migration;positive regulation of endothelial cell apoptotic process;positive regulation of G1/S transition of mitotic cell cycle;negative regulation of cell population proliferation;negative regulation of endothelial cell proliferation;negative regulation of angiogenesis;positive regulation of DNA-binding transcription factor activity;positive regulation of cell cycle arrest;positive regulation of epithelial to mesenchymal transition;positive regulation of transcription by RNA polymerase II;cytoplasm;cellular response to hypoxia;nucleus;negative regulation of fibroblast growth factor production;nucleoplasm;nucleolus;cytoskeleton;cell cycle;microtubule organizing center;activation of protein kinase activity;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cytosol;protein binding;protein kinase binding;R-SMAD binding;positive regulation of stress fiber assembly;centrosome;negative regulation of cytokine secretion;positive regulation of mitotic nuclear division;positive regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of collagen biosynthetic process;negative regulation of cell-cell adhesion mediated by cadherin;complement activation;positive regulation of cytokine secretion;protein kinase activator activity;mitotic cell cycle arrest;positive regulation of extracellular matrix assembly;negative regulation of exit from mitosis;positive regulation of extracellular matrix constituent secretion;fibroblast activation;negative regulation of mitotic cell cycle phase transition;positive regulation of DNA biosynthetic process	Alternative splicing;Cell cycle;Cytoplasm;Cytoskeleton;Nucleus;Phosphoprotein;Reference proteome	R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-6804115	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
COQ7	negative	NME4	ENSG00000103202	COQ7	1	COQ7	1	0.00128877417972895	WBGene00009119				GO:0016020;GO:0046872;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005739;GO:0005759;GO:0005515;GO:0006869;GO:0004550;GO:0006165;GO:0006183;GO:0006228;GO:0006241;GO:0009117;GO:0008289;GO:0005758;GO:0005743;GO:1901612;GO:0006163;GO:0006220;GO:0009116;GO:0015949	nucleoside diphosphate kinase activity;nucleoside diphosphate phosphorylation;GTP biosynthetic process;UTP biosynthetic process;CTP biosynthetic process;membrane;metal ion binding;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;mitochondrion;mitochondrial matrix;protein binding;lipid transport;lipid binding;nucleotide metabolic process;mitochondrial intermembrane space;regulation of apoptotic process;mitochondrial inner membrane;cardiolipin binding;purine nucleotide metabolic process;pyrimidine nucleotide metabolic process;nucleoside metabolic process;nucleobase-containing small molecule interconversion	3D-structure;ATP-binding;Alternative splicing;Direct protein sequencing;Kinase;Lipid transport;Lipid-binding;Magnesium;Membrane;Metal-binding;Mitochondrion;Nucleotide metabolism;Nucleotide-binding;Reference proteome;Transferase;Transit peptide;Transport	R-HSA-1430728;R-HSA-15869;R-HSA-499943	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
COQ7	negative	PLIN3	ENSG00000105355	COQ7	1	COQ7	1	0.00128877417972895					GO:0005737;GO:0016020;GO:0005829;GO:0005515;GO:0005811;GO:0005768;GO:0045296;GO:0010008;GO:0005794;GO:0030133;GO:0016192	cytoplasm;membrane;cytosol;endosome;protein binding;lipid droplet;cadherin binding;endosome membrane;Golgi apparatus;transport vesicle;vesicle-mediated transport	Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Endosome;Isopeptide bond;Lipid droplet;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transport;Ubl conjugation	R-HSA-5653656;R-HSA-1430728;R-HSA-556833;R-HSA-199991;R-HSA-6811442;R-HSA-9612973;R-HSA-9615710;R-HSA-163560;R-HSA-8979227;R-HSA-6811440;R-HSA-9613354;R-HSA-9613829	Vesicle-mediated transport;Metabolism;Metabolism of lipids;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Autophagy;Late endosomal microautophagy;Triglyceride catabolism;Triglyceride metabolism;Retrograde transport at the Trans-Golgi-Network;Lipophagy;Chaperone Mediated Autophagy
COQ7	negative	EMILIN1	ENSG00000138080	COQ7	1	COQ7	1	0.00128877417972895				EMILIN-1-related connective tissue disease	GO:0010628;GO:0010629;GO:0016525;GO:0070373;GO:0032966;GO:0030512;GO:1904027;GO:0060394;GO:1905522;GO:0007155;GO:0005615;GO:0005515;GO:0005576;GO:0005581;GO:0042802;GO:0070062;GO:0062023;GO:0005201;GO:0030948;GO:0070207;GO:0003180;GO:0030023;GO:0048251;GO:1901203;GO:0098640;GO:0007160;GO:0010811;GO:0016477;GO:0030198;GO:0050866;GO:0031012;GO:0034668;GO:1990971	protein binding;positive regulation of gene expression;negative regulation of gene expression;negative regulation of angiogenesis;negative regulation of ERK1 and ERK2 cascade;negative regulation of vascular endothelial growth factor receptor signaling pathway;negative regulation of collagen biosynthetic process;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of collagen fibril organization;negative regulation of pathway-restricted SMAD protein phosphorylation;negative regulation of macrophage migration;cell adhesion;extracellular space;extracellular region;collagen trimer;identical protein binding;extracellular exosome;collagen-containing extracellular matrix;extracellular matrix structural constituent;aortic valve morphogenesis;extracellular matrix constituent conferring elasticity;elastic fiber assembly;positive regulation of extracellular matrix assembly;integrin binding involved in cell-matrix adhesion;cell-matrix adhesion;positive regulation of cell-substrate adhesion;cell migration;extracellular matrix organization;negative regulation of cell activation;extracellular matrix;integrin alpha4-beta1 complex;EMILIN complex	3D-structure;Alternative splicing;Cell adhesion;Coiled coil;Collagen;Disulfide bond;Extracellular matrix;Glycoprotein;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-1474244;R-HSA-1566948;R-HSA-2129379	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
COQ7	negative	VPS37B	ENSG00000139722	COQ7	1	COQ7	1	0.00128877417972895	WBGene00016990;WBGene00016991				GO:0005737;GO:0016020;GO:0015031;GO:0005886;GO:0005515;GO:0000813;GO:0032509;GO:0030496;GO:0005768;GO:0031902;GO:0043231;GO:0070062;GO:0048306;GO:0006612;GO:0006623;GO:0016197;GO:0016236;GO:0019058;GO:0036258;GO:0039702;GO:0043162;GO:0075733;GO:0010008;GO:0043657;GO:1902188;GO:1903774	endosome transport via multivesicular body sorting pathway;ESCRT I complex;cytoplasm;membrane;protein transport;endosome;plasma membrane;protein binding;midbody;late endosome membrane;intracellular membrane-bounded organelle;extracellular exosome;calcium-dependent protein binding;protein targeting to membrane;protein targeting to vacuole;endosomal transport;macroautophagy;viral life cycle;multivesicular body assembly;viral budding via host ESCRT complex;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;intracellular transport of virus;endosome membrane;host cell;positive regulation of viral release from host cell;positive regulation of viral budding via host ESCRT complex	Endosome;Membrane;Methylation;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-199991;R-HSA-1643685;R-HSA-162587;R-HSA-162588;R-HSA-162599;R-HSA-162906;R-HSA-174490;R-HSA-174495;R-HSA-175474;R-HSA-5663205;R-HSA-917729;R-HSA-9612973;R-HSA-9615710	Vesicle-mediated transport;Membrane Trafficking;Disease;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);Autophagy;Late endosomal microautophagy
COQ7	negative	EML3	ENSG00000149499	COQ7	1	COQ7	1	0.00128877417972895	WBGene00001248				GO:0005515;GO:0005737;GO:0005856;GO:0005874;GO:0000226;GO:0072686;GO:0008017	protein binding;cytoplasm;cytoskeleton;microtubule;microtubule cytoskeleton organization;mitotic spindle;microtubule binding	Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Microtubule;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat		
COQ7	negative	CCDC28B	ENSG00000160050	COQ7	1	COQ7	1	0.00128877417972895				BARDET-BIEDL SYNDROME 1	GO:0005737;GO:0005856;GO:0005515;GO:0005813;GO:0005815;GO:0060271;GO:0030030	cytoplasm;cytoskeleton;protein binding;centrosome;microtubule organizing center;cilium assembly;cell projection organization	Acetylation;Alternative splicing;Bardet-Biedl syndrome;Ciliopathy;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Obesity;Phosphoprotein;Polymorphism;Reference proteome		
COQ7	negative	LAPTM5	ENSG00000162511	COQ7	1	COQ7	1	0.00128877417972895					GO:0016020;GO:0016021;GO:0005765;GO:0005764;GO:0005515;GO:0005887;GO:1990830	integral component of membrane;lysosome;membrane;lysosomal membrane;protein binding;integral component of plasma membrane;cellular response to leukemia inhibitory factor	Lysosome;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ7	negative	RHOG	ENSG00000177105	COQ7	1	COQ7	1	0.00128877417972895	WBGene00000424;WBGene00004287;WBGene00003239	WBGene00003239(1)			GO:0016020;GO:0000166;GO:0003924;GO:0005525;GO:0007264;GO:0005886;GO:0005515;GO:0005925;GO:0005737;GO:0008045;GO:0005789;GO:0005829;GO:0070062;GO:0051056;GO:0019901;GO:0090630;GO:0005938;GO:0007266;GO:0008360;GO:0030036;GO:0043312;GO:0007015;GO:0032956;GO:0030667;GO:0051897;GO:0060326;GO:0043652;GO:0007163;GO:0045893;GO:0008284;GO:1903078;GO:0042995;GO:0016601;GO:0030031;GO:1902622;GO:1900027;GO:0005622	GTP binding;GTPase activity;small GTPase mediated signal transduction;membrane;nucleotide binding;focal adhesion;plasma membrane;protein binding;cytoplasm;intracellular membrane-bounded organelle;motor neuron axon guidance;endoplasmic reticulum membrane;cytosol;extracellular exosome;regulation of small GTPase mediated signal transduction;cytoskeleton;regulation of cell shape;protein kinase binding;activation of GTPase activity;cell cortex;Rho protein signal transduction;actin cytoskeleton organization;actin filament organization;neutrophil degranulation;cytoplasmic vesicle;establishment or maintenance of cell polarity;regulation of actin cytoskeleton organization;secretory granule membrane;positive regulation of protein kinase B signaling;cell chemotaxis;engulfment of apoptotic cell;positive regulation of transcription, DNA-templated;positive regulation of cell population proliferation;positive regulation of protein localization to plasma membrane;cell projection;Rac protein signal transduction;cortical cytoskeleton organization;cell projection assembly;regulation of neutrophil migration;regulation of ruffle assembly	ADP-ribosylation;Cell membrane;GTP-binding;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Phosphoprotein;Prenylation;Reference proteome	R-HSA-109582;R-HSA-168249;R-HSA-168256;R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-1643685;R-HSA-1257604;R-HSA-5663202;R-HSA-9006925;R-HSA-195258;R-HSA-76002;R-HSA-2219528;R-HSA-6798695;R-HSA-199418;R-HSA-2219530;R-HSA-6811558;R-HSA-114604;R-HSA-5625970	Hemostasis;Innate Immune System;Immune System;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Disease;PIP3 activates AKT signaling;Diseases of signal transduction;Intracellular signaling by second messengers;RHO GTPase Effectors;Platelet activation, signaling and aggregation;PI3K/AKT Signaling in Cancer;Neutrophil degranulation;Negative regulation of the PI3K/AKT network;Constitutive Signaling by Aberrant PI3K in Cancer;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;GPVI-mediated activation cascade;RHO GTPases activate KTN1
COQ7	negative	TSPYL2	ENSG00000184205	COQ7	1	COQ7	1	0.00128877417972895	WBGene00005007	WBGene00005007(0)			GO:0005634;GO:0005737;GO:0006325;GO:0006334;GO:0005515;GO:0007049;GO:0005730;GO:0005654;GO:0030308;GO:0045786;GO:0009966;GO:0036498;GO:0045859;GO:0000182;GO:0008156	nucleus;nucleosome assembly;cytoplasm;chromatin organization;protein binding;cell cycle;nucleolus;nucleoplasm;negative regulation of cell growth;negative regulation of cell cycle;regulation of signal transduction;IRE1-mediated unfolded protein response;regulation of protein kinase activity;rDNA binding;negative regulation of DNA replication	Cell cycle;Chromatin regulator;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
COQ7	negative	S100A16	ENSG00000188643	COQ7	1	COQ7	1	0.00128877417972895					GO:0003723;GO:0005634;GO:0005737;GO:0046872;GO:0005829;GO:0005509;GO:0005886;GO:0005615;GO:0042803;GO:0005515;GO:0005730;GO:0070062;GO:0051592	calcium ion binding;RNA binding;nucleus;cytoplasm;metal ion binding;cytosol;plasma membrane;extracellular space;protein homodimerization activity;protein binding;nucleolus;extracellular exosome;identical protein binding;response to calcium ion	3D-structure;Calcium;Cytoplasm;Metal-binding;Nucleus;Reference proteome;Repeat;Zinc		
COQ7	negative	GPSM3	ENSG00000213654	COQ7	1	COQ7	1	0.00128877417972895					GO:0030695;GO:0050790;GO:0005515;GO:0005737;GO:0003674;GO:0008150;GO:0005575;GO:0050729;GO:0002690;GO:1900017;GO:0005886;GO:0006955	protein binding;GTPase regulator activity;regulation of inflammatory response;regulation of catalytic activity;cytoplasm;molecular_function;biological_process;cellular_component;positive regulation of inflammatory response;positive regulation of leukocyte chemotaxis;positive regulation of cytokine production involved in inflammatory response;plasma membrane;immune response	Cytoplasm;Phosphoprotein;Reference proteome;Repeat	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
COQ7	negative	MAOB	ENSG00000069535	COQ7	1	COQ7	1	0.00197384201450013	WBGene00000138	WBGene00000137(0);WBGene00011615(0);WBGene00005010(0)			GO:0016020;GO:0016021;GO:0016491;GO:0055114;GO:0005739;GO:0005515;GO:0005741;GO:0022900;GO:0021762;GO:0009055;GO:0005740;GO:0042420;GO:0008131;GO:0042803;GO:0050660;GO:0009636;GO:0010044;GO:0010269;GO:0014063;GO:0032496;GO:0042135;GO:0042493;GO:0045471;GO:0045964;GO:0048545;GO:0050665;GO:0051412	oxidation-reduction process;oxidoreductase activity;membrane;integral component of membrane;mitochondrion;protein binding;mitochondrial outer membrane;electron transport chain;substantia nigra development;electron transfer activity;mitochondrial envelope;dopamine catabolic process;primary amine oxidase activity;identical protein binding;flavin adenine dinucleotide binding;response to toxic substance;response to aluminum ion;response to selenium ion;negative regulation of serotonin secretion;response to lipopolysaccharide;neurotransmitter catabolic process;response to drug;response to ethanol;positive regulation of dopamine metabolic process;response to steroid hormone;hydrogen peroxide biosynthetic process;response to corticosterone	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;FAD;Flavoprotein;Membrane;Mitochondrion;Mitochondrion outer membrane;Oxidoreductase;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-211859;R-HSA-211945;R-HSA-140179;R-HSA-141333	Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Amine Oxidase reactions;Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB
COQ7	negative	KIF3C	ENSG00000084731	COQ7	1	COQ7	1	0.00197384201450013	WBGene00002222;WBGene00002230	WBGene00002222(1)			GO:0005737;GO:0000166;GO:0005524;GO:0003774;GO:0003777;GO:0005856;GO:0005515;GO:0008017;GO:0005874;GO:0007018;GO:0016887;GO:0035735;GO:0005929;GO:0097542;GO:0005829;GO:0006890;GO:0072384;GO:0019886;GO:0005871	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;cytoplasm;nucleotide binding;motor activity;cytoskeleton;protein binding;microtubule;ATPase activity;intraciliary transport involved in cilium assembly;cilium;ciliary tip;cytosol;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;organelle transport along microtubule;antigen processing and presentation of exogenous peptide antigen via MHC class II;kinesin complex	3D-structure;ATP-binding;Coiled coil;Cytoplasm;Cytoskeleton;Disease mutation;Microtubule;Motor protein;Nucleotide-binding;Polymorphism;Reference proteome	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2132295;R-HSA-983189;R-HSA-983231	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;MHC class II antigen presentation;Kinesins;Factors involved in megakaryocyte development and platelet production
COQ7	negative	BBC3	ENSG00000105327	COQ7	1	COQ7	1	0.00197384201450013	WBGene00000698;WBGene00000749				GO:0005739;GO:0043065;GO:0097193;GO:0006919;GO:0005515;GO:2001244;GO:0070059;GO:0005764;GO:0051117;GO:0090200;GO:0001836;GO:0006915;GO:0097194;GO:1900740;GO:2001056;GO:0005829;GO:0005783;GO:0031334;GO:0042981;GO:0005741;GO:0034976;GO:0071456;GO:0045926;GO:0001844;GO:1902237;GO:1903896;GO:0043525;GO:0051209;GO:0006974;GO:0008340;GO:0070245;GO:0032464;GO:0032471	mitochondrion;positive regulation of apoptotic process;intrinsic apoptotic signaling pathway;positive regulation of release of cytochrome c from mitochondria;activation of cysteine-type endopeptidase activity involved in apoptotic process;protein binding;positive regulation of intrinsic apoptotic signaling pathway;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;lysosome;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATPase binding;release of cytochrome c from mitochondria;apoptotic process;execution phase of apoptosis;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;positive regulation of cysteine-type endopeptidase activity;cell;cytosol;endoplasmic reticulum;positive regulation of protein-containing complex assembly;regulation of apoptotic process;mitochondrial outer membrane;response to endoplasmic reticulum stress;cellular response to hypoxia;negative regulation of growth;protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;positive regulation of IRE1-mediated unfolded protein response;positive regulation of neuron apoptotic process;release of sequestered calcium ion into cytosol;cellular response to DNA damage stimulus;determination of adult lifespan;positive regulation of thymocyte apoptotic process;negative regulation of endoplasmic reticulum calcium ion concentration;positive regulation of protein homooligomerization	3D-structure;Alternative splicing;Apoptosis;Mitochondrion;Phosphoprotein;Reference proteome;Alternative splicing;Reference proteome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-109581;R-HSA-5357801;R-HSA-9614085;R-HSA-5633008;R-HSA-109606;R-HSA-114452;R-HSA-139915;R-HSA-6803204;R-HSA-111453;R-HSA-9614657	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptosis;Programmed Cell Death;FOXO-mediated transcription;TP53 Regulates Transcription of Cell Death Genes;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;Activation of PUMA and translocation to mitochondria;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;FOXO-mediated transcription of cell death genes
COQ7	negative	KHK	ENSG00000138030	COQ7	1	COQ7	1	0.00197384201450013				Essential fructosuria;FRUCTOSURIA ESSENTIAL	GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005515;GO:0005975;GO:0046835;GO:0005737;GO:0004454;GO:0006000;GO:0009744;GO:0009749;GO:0009750;GO:0010043;GO:0032868;GO:0005829;GO:0070062;GO:0061624;GO:0019200;GO:0070873	fructose metabolic process;ketohexokinase activity;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;protein binding;carbohydrate phosphorylation;carbohydrate metabolic process;cytoplasm;response to sucrose;response to glucose;response to fructose;response to zinc ion;response to insulin;cytosol;extracellular exosome;fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate;carbohydrate kinase activity;regulation of glycogen metabolic process	3D-structure;ATP-binding;Alternative splicing;Carbohydrate metabolism;Disease mutation;Kinase;Nucleotide-binding;Polymorphism;Reference proteome;Transferase	R-HSA-1430728;R-HSA-1643685;R-HSA-71387;R-HSA-5668914;R-HSA-5663084;R-HSA-5652084;R-HSA-70350;R-HSA-5657562	Metabolism;Disease;Metabolism of carbohydrates;Diseases of metabolism;Diseases of carbohydrate metabolism;Fructose metabolism;Fructose catabolism;Essential fructosuria
COQ7	negative	KIFC3	ENSG00000140859	COQ7	1	COQ7	1	0.00197384201450013	WBGene00002216;WBGene00002227;WBGene00002225;WBGene00002226	WBGene00002216(0)			GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0003777;GO:0005856;GO:0005515;GO:0008017;GO:0030054;GO:0031410;GO:0005874;GO:0030659;GO:0007018;GO:0005813;GO:0005815;GO:0008569;GO:0016887;GO:0070062;GO:0005912;GO:0007601;GO:0005871;GO:0090136;GO:0045218;GO:0005915;GO:0007017;GO:0007030;GO:0005794;GO:0003774	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;ATP-dependent microtubule motor activity, minus-end-directed;cytoplasm;membrane;nucleotide binding;cytoskeleton;protein binding;cell junction;cytoplasmic vesicle;microtubule;cytoplasmic vesicle membrane;centrosome;microtubule organizing center;ATPase activity;extracellular exosome;adherens junction;visual perception;kinesin complex;epithelial cell-cell adhesion;zonula adherens maintenance;zonula adherens;microtubule-based process;Golgi organization;Golgi apparatus;motor activity	3D-structure;ATP-binding;Alternative splicing;Cell junction;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Membrane;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome		
COQ7	negative	EVA1B	ENSG00000142694	COQ7	1	COQ7	1	0.00197384201450013					GO:0016020;GO:0016021;GO:0005515	membrane;integral component of membrane;protein binding	Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
COQ7	negative	GUK1	ENSG00000143774	COQ7	1	COQ7	1	0.00197384201450013	WBGene00020190	WBGene00020190(1)			GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005829;GO:0006163;GO:0005515;GO:0001917;GO:0004385;GO:0046037;GO:0046710;GO:0015949;GO:0006185;GO:0019673;GO:0034436;GO:0046034;GO:0046054;GO:0046060;GO:0046711;GO:0046939	guanylate kinase activity;purine nucleotide metabolic process;cytoplasm;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;cytosol;protein binding;xenobiotic metabolic process;photoreceptor inner segment;GMP metabolic process;GDP metabolic process;nucleobase-containing small molecule interconversion;dGDP biosynthetic process;GDP-mannose metabolic process;glycoprotein transport;ATP metabolic process;dGMP metabolic process;dATP metabolic process;GDP biosynthetic process;nucleotide phosphorylation	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Kinase;Nucleotide-binding;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-499943;R-HSA-2161522;R-HSA-2161541	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates;Abacavir transport and metabolism;Abacavir metabolism
COQ7	negative	HSF1	ENSG00000185122	COQ7	1	COQ7	1	0.00197384201450013	WBGene00002004		ATG7;HSPA4;LDHA;MICA;MICB;NAT1;POLK;SERPINE1		GO:0005634;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0006397;GO:0051028;GO:0005737;GO:0031490;GO:0005694;GO:0005856;GO:0005515;GO:0006281;GO:0006974;GO:0048471;GO:0000922;GO:0005813;GO:0005815;GO:0042802;GO:0000775;GO:0000776;GO:0000777;GO:0000122;GO:0000978;GO:0034605;GO:0061408;GO:0000981;GO:0000790;GO:0001227;GO:0045944;GO:0019901;GO:0051260;GO:1900034;GO:1990904;GO:0016605;GO:0008284;GO:0000165;GO:0046982;GO:0097431;GO:0120162;GO:0043621;GO:0009299;GO:1903936;GO:1990841;GO:1900365;GO:0031072;GO:0051879;GO:0045931;GO:0071276;GO:0043497;GO:0070207;GO:0071480;GO:0071280;GO:2001033;GO:0097165;GO:0001162;GO:0003682;GO:0061770;GO:0097677;GO:0098847;GO:0001701;GO:0001892;GO:0006468;GO:0006952;GO:0007143;GO:0007283;GO:0007584;GO:0008285;GO:0009408;GO:0010243;GO:0010628;GO:0010629;GO:0010667;GO:0014070;GO:0014823;GO:0032355;GO:0032496;GO:0032720;GO:0033574;GO:0034620;GO:0034622;GO:0035690;GO:0035865;GO:0040018;GO:0042531;GO:0043200;GO:0043280;GO:0060136;GO:0070301;GO:0071222;GO:0071230;GO:0071392;GO:0071407;GO:0071478;GO:0072738;GO:0090084;GO:0090261;GO:1901215;GO:1901652;GO:1902512;GO:1904385;GO:1904528;GO:1904843;GO:1904845;GO:1990910;GO:1990911;GO:0000791;GO:0000792;GO:0032991;GO:0045120	DNA binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;sequence-specific DNA binding;nucleoplasm;cytosol;mRNA processing;mRNA transport;cytoplasm;cytoskeleton;chromatin DNA binding;chromosome;protein binding;DNA repair;cellular response to DNA damage stimulus;perinuclear region of cytoplasm;identical protein binding;spindle pole;centrosome;microtubule organizing center;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;RNA polymerase II cis-regulatory region sequence-specific DNA binding;negative regulation of transcription by RNA polymerase II;cellular response to heat;regulation of transcription from RNA polymerase II promoter in response to stress;positive regulation of transcription from RNA polymerase II promoter in response to heat stress;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;PML body;DNA-binding transcription repressor activity, RNA polymerase II-specific;positive regulation of transcription by RNA polymerase II;protein kinase binding;viral process;regulation of cellular response to heat;ribonucleoprotein complex;positive regulation of cell population proliferation;MAPK cascade;protein heterodimerization activity;mitotic spindle pole;positive regulation of cold-induced thermogenesis;protein self-association;mRNA transcription;cellular response to sodium arsenite;promoter-specific chromatin binding;positive regulation of mRNA polyadenylation;heat shock protein binding;Hsp90 protein binding;positive regulation of mitotic cell cycle;cellular response to cadmium ion;negative regulation of protein-containing complex assembly;cellular response to gamma radiation;cellular response to copper ion;negative regulation of double-strand break repair via nonhomologous end joining;nuclear stress granule;RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding;chromatin binding;translation elongation factor binding;STAT family protein binding;sequence-specific single stranded DNA binding;in utero embryonic development;embryonic placenta development;protein phosphorylation;defense response;female meiotic nuclear division;spermatogenesis;response to nutrient;negative regulation of cell population proliferation;response to heat;response to organonitrogen compound;positive regulation of gene expression;negative regulation of gene expression;negative regulation of cardiac muscle cell apoptotic process;response to organic cyclic compound;response to activity;response to estradiol;response to lipopolysaccharide;negative regulation of tumor necrosis factor production;response to testosterone;cellular response to unfolded protein;cellular protein-containing complex assembly;cellular response to drug;cellular response to potassium ion;positive regulation of multicellular organism growth;positive regulation of tyrosine phosphorylation of STAT protein;response to amino acid;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;embryonic process involved in female pregnancy;cellular response to hydrogen peroxide;cellular response to lipopolysaccharide;cellular response to amino acid stimulus;cellular response to estradiol stimulus;cellular response to organic cyclic compound;cellular response to radiation;cellular response to diamide;negative regulation of inclusion body assembly;positive regulation of inclusion body assembly;negative regulation of neuron death;response to peptide;positive regulation of apoptotic DNA fragmentation;cellular response to angiotensin;positive regulation of microtubule binding;cellular response to nitroglycerin;cellular response to L-glutamine;response to hypobaric hypoxia;response to psychosocial stress;euchromatin;heterochromatin;protein-containing complex;pronucleus;chaperone complex	3D-structure;Acetylation;Activator;Alternative splicing;Centromere;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Host-virus interaction;Isopeptide bond;Kinetochore;Nucleus;Phosphoprotein;Reference proteome;Stress response;Transcription;Transcription regulation;Transport;Ubl conjugation;mRNA processing;mRNA transport	R-HSA-2262752;R-HSA-8953897;R-HSA-3371453;R-HSA-3371556;R-HSA-3371511;R-HSA-3371568;R-HSA-3371571	Cellular responses to stress;Cellular responses to external stimuli;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;HSF1 activation;Attenuation phase;HSF1-dependent transactivation
COQ7	negative	IRF7	ENSG00000185507	COQ7	1	COQ7	1	0.00197384201450013			ATF4;CD80;CXCL10;IFNA1;IFNA13;IFNA2;IFNB1	IMMUNODEFICIENCY 39	GO:0044212;GO:0045944;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0005515;GO:0006974;GO:0045893;GO:0002376;GO:0045087;GO:0051607;GO:0000981;GO:0000790;GO:0010008;GO:0009615;GO:0016032;GO:0032727;GO:0035666;GO:0006366;GO:0000978;GO:0032728;GO:0060333;GO:0000122;GO:0032481;GO:0060337;GO:0050776;GO:0002819;GO:0034124;GO:0039530;GO:0032608;GO:0019043;GO:0032479;GO:0032607;GO:0034127;GO:0045655;GO:2000110;GO:0000987;GO:0001158;GO:0010468;GO:0016064;GO:0045351;GO:0060340	transcription regulatory region DNA binding;regulation of transcription, DNA-templated;protein binding;DNA-binding transcription factor activity;positive regulation of transcription by RNA polymerase II;nucleus;cytoplasm;nucleoplasm;cytosol;DNA binding;cellular response to DNA damage stimulus;positive regulation of transcription, DNA-templated;immune system process;innate immune response;defense response to virus;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;endosome membrane;response to virus;viral process;positive regulation of interferon-alpha production;TRIF-dependent toll-like receptor signaling pathway;transcription by RNA polymerase II;RNA polymerase II cis-regulatory region sequence-specific DNA binding;positive regulation of interferon-beta production;interferon-gamma-mediated signaling pathway;negative regulation of transcription by RNA polymerase II;positive regulation of type I interferon production;type I interferon signaling pathway;regulation of immune response;regulation of type I interferon production;regulation of adaptive immune response;regulation of MyD88-dependent toll-like receptor signaling pathway;MDA-5 signaling pathway;interferon-beta production;establishment of viral latency;interferon-alpha production;regulation of MyD88-independent toll-like receptor signaling pathway;regulation of monocyte differentiation;negative regulation of macrophage apoptotic process;cis-regulatory region sequence-specific DNA binding;regulation of gene expression;immunoglobulin mediated immune response;type I interferon biosynthetic process;positive regulation of type I interferon-mediated signaling pathway	3D-structure;Acetylation;Activator;Alternative splicing;Antiviral defense;Cytoplasm;DNA-binding;Disease mutation;Host-virus interaction;Immunity;Innate immunity;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1280215;R-HSA-913531;R-HSA-166016;R-HSA-166166;R-HSA-168138;R-HSA-168181;R-HSA-168898;R-HSA-936964;R-HSA-937061;R-HSA-975155;R-HSA-877300;R-HSA-909733;R-HSA-168164;R-HSA-1834949;R-HSA-168928;R-HSA-9013973;R-HSA-918233;R-HSA-933541;R-HSA-975110;R-HSA-3134963	Innate Immune System;Immune System;Cytokine Signaling in Immune system;Interferon Signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll-like Receptor Cascades;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling ;MyD88 dependent cascade initiated on endosome;Interferon gamma signaling;Interferon alpha/beta signaling;Toll Like Receptor 3 (TLR3) Cascade;Cytosolic sensors of pathogen-associated DNA ;DDX58/IFIH1-mediated induction of interferon-alpha/beta;TICAM1-dependent activation of IRF3/IRF7;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;DEx/H-box helicases activate type I IFN and inflammatory cytokines production 
COQ7	negative	ALOX5	ENSG00000012779	COQ7	1	COQ7	1	0.00297487008243458				ASTHMA SUSCEPTIBILITY TO	GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0005654;GO:0016491;GO:0055114;GO:0005615;GO:0005829;GO:0005506;GO:0005515;GO:0051213;GO:0005576;GO:0016702;GO:0019370;GO:0005635;GO:0031965;GO:0043312;GO:0034774;GO:1904813;GO:0016363;GO:0019221;GO:0019372;GO:0035655;GO:0042759;GO:0004051;GO:0002540;GO:0006691;GO:0006954;GO:2001301;GO:0005641	metal ion binding;protein binding;oxidation-reduction process;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;iron ion binding;nucleus;cytoplasm;membrane;nucleoplasm;oxidoreductase activity;extracellular space;cytosol;perinuclear region of cytoplasm;dioxygenase activity;plasma membrane;extracellular region;arachidonic acid metabolic process;leukotriene biosynthetic process;nuclear envelope;negative regulation of inflammatory response;nuclear membrane;neutrophil degranulation;positive regulation of bone mineralization;secretory granule lumen;ficolin-1-rich granule lumen;nuclear matrix;regulation of insulin secretion;cytokine-mediated signaling pathway;negative regulation of endothelial cell proliferation;negative regulation of angiogenesis;regulation of inflammatory response;lipoxygenase pathway;lipid oxidation;hepoxilin biosynthetic process;regulation of cytokine production involved in inflammatory response;leukocyte chemotaxis involved in inflammatory response;glucose homeostasis;humoral immune response;interleukin-18-mediated signaling pathway;regulation of reactive oxygen species biosynthetic process;long-chain fatty acid biosynthetic process;leukocyte migration involved in inflammatory response;negative regulation of wound healing;arachidonate 5-lipoxygenase activity;leukotriene production involved in inflammatory response;leukotriene metabolic process;inflammatory response;dendritic cell migration;regulation of fat cell differentiation;negative regulation of vascular wound healing;regulation of inflammatory response to wounding;regulation of cellular response to oxidative stress;leukotriene A4 biosynthetic process;negative regulation of response to endoplasmic reticulum stress;negative regulation of sprouting angiogenesis;positive regulation of leukocyte adhesion to arterial endothelial cell;lipoxin biosynthetic process;nuclear envelope lumen	3D-structure;Alternative splicing;Calcium;Cytoplasm;Dioxygenase;Direct protein sequencing;Iron;Leukotriene biosynthesis;Membrane;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-6798695;R-HSA-2142753;R-HSA-6785807;R-HSA-9012546;R-HSA-9018677;R-HSA-9018678;R-HSA-9018682;R-HSA-2142688;R-HSA-2142691;R-HSA-2142700;R-HSA-9018676;R-HSA-9018679;R-HSA-9018683;R-HSA-9018896;R-HSA-9020265;R-HSA-9023661;R-HSA-9025094;R-HSA-9026286;R-HSA-9026290;R-HSA-9026403	Innate Immune System;Immune System;Metabolism;Metabolism of lipids;Fatty acid metabolism;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Neutrophil degranulation;Arachidonic acid metabolism;Interleukin-4 and Interleukin-13 signaling;Interleukin-18 signaling;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of maresins;Synthesis of 5-eicosatetraenoic acids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Synthesis of Lipoxins (LX);Biosynthesis of D-series resolvins;Biosynthesis of EPA-derived SPMs;Biosynthesis of DPA-derived SPMs;Biosynthesis of E-series 18(S)-resolvins;Biosynthesis of aspirin-triggered D-series resolvins;Biosynthesis of E-series 18(R)-resolvins;Biosynthesis of DPAn-3 SPMs;Biosynthesis of DPAn-3-derived protectins and resolvins;Biosynthesis of DPAn-3-derived maresins;Biosynthesis of DPAn-3-derived 13-series resolvins
COQ7	negative	WWC3	ENSG00000047644	COQ7	1	COQ7	1	0.00297487008243458					GO:0060090;GO:0005829;GO:0000122;GO:0019900;GO:0046621;GO:0035331	molecular adaptor activity;cytosol;negative regulation of transcription by RNA polymerase II;kinase binding;negative regulation of organ growth;negative regulation of hippo signaling	Alternative splicing;Coiled coil;Polymorphism;Reference proteome		
COQ7	negative	HOMER3	ENSG00000051128	COQ7	1	COQ7	1	0.00297487008243458					GO:0005737;GO:0016020;GO:0005886;GO:0005515;GO:0030054;GO:0045202;GO:0045211;GO:0042802;GO:0043005;GO:0005829;GO:0005575;GO:0014069;GO:0030425;GO:0035256;GO:0007216;GO:2001256;GO:0006605;GO:0070885;GO:0032703	cytoplasm;protein binding;cell junction;synapse;plasma membrane;identical protein binding;neuron projection;cytosol;cellular_component;postsynaptic density;dendrite;G protein-coupled glutamate receptor binding;G protein-coupled glutamate receptor signaling pathway;regulation of store-operated calcium entry;protein targeting;negative regulation of calcineurin-NFAT signaling cascade;negative regulation of interleukin-2 production	3D-structure;Alternative splicing;Cell junction;Coiled coil;Cytoplasm;Phosphoprotein;Polymorphism;Reference proteome;Synapse	R-HSA-112316;R-HSA-6794361;R-HSA-6794362	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
COQ7	negative	FOXC1	ENSG00000054598	COQ7	1	COQ7	1	0.00297487008243458			FGF19	Axenfeld anomaly;Axenfeld-Rieger syndrome;Isolated aniridia;PETERS ANOMALY;RIEGER ANOMALY;Axenfeld-Rieger syndrome type 3;IRIDOGONIODYSGENESIS ANOMALY;PETERS ANOMALY;ANTERIOR SEGMENT DYSGENESIS 3;Axenfeld-Rieger syndrome type 3	GO:0045944;GO:0044212;GO:0005634;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0005515;GO:0007275;GO:0001822;GO:0003713;GO:0045893;GO:0000981;GO:0030154;GO:0006357;GO:0000122;GO:0000790;GO:0009653;GO:0016477;GO:0008283;GO:0001228;GO:0001525;GO:0008134;GO:0016525;GO:0010718;GO:0000977;GO:0070098;GO:0045930;GO:0008301;GO:0001958;GO:0042475;GO:1990841;GO:0001223;GO:0071364;GO:0043388;GO:0045618;GO:0001657;GO:0005720;GO:1904798;GO:0038084;GO:0021549;GO:1990869;GO:0001501;GO:0001503;GO:0001541;GO:0001568;GO:0001654;GO:0001701;GO:0001756;GO:0001945;GO:0001974;GO:0003007;GO:0007219;GO:0007420;GO:0007507;GO:0008354;GO:0010628;GO:0014031;GO:0014032;GO:0030199;GO:0030203;GO:0032808;GO:0035050;GO:0036438;GO:0043010;GO:0046620;GO:0048010;GO:0048341;GO:0048762;GO:0048844;GO:0055010;GO:0060038;GO:0072010;GO:0097746;GO:1901491;GO:1901534;GO:1902038;GO:1902257	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II;transcription regulatory region DNA binding;nucleus;nucleoplasm;cytosol;DNA binding;protein binding;multicellular organism development;kidney development;transcription coactivator activity;positive regulation of transcription, DNA-templated;DNA-binding transcription factor activity, RNA polymerase II-specific;anatomical structure morphogenesis;cell differentiation;regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;nuclear chromatin;cell migration;DNA-binding transcription activator activity, RNA polymerase II-specific;angiogenesis;transcription factor binding;negative regulation of angiogenesis;positive regulation of epithelial to mesenchymal transition;RNA polymerase II regulatory region sequence-specific DNA binding;chemokine-mediated signaling pathway;negative regulation of mitotic cell cycle;DNA binding, bending;endochondral ossification;cell population proliferation;odontogenesis of dentin-containing tooth;promoter-specific chromatin binding;transcription coactivator binding;cellular response to epidermal growth factor stimulus;positive regulation of DNA binding;positive regulation of keratinocyte differentiation;ureteric bud development;nuclear heterochromatin;positive regulation of core promoter binding;vascular endothelial growth factor signaling pathway;cerebellum development;cellular response to chemokine;skeletal system development;ossification;ovarian follicle development;blood vessel development;eye development;in utero embryonic development;somitogenesis;lymph vessel development;blood vessel remodeling;heart morphogenesis;Notch signaling pathway;brain development;heart development;germ cell migration;positive regulation of gene expression;mesenchymal cell development;neural crest cell development;collagen fibril organization;glycosaminoglycan metabolic process;lacrimal gland development;embryonic heart tube development;maintenance of lens transparency;camera-type eye development;regulation of organ growth;vascular endothelial growth factor receptor signaling pathway;paraxial mesoderm formation;mesenchymal cell differentiation;artery morphogenesis;ventricular cardiac muscle tissue morphogenesis;cardiac muscle cell proliferation;glomerular epithelium development;regulation of blood vessel diameter;negative regulation of lymphangiogenesis;positive regulation of hematopoietic progenitor cell differentiation;positive regulation of hematopoietic stem cell differentiation;negative regulation of apoptotic process involved in outflow tract morphogenesis	Activator;Angiogenesis;DNA-binding;Deafness;Developmental protein;Disease mutation;Nucleus;Peters anomaly;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation		
COQ7	negative	GNA15	ENSG00000060558	COQ7	1	COQ7	1	0.00297487008243458		WBGene00001664(0);WBGene00001675(0);WBGene00001665(0);WBGene00001678(0);WBGene00001666(0);WBGene00001745(0);WBGene00001670(0);WBGene00001671(0);WBGene00001674(0);WBGene00001673(0);WBGene00001668(0);WBGene00001676(0);WBGene00001667(0)			GO:0046872;GO:0000166;GO:0007186;GO:0007165;GO:0003924;GO:0005525;GO:0001664;GO:0005834;GO:0019001;GO:0031683;GO:0005886;GO:0007188;GO:0030168;GO:0060158;GO:0007202;GO:0051482;GO:0007207;GO:0007200	G protein-coupled receptor signaling pathway;signal transduction;GTPase activity;G-protein beta/gamma-subunit complex binding;G protein-coupled receptor binding;guanyl nucleotide binding;cell;metal ion binding;nucleotide binding;GTP binding;heterotrimeric G-protein complex;synapse;plasma membrane;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;platelet activation;phospholipase C-activating dopamine receptor signaling pathway;activation of phospholipase C activity;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway	ADP-ribosylation;GTP-binding;Magnesium;Metal-binding;Nucleotide-binding;Polymorphism;Reference proteome;Transducer	R-HSA-109582;R-HSA-1430728;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416476;R-HSA-392518;R-HSA-76002;R-HSA-456926;R-HSA-163685;R-HSA-422356;R-HSA-418592;R-HSA-428930;R-HSA-400451;R-HSA-434316;R-HSA-399997	Hemostasis;Metabolism;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Signal amplification;Platelet activation, signaling and aggregation;Thrombin signalling through proteinase activated receptors (PARs);Integration of energy metabolism;Regulation of insulin secretion;ADP signalling through P2Y purinoceptor 1;Thromboxane signalling through TP receptor;Free fatty acids regulate insulin secretion;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Acetylcholine regulates insulin secretion
COQ7	negative	LTBP4	ENSG00000090006	COQ7	1	COQ7	1	0.00297487008243458	WBGene00022816;WBGene00010573			Cutis laxa with severe pulmonary gastrointestinal and urinary anomalies;Duchenne Muscular Dystrophy;CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IC	GO:0005509;GO:0005615;GO:0005515;GO:0005576;GO:0007275;GO:0062023;GO:0030162;GO:0006457;GO:0001558;GO:0005178;GO:0005201;GO:0031012;GO:0019838;GO:0045595;GO:0005539;GO:0017015;GO:0050431;GO:0030252;GO:0005024;GO:0007179;GO:0046879	calcium ion binding;extracellular space;protein binding;extracellular region;multicellular organism development;collagen-containing extracellular matrix;regulation of proteolysis;protein folding;regulation of cell growth;integrin binding;extracellular matrix structural constituent;extracellular matrix;growth factor binding;regulation of cell differentiation;glycosaminoglycan binding;regulation of transforming growth factor beta receptor signaling pathway;transforming growth factor beta binding;growth hormone secretion;transforming growth factor beta-activated receptor activity;transforming growth factor beta receptor signaling pathway;hormone secretion	Alternative splicing;Disease mutation;Disulfide bond;EGF-like domain;Extracellular matrix;Glycoprotein;Growth factor binding;Polymorphism;Reference proteome;Repeat;Secreted;Signal	R-HSA-1474244;R-HSA-1566948;R-HSA-2129379	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
COQ7	negative	YPEL3	ENSG00000090238	COQ7	1	COQ7	1	0.00297487008243458	WBGene00009503;WBGene00015251				GO:0005634;GO:0046872;GO:0005730;GO:2000774	nucleus;metal ion binding;nucleolus;positive regulation of cellular senescence	Alternative splicing;Metal-binding;Nucleus;Reference proteome;Ubl conjugation;Zinc		
COQ7	negative	CST3	ENSG00000101439	COQ7	1	COQ7	1	0.00297487008243458	WBGene00000534;WBGene00000535	WBGene00000535(0);WBGene00023486(0);WBGene00000534(0)		ACys amyloidosis;CEREBRAL AMYLOID ANGIOPATHY CST3-RELATED;MACULAR DEGENERATION AGE-RELATED 11	GO:0005615;GO:0005886;GO:0010951;GO:0005576;GO:0042802;GO:0004869;GO:0005515;GO:0030414;GO:0010466;GO:0070062;GO:0044267;GO:0043687;GO:0043312;GO:1904813;GO:0005788;GO:0005783;GO:1904724;GO:0097435;GO:0002020;GO:0005794;GO:0001540;GO:0004866;GO:0006952;GO:0010711;GO:0010716;GO:0034103;GO:0045861;GO:0060311;GO:0060313	cysteine-type endopeptidase inhibitor activity;extracellular space;plasma membrane;negative regulation of endopeptidase activity;extracellular region;protein binding;identical protein binding;protease binding;peptidase inhibitor activity;eye development;response to hypoxia;cell activation;apoptotic process;response to oxidative stress;brain development;salivary gland development;embryo implantation;positive regulation of cell population proliferation;male gonad development;response to toxic substance;response to carbohydrate;response to inorganic substance;negative regulation of peptidase activity;response to organic cyclic compound;response to nutrient levels;response to estradiol;cellular response to oxidative stress;response to drug;circadian sleep/wake cycle, REM sleep;regulation of programmed cell death;positive regulation of DNA replication;response to axon injury;Sertoli cell development;negative regulation of cell death;cellular response to hydrogen peroxide;basement membrane;cytoplasm;lysosome;multivesicular body;endoplasmic reticulum;axon;nuclear membrane;vesicle;cell projection;neuronal cell body;contractile fiber;perinuclear region of cytoplasm;extracellular exosome;cellular protein metabolic process;post-translational protein modification;neutrophil degranulation;ficolin-1-rich granule lumen;endoplasmic reticulum lumen;tertiary granule lumen;supramolecular fiber organization;Golgi apparatus;amyloid-beta binding;endopeptidase inhibitor activity;defense response;negative regulation of collagen catabolic process;negative regulation of extracellular matrix disassembly;regulation of tissue remodeling;negative regulation of proteolysis;negative regulation of elastin catabolic process;negative regulation of blood vessel remodeling	3D-structure;Age-related macular degeneration;Amyloid;Amyloidosis;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Phosphoprotein;Polymorphism;Protease inhibitor;Reference proteome;Secreted;Signal;Thiol protease inhibitor	R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-977225;R-HSA-6798695;R-HSA-381426;R-HSA-8957275	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Amyloid fiber formation;Neutrophil degranulation;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation
COQ7	negative	TNNC2	ENSG00000101470	COQ7	1	COQ7	1	0.00297487008243458	WBGene00003934;WBGene00006583				GO:0046872;GO:0005509;GO:0003779;GO:0005515;GO:0051015;GO:0005829;GO:0003009;GO:0030049;GO:0006937;GO:0048306;GO:0005861	calcium ion binding;metal ion binding;actin binding;protein binding;actin filament binding;cytosol;skeletal muscle contraction;muscle filament sliding;regulation of muscle contraction;calcium-dependent protein binding;troponin complex	Acetylation;Calcium;Direct protein sequencing;Metal-binding;Muscle protein;Reference proteome;Repeat	R-HSA-397014;R-HSA-390522	Muscle contraction;Striated Muscle Contraction
COQ7	negative	RIOK3	ENSG00000101782	COQ7	1	COQ7	1	0.00297487008243458	WBGene00014012	WBGene00014012(1)			GO:0005737;GO:0046872;GO:0000166;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005515;GO:0002376;GO:0045087;GO:0042254;GO:0030688;GO:0051607;GO:0005829;GO:0098586;GO:0032728;GO:0089720;GO:0007059;GO:0030490;GO:0032463;GO:0039534;GO:0043124;GO:0045089;GO:0071359;GO:1990786	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;cytoplasm;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;protein binding;immune system process;innate immune response;ribosome biogenesis;cytosol;preribosome, small subunit precursor;defense response to virus;cellular response to virus;negative regulation of protein-containing complex assembly;positive regulation of interferon-beta production;caspase binding;chromosome segregation;maturation of SSU-rRNA;negative regulation of MDA-5 signaling pathway;negative regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of innate immune response;cellular response to dsRNA;cellular response to dsDNA	ATP-binding;Alternative splicing;Antiviral defense;Cytoplasm;Immunity;Innate immunity;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Ribosome biogenesis;Serine/threonine-protein kinase;Transferase	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
COQ7	negative	STUB1	ENSG00000103266	COQ7	1	COQ7	1	0.00297487008243458	WBGene00000500	WBGene00000500(1)		Autosomal recessive cerebellar ataxia due to STUB1 deficiency;SPINOCEREBELLAR ATAXIA 48;SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 16	GO:0005737;GO:0071456;GO:0005634;GO:0002931;GO:0016740;GO:0005829;GO:0005654;GO:0016567;GO:0004842;GO:0042803;GO:0005515;GO:0006281;GO:0006974;GO:0051865;GO:0006511;GO:0061630;GO:0000209;GO:0030433;GO:0005783;GO:0019899;GO:0046332;GO:0043161;GO:0070534;GO:0051879;GO:0048156;GO:0051087;GO:0000151;GO:0038128;GO:0031647;GO:0030512;GO:0031398;GO:0030544;GO:0031625;GO:0001664;GO:0019900;GO:0034450;GO:0101031;GO:0051787;GO:0031371;GO:0006515;GO:0090035;GO:0030674;GO:0030911;GO:0031072;GO:0030579;GO:0031943;GO:0032436;GO:0034605;GO:0051604;GO:0071218;GO:0042405;GO:0030968;GO:0032091;GO:0051443;GO:0061684;GO:0030018	protein binding;ubiquitin-protein transferase activity;protein ubiquitination;cytoplasm;cellular response to hypoxia;nucleus;response to ischemia;transferase activity;nucleoplasm;cytosol;protein homodimerization activity;DNA repair;cellular response to DNA damage stimulus;protein autoubiquitination;ubiquitin-dependent protein catabolic process;ubiquitin protein ligase activity;protein polyubiquitination;ubiquitin-dependent ERAD pathway;endoplasmic reticulum;enzyme binding;SMAD binding;proteasome-mediated ubiquitin-dependent protein catabolic process;protein K63-linked ubiquitination;Hsp90 protein binding;tau protein binding;chaperone binding;ubiquitin ligase complex;ERBB2 signaling pathway;regulation of protein stability;negative regulation of transforming growth factor beta receptor signaling pathway;positive regulation of protein ubiquitination;Hsp70 protein binding;ubiquitin protein ligase binding;G protein-coupled receptor binding;kinase binding;ubiquitin-ubiquitin ligase activity;chaperone complex;misfolded protein binding;ubiquitin conjugating enzyme complex;protein quality control for misfolded or incompletely synthesized proteins;protein binding, bridging;TPR domain binding;heat shock protein binding;ubiquitin-dependent SMAD protein catabolic process;regulation of glucocorticoid metabolic process;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;cellular response to heat;protein maturation;cellular response to misfolded protein;positive regulation of chaperone-mediated protein complex assembly;nuclear inclusion body;endoplasmic reticulum unfolded protein response;negative regulation of protein binding;positive regulation of ubiquitin-protein transferase activity;chaperone-mediated autophagy;Z disc	3D-structure;Alternative splicing;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Isopeptide bond;Neurodegeneration;Nucleus;Phosphoprotein;Reference proteome;Repeat;Spinocerebellar ataxia;TPR repeat;Transferase;Ubl conjugation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-162582;R-HSA-1257604;R-HSA-6807070;R-HSA-8878166;R-HSA-8939902;R-HSA-8948751;R-HSA-9006925;R-HSA-9006934;R-HSA-9006936;R-HSA-170834;R-HSA-1227986;R-HSA-8863795;R-HSA-2173788;R-HSA-2173789	Adaptive Immune System;Immune System;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signal Transduction;PIP3 activates AKT signaling;PTEN Regulation;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Signaling by ERBB2;Downregulation of ERBB2 signaling;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs
COQ7	negative	LOX	ENSG00000113083	COQ7	1	COQ7	1	0.00297487008243458				Familial thoracic aortic aneurysm and aortic dissection;AORTIC ANEURYSM FAMILIAL THORACIC 10	GO:0046872;GO:0016491;GO:0055114;GO:0005615;GO:0005515;GO:0005576;GO:0005507;GO:0016641;GO:0004720;GO:0001568;GO:0001649;GO:0001932;GO:0007507;GO:0009725;GO:0010468;GO:0016202;GO:0017015;GO:0018158;GO:0030199;GO:0030282;GO:0030324;GO:0035791;GO:0035904;GO:0035905;GO:0035906;GO:0042060;GO:0042493;GO:0042981;GO:0043491;GO:0045652;GO:0046716;GO:0048251;GO:0048514;GO:0048545;GO:0048747;GO:0060326;GO:0061448;GO:0071310;GO:0071897;GO:1900120;GO:1903010;GO:1990869;GO:2000586;GO:0005581;GO:0005634;GO:0031012;GO:0006464;GO:0030198;GO:0005518;GO:0018057	oxidation-reduction process;copper ion binding;oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor;cell;metal ion binding;oxidoreductase activity;extracellular space;protein binding;extracellular region;protein-lysine 6-oxidase activity;blood vessel development;osteoblast differentiation;regulation of protein phosphorylation;heart development;response to hormone;regulation of gene expression;regulation of striated muscle tissue development;regulation of transforming growth factor beta receptor signaling pathway;protein oxidation;collagen fibril organization;bone mineralization;lung development;platelet-derived growth factor receptor-beta signaling pathway;aorta development;ascending aorta development;descending aorta development;wound healing;response to drug;regulation of apoptotic process;protein kinase B signaling;regulation of megakaryocyte differentiation;muscle cell cellular homeostasis;elastic fiber assembly;blood vessel morphogenesis;response to steroid hormone;muscle fiber development;cell chemotaxis;connective tissue development;cellular response to organic substance;DNA biosynthetic process;regulation of receptor binding;regulation of bone development;cellular response to chemokine;regulation of platelet-derived growth factor receptor-beta signaling pathway;collagen trimer;nucleus;extracellular matrix;cellular protein modification process;extracellular matrix organization;collagen binding;peptidyl-lysine oxidation	Aortic aneurysm;Copper;Disease mutation;Disulfide bond;Glycoprotein;LTQ;Metal-binding;Oxidoreductase;Polymorphism;Reference proteome;Secreted;Signal;Sulfation;TPQ	R-HSA-1474244;R-HSA-1474290;R-HSA-2022090;R-HSA-2243919;R-HSA-1566948	Extracellular matrix organization;Collagen formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils;Elastic fibre formation
COQ7	negative	POMC	ENSG00000115138	COQ7	1	COQ7	1	0.00297487008243458				Obesity due to pro-opiomelanocortin deficiency;OBESITY EARLY-ONSET WITH ADRENAL INSUFFICIENCY AND RED HAIR;OBESITY LEANNESS INCLUDED	GO:0045944;GO:0005737;GO:0005576;GO:0005615;GO:0007165;GO:0005179;GO:0007218;GO:0030141;GO:0001664;GO:0007186;GO:0008217;GO:0005102;GO:0032720;GO:0034774;GO:0019221;GO:0007267;GO:0031781;GO:0031782;GO:0070996;GO:0006091;GO:0032098;GO:0033059;GO:0042593;GO:0070873;GO:2000852	extracellular region;hormone activity;positive regulation of transcription by RNA polymerase II;cytoplasm;extracellular space;signal transduction;neuropeptide signaling pathway;secretory granule;G protein-coupled receptor binding;G protein-coupled receptor signaling pathway;regulation of blood pressure;signaling receptor binding;negative regulation of tumor necrosis factor production;secretory granule lumen;cytokine-mediated signaling pathway;cell-cell signaling;type 3 melanocortin receptor binding;type 4 melanocortin receptor binding;type 1 melanocortin receptor binding;generation of precursor metabolites and energy;regulation of appetite;cellular pigmentation;glucose homeostasis;regulation of glycogen metabolic process;regulation of corticosterone secretion	3D-structure;Acetylation;Amidation;Cleavage on pair of basic residues;Direct protein sequencing;Disulfide bond;Endorphin;Glycoprotein;Hormone;Obesity;Phosphoprotein;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-168256;R-HSA-392499;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-1643685;R-HSA-418555;R-HSA-1280215;R-HSA-449147;R-HSA-418594;R-HSA-211859;R-HSA-111885;R-HSA-202040;R-HSA-2980736;R-HSA-9614085;R-HSA-9615017;R-HSA-211897;R-HSA-211945;R-HSA-211976;R-HSA-196071;R-HSA-8957322;R-HSA-500792;R-HSA-373076;R-HSA-375276;R-HSA-6785807;R-HSA-5668914;R-HSA-5579029;R-HSA-193048;R-HSA-194002;R-HSA-209952;R-HSA-5579031	Immune System;Metabolism of proteins;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Disease;G alpha (s) signalling events;Cytokine Signaling in Immune system;Signaling by Interleukins;G alpha (i) signalling events;Biological oxidations;Opioid Signalling;G-protein activation;Peptide hormone metabolism;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of steroid hormones;Metabolism of steroids;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Interleukin-4 and Interleukin-13 signaling;Diseases of metabolism;Metabolic disorders of biological oxidation enzymes;Androgen biosynthesis;Glucocorticoid biosynthesis;Peptide hormone biosynthesis;Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
COQ7	negative	SLC39A4	ENSG00000147804	COQ7	1	COQ7	1	0.00297487008243458	WBGene00006487	WBGene00021936(0)		Acrodermatitis enteropathica;ACRODERMATITIS ENTEROPATHICA ZINC-DEFICIENCY TYPE	GO:0016020;GO:0016021;GO:0055085;GO:0006811;GO:0005886;GO:0031410;GO:0046873;GO:0030001;GO:0005768;GO:0007165;GO:0005887;GO:0055038;GO:0005385;GO:0006829;GO:0006882;GO:0071578;GO:0034224;GO:0016324	membrane;transmembrane transport;metal ion transmembrane transporter activity;metal ion transport;cell;integral component of membrane;endosome;ion transport;plasma membrane;cytoplasmic vesicle;signal transduction;integral component of plasma membrane;recycling endosome membrane;zinc ion transmembrane transporter activity;zinc ion transport;cellular zinc ion homeostasis;zinc ion import across plasma membrane;cellular response to zinc ion starvation;apical plasma membrane	Alternative splicing;Cell membrane;Disease mutation;Endosome;Glycoprotein;Ion transport;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix;Transport;Zinc;Zinc transport	R-HSA-382551;R-HSA-425407;R-HSA-1643685;R-HSA-5619115;R-HSA-5619102;R-HSA-425366;R-HSA-425410;R-HSA-435354;R-HSA-442380;R-HSA-5619088	Transport of small molecules;SLC-mediated transmembrane transport;Disease;Disorders of transmembrane transporters;SLC transporter disorders;Transport of bile salts and organic acids, metal ions and amine compounds;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family;Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)
COQ7	negative	HK1	ENSG00000156515	COQ7	1	COQ7	1	0.00297487008243458	WBGene00008780;WBGene00010416	WBGene00022306(0);WBGene00010416(0)		Charcot-Marie-Tooth disease type 4G;Nonspherocytic hemolytic anemia due to hexokinase deficiency;HEMOLYTIC ANEMIA NONSPHEROCYTIC DUE TO HEXOKINASE DEFICIENCY;NEUROPATHY HEREDITARY MOTOR AND SENSORY RUSSE TYPE;RETINITIS PIGMENTOSA 79	GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005739;GO:0006096;GO:0004396;GO:0005536;GO:0016773;GO:0001678;GO:0005975;GO:0005829;GO:0005515;GO:0003824;GO:0008152;GO:0006954;GO:0005741;GO:0046835;GO:0002376;GO:0045087;GO:0042802;GO:0019318;GO:0061621;GO:0006002;GO:0051156;GO:0004340;GO:0008865;GO:0019158;GO:0042834;GO:0006013;GO:0072655;GO:0072656;GO:0002741;GO:0050718;GO:0045121;GO:0005623	glycolytic process;ATP binding;carbohydrate metabolic process;phosphotransferase activity, alcohol group as acceptor;hexokinase activity;glucose binding;cellular glucose homeostasis;cell;cytoplasm;membrane;nucleotide binding;kinase activity;transferase activity;phosphorylation;mitochondrion;cytosol;protein binding;catalytic activity;metabolic process;inflammatory response;mitochondrial outer membrane;immune system process;innate immune response;identical protein binding;hexose metabolic process;canonical glycolysis;glucose 6-phosphate metabolic process;fructose 6-phosphate metabolic process;glucokinase activity;fructokinase activity;mannokinase activity;peptidoglycan binding;mannose metabolic process;carbohydrate phosphorylation;establishment of protein localization to mitochondrion;maintenance of protein location in mitochondrion;positive regulation of cytokine secretion involved in immune response;positive regulation of interleukin-1 beta secretion;membrane raft	3D-structure;ATP-binding;Acetylation;Allosteric enzyme;Alternative splicing;Charcot-Marie-Tooth disease;Cytoplasm;Direct protein sequencing;Disease mutation;Glycolysis;Immunity;Inflammatory response;Innate immunity;Kinase;Membrane;Mental retardation;Mitochondrion;Mitochondrion outer membrane;Neurodegeneration;Neuropathy;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Retinitis pigmentosa;Transferase	R-HSA-1430728;R-HSA-1643685;R-HSA-5619115;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-5619102;R-HSA-5619056	Metabolism;Disease;Disorders of transmembrane transporters;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;SLC transporter disorders;Defective HK1 causes hexokinase deficiency (HK deficiency)
COQ7	negative	SPON2	ENSG00000159674	COQ7	1	COQ7	1	0.00297487008243458					GO:0046872;GO:0007155;GO:0005515;GO:0005576;GO:0002376;GO:0045087;GO:0031012;GO:0070062;GO:0001530;GO:0003823;GO:0002448;GO:0008228;GO:0032496;GO:0032755;GO:0032760;GO:0042742;GO:0043152;GO:0050832;GO:0051607;GO:0060907;GO:0071222;GO:0005615	metal ion binding;cell adhesion;protein binding;extracellular region;immune system process;innate immune response;extracellular matrix;extracellular exosome;lipopolysaccharide binding;antigen binding;mast cell mediated immunity;opsonization;response to lipopolysaccharide;positive regulation of interleukin-6 production;positive regulation of tumor necrosis factor production;defense response to bacterium;induction of bacterial agglutination;defense response to fungus;defense response to virus;positive regulation of macrophage cytokine production;cellular response to lipopolysaccharide;extracellular space	3D-structure;Calcium;Cell adhesion;Direct protein sequencing;Disulfide bond;Extracellular matrix;Glycoprotein;Immunity;Innate immunity;Metal-binding;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-392499;R-HSA-597592;R-HSA-1643685;R-HSA-3781865;R-HSA-3906995;R-HSA-5083635;R-HSA-5173105;R-HSA-5173214	Metabolism of proteins;Post-translational protein modification;Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins
COQ7	negative	NLRX1	ENSG00000160703	COQ7	1	COQ7	1	0.00297487008243458					GO:0005739;GO:0005886;GO:0030054;GO:0016020;GO:0000166;GO:0005524;GO:0005515;GO:0005741;GO:0002376;GO:0045087;GO:0005737;GO:0035556;GO:0016032;GO:0032480;GO:0043124;GO:0032688;GO:0032715;GO:0039536;GO:0045824;GO:0050728	plasma membrane;mitochondrion;cell junction;protein binding;membrane;nucleotide binding;ATP binding;mitochondrial outer membrane;immune system process;innate immune response;intracellular signal transduction;viral process;negative regulation of type I interferon production;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of interferon-beta production;negative regulation of interleukin-6 production;negative regulation of RIG-I signaling pathway;negative regulation of innate immune response;negative regulation of inflammatory response	3D-structure;ATP-binding;Alternative splicing;Host-virus interaction;Immunity;Innate immunity;Leucine-rich repeat;Membrane;Mitochondrion;Mitochondrion outer membrane;Nucleotide-binding;Polymorphism;Reference proteome;Repeat;Transit peptide	R-HSA-168249;R-HSA-168256;R-HSA-168928;R-HSA-936440	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Negative regulators of DDX58/IFIH1 signaling
COQ7	negative	AP2M1	ENSG00000161203	COQ7	1	COQ7	1	0.00297487008243458	WBGene00001082				GO:0016020;GO:0006886;GO:0015031;GO:0016192;GO:0005886;GO:0030131;GO:0005515;GO:0005905;GO:0008289;GO:0005829;GO:0006897;GO:0070062;GO:0060071;GO:0044325;GO:0019886;GO:0061024;GO:0048013;GO:0030666;GO:0072583;GO:0005765;GO:0034383;GO:0036020;GO:0050690;GO:0035615;GO:0032802;GO:0030122;GO:0030669;GO:0045334;GO:0050750;GO:1903077;GO:0005048;GO:0031623;GO:0034622;GO:0006900;GO:0097494;GO:0098793;GO:0098794;GO:0097718;GO:0002092;GO:0048488;GO:0065003;GO:0098884;GO:1900244;GO:0098978	intracellular protein transport;vesicle-mediated transport;clathrin adaptor complex;membrane;protein transport;plasma membrane;protein binding;lipid binding;clathrin-coated pit;endocytosis;cytosol;extracellular exosome;Wnt signaling pathway, planar cell polarity pathway;ion channel binding;antigen processing and presentation of exogenous peptide antigen via MHC class II;membrane organization;ephrin receptor signaling pathway;endocytic vesicle membrane;clathrin-dependent endocytosis;lysosomal membrane;low-density lipoprotein particle clearance;endolysosome membrane;regulation of defense response to virus by virus;clathrin adaptor activity;low-density lipoprotein particle receptor catabolic process;AP-2 adaptor complex;clathrin-coated endocytic vesicle membrane;clathrin-coated endocytic vesicle;low-density lipoprotein particle receptor binding;negative regulation of protein localization to plasma membrane;signal sequence binding;receptor internalization;cellular protein-containing complex assembly;vesicle budding from membrane;regulation of vesicle size;presynapse;postsynapse;disordered domain specific binding;positive regulation of receptor internalization;synaptic vesicle endocytosis;protein-containing complex assembly;postsynaptic neurotransmitter receptor internalization;positive regulation of synaptic vesicle endocytosis;glutamatergic synapse	3D-structure;Alternative splicing;Cell membrane;Coated pit;Disease mutation;Endocytosis;Epilepsy;Lipid-binding;Membrane;Mental retardation;Phosphoprotein;Protein transport;Reference proteome;Transport	R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-382551;R-HSA-162582;R-HSA-199991;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-195721;R-HSA-3858494;R-HSA-4086400;R-HSA-157858;R-HSA-190828;R-HSA-2132295;R-HSA-9006934;R-HSA-8856828;R-HSA-2682334;R-HSA-166520;R-HSA-187037;R-HSA-8856825;R-HSA-5099900;R-HSA-3928665;R-HSA-174824;R-HSA-8964038;R-HSA-8964043;R-HSA-164938;R-HSA-164952;R-HSA-167590;R-HSA-177504;R-HSA-182218;R-HSA-5140745;R-HSA-8866427;R-HSA-190873;R-HSA-196025;R-HSA-164939	Adaptive Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Transport of small molecules;Signal Transduction;Membrane Trafficking;Disease;HIV Infection;Infectious disease;Host Interactions of HIV factors;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway;Gap junction trafficking and regulation;Gap junction trafficking;MHC class II antigen presentation;Signaling by Receptor Tyrosine Kinases;Clathrin-mediated endocytosis;EPH-Ephrin signaling;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Cargo recognition for clathrin-mediated endocytosis;WNT5A-dependent internalization of FZD4;EPH-ephrin mediated repulsion of cells;Plasma lipoprotein assembly, remodeling, and clearance;LDL clearance;Plasma lipoprotein clearance;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Nef Mediated CD4 Down-regulation;Retrograde neurotrophin signalling;Nef Mediated CD8 Down-regulation;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;VLDLR internalisation and degradation;Gap junction degradation;Formation of annular gap junctions;Nef mediated downregulation of CD28 cell surface expression
COQ7	negative	UBTD1	ENSG00000165886	COQ7	1	COQ7	1	0.00297487008243458					GO:0005515	protein binding	Reference proteome		
COQ7	negative	FOSL1	ENSG00000175592	COQ7	1	COQ7	1	0.00297487008243458	WBGene00001345				GO:0005634;GO:0005654;GO:0006355;GO:0003677;GO:0006357;GO:0003700;GO:0005515;GO:0000978;GO:0000981;GO:0000790;GO:0006935;GO:0006366;GO:0009615;GO:0061614;GO:0006968;GO:0008284;GO:2000144;GO:0000977;GO:0001228;GO:0001701;GO:0007296;GO:0007565;GO:0007612;GO:0008285;GO:0009612;GO:0009629;GO:0014070;GO:0031668;GO:0032570;GO:0034097;GO:0042493;GO:0042542;GO:0043065;GO:0045787;GO:0045944;GO:0051091;GO:0051412;GO:0051591;GO:0060674;GO:0005829;GO:0042734;GO:0043005;GO:0043231	DNA binding;nucleus;DNA-binding transcription factor activity;regulation of transcription by RNA polymerase II;nucleoplasm;regulation of transcription, DNA-templated;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II cis-regulatory region sequence-specific DNA binding;nuclear chromatin;chemotaxis;transcription by RNA polymerase II;response to virus;pri-miRNA transcription by RNA polymerase II;cellular defense response;positive regulation of cell population proliferation;positive regulation of DNA-templated transcription, initiation;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;in utero embryonic development;vitellogenesis;female pregnancy;learning;negative regulation of cell population proliferation;response to mechanical stimulus;response to gravity;response to organic cyclic compound;cellular response to extracellular stimulus;response to progesterone;response to cytokine;response to drug;response to hydrogen peroxide;positive regulation of apoptotic process;positive regulation of cell cycle;positive regulation of transcription by RNA polymerase II;positive regulation of DNA-binding transcription factor activity;response to corticosterone;response to cAMP;placenta blood vessel development;cytosol;presynaptic membrane;neuron projection;intracellular membrane-bounded organelle	Alternative splicing;DNA-binding;Nucleus;Phosphoprotein;Reference proteome		
COQ7	negative	CD151	ENSG00000177697	COQ7	1	COQ7	1	0.00297487008243458				Nephrotic syndrome-deafness-pretibial epidermolysis bullosa syndrome;nephropathy with pretibial epidermolysis bullosa and deafness;nephropathy with pretibial epidermolysis bullosa and deafness;RAPH BLOOD GROUP SYSTEM	GO:0016020;GO:0016021;GO:0005515;GO:0005925;GO:0016477;GO:0042098;GO:0005886;GO:0005887;GO:0005829;GO:0007155;GO:0005178;GO:0005604;GO:0009986;GO:0030335;GO:0031581;GO:0044319;GO:0045807	integral component of membrane;membrane;focal adhesion;protein binding;cell migration;T cell proliferation;plasma membrane;integral component of plasma membrane;cytosol;viral process;cell adhesion;integrin binding;basement membrane;cell surface;positive regulation of cell migration;hemidesmosome assembly;wound healing, spreading of cells;positive regulation of endocytosis	Blood group antigen;Deafness;Epidermolysis bullosa;Glycoprotein;Host-virus interaction;Lipoprotein;Membrane;Palmitate;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1474244;R-HSA-1474290;R-HSA-2022090;R-HSA-1500931;R-HSA-446728;R-HSA-446107	Extracellular matrix organization;Collagen formation;Assembly of collagen fibrils and other multimeric structures;Cell-Cell communication;Cell junction organization;Type I hemidesmosome assembly
COQ7	negative	VWA1	ENSG00000179403	COQ7	1	COQ7	1	0.00297487008243458					GO:0005615;GO:0005576;GO:0031012;GO:0070062;GO:0044267;GO:0005604;GO:0043687;GO:0062023;GO:0005788;GO:0005201;GO:0003429;GO:0042802;GO:0030198;GO:0048266;GO:0005614;GO:0005515	extracellular space;extracellular region;extracellular matrix;extracellular exosome;cellular protein metabolic process;basement membrane;post-translational protein modification;collagen-containing extracellular matrix;endoplasmic reticulum lumen;extracellular matrix structural constituent;growth plate cartilage chondrocyte morphogenesis;protein binding;identical protein binding;extracellular matrix organization;behavioral response to pain;interstitial matrix	Alternative splicing;Basement membrane;Disulfide bond;Extracellular matrix;Glycoprotein;Phosphoprotein;Reference proteome;Repeat;Secreted;Signal	R-HSA-392499;R-HSA-597592;R-HSA-381426;R-HSA-8957275	Metabolism of proteins;Post-translational protein modification;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation
COQ7	negative	OSBP2	ENSG00000184792	COQ7	1	COQ7	1	0.00297487008243458	WBGene00012930;WBGene00008832				GO:0016020;GO:0005515;GO:0006869;GO:0008289;GO:0043231;GO:0005829;GO:0015485;GO:0032934;GO:0007286;GO:0097440	membrane;protein binding;lipid transport;lipid binding;cytosol;intracellular membrane-bounded organelle;sterol transport;cholesterol binding;sterol transporter activity;sterol binding;spermatid development;apical dendrite	Alternative splicing;Lipid transport;Lipid-binding;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transport		
COQ7	negative	ENO1	ENSG00000074800	COQ7	1	COQ7	1	0.00441243856168061	WBGene00011884				GO:0005737;GO:0003723;GO:0005634;GO:0016020;GO:0046872;GO:0005829;GO:0000287;GO:0016829;GO:0006096;GO:0003677;GO:0005886;GO:0005615;GO:0005515;GO:0004634;GO:0000015;GO:0001227;GO:0000122;GO:0045296;GO:0070062;GO:0009615;GO:0031430;GO:0030308;GO:0045892;GO:0000977;GO:0006094;GO:0061621;GO:0042803;GO:0051020;GO:0010756;GO:0045933;GO:1903298;GO:2001171;GO:0009986;GO:0099738	glycolytic process;magnesium ion binding;phosphopyruvate hydratase activity;phosphopyruvate hydratase complex;cytoplasm;RNA binding;nucleus;membrane;metal ion binding;cytosol;plasma membrane;lyase activity;DNA binding;extracellular space;protein binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;cadherin binding;extracellular exosome;response to virus;M band;negative regulation of cell growth;negative regulation of transcription, DNA-templated;RNA polymerase II regulatory region sequence-specific DNA binding;gluconeogenesis;canonical glycolysis;GTPase binding;protein homodimerization activity;positive regulation of plasminogen activation;positive regulation of muscle contraction;negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway;positive regulation of ATP biosynthetic process;cell surface;cell cortex region	3D-structure;Acetylation;Alternative initiation;Cell membrane;Cytoplasm;DNA-binding;Direct protein sequencing;Glycolysis;Hydroxylation;Isopeptide bond;Lyase;Magnesium;Membrane;Metal-binding;Nucleus;Phosphoprotein;Plasminogen activation;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-1430728;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-70263	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Gluconeogenesis
COQ7	negative	UNC13D	ENSG00000092929	COQ7	1	COQ7	1	0.00441243856168061	WBGene00018837	WBGene00000084(0)		Familial hemophagocytic lymphohistiocytosis;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FAMILIAL 3	GO:0005737;GO:0016020;GO:0043231;GO:0005829;GO:0006887;GO:0005764;GO:0005576;GO:0005768;GO:0005515;GO:0005770;GO:0055037;GO:0043312;GO:0045921;GO:0035578;GO:0017137;GO:1903307;GO:0033093;GO:0070382;GO:0043304;GO:0002432;GO:0002467;GO:0006909;GO:0043320;GO:0051607;GO:1900026	cytoplasm;membrane;intracellular membrane-bounded organelle;cytosol;endosome;exocytosis;protein binding;lysosome;extracellular region;late endosome;recycling endosome;neutrophil degranulation;positive regulation of exocytosis;azurophil granule lumen;Rab GTPase binding;positive regulation of regulated secretory pathway;Weibel-Palade body;exocytic vesicle;regulation of mast cell degranulation;granuloma formation;germinal center formation;phagocytosis;natural killer cell degranulation;defense response to virus;positive regulation of substrate adhesion-dependent cell spreading	Alternative splicing;Calcium;Cytoplasm;Endosome;Exocytosis;Familial hemophagocytic lymphohistiocytosis;Lysosome;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ7	negative	CHMP4B	ENSG00000101421	COQ7	1	COQ7	1	0.00441243856168061	WBGene00016961;WBGene00016497	WBGene00016961(1)		Early-onset posterior polar cataract;Early-onset posterior subcapsular cataract;CATARACT 31 MULTIPLE TYPES	GO:0005634;GO:0005737;GO:0016020;GO:0015031;GO:0005829;GO:0042803;GO:0005515;GO:0007034;GO:0030496;GO:0042802;GO:0005768;GO:0031902;GO:0045296;GO:0070062;GO:0016197;GO:0016236;GO:0019058;GO:0036258;GO:0039702;GO:0051260;GO:0009898;GO:0010458;GO:0005635;GO:0000281;GO:0031982;GO:0007080;GO:0010824;GO:0006997;GO:0031468;GO:0050792;GO:0060548;GO:0061952;GO:1901673;GO:1902188;GO:0000815;GO:0030117;GO:1902902;GO:0090611;GO:0090148;GO:1901215;GO:0036438;GO:0046755;GO:0006914;GO:0006620;GO:0010506	vacuolar transport;cell;nucleus;cytoplasm;membrane;protein transport;endosome;cytosol;protein homodimerization activity;protein binding;identical protein binding;midbody;late endosome membrane;cadherin binding;extracellular exosome;endosomal transport;macroautophagy;viral life cycle;multivesicular body assembly;viral budding via host ESCRT complex;viral process;cytoplasmic side of plasma membrane;exit from mitosis;nuclear envelope;mitotic cytokinesis;protein polymerization;vesicle;mitotic metaphase plate congression;regulation of centrosome duplication;nucleus organization;nuclear envelope reassembly;regulation of viral process;negative regulation of cell death;midbody abscission;regulation of mitotic spindle assembly;positive regulation of viral release from host cell;ESCRT III complex;membrane coat;negative regulation of autophagosome assembly;ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;membrane fission;negative regulation of neuron death;maintenance of lens transparency;viral budding;autophagy;posttranslational protein targeting to endoplasmic reticulum membrane;regulation of autophagy	3D-structure;Acetylation;Cataract;Coiled coil;Cytoplasm;Direct protein sequencing;Disease mutation;Endosome;Host-virus interaction;Membrane;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transport;Ubl conjugation	R-HSA-5653656;R-HSA-199991;R-HSA-1643685;R-HSA-162587;R-HSA-162588;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-917729;R-HSA-9612973;R-HSA-9615710;R-HSA-8953897;R-HSA-1632852	Vesicle-mediated transport;Membrane Trafficking;Disease;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);Autophagy;Late endosomal microautophagy;Cellular responses to external stimuli;Macroautophagy
COQ7	negative	TIMP1	ENSG00000102265	COQ7	1	COQ7	1	0.00441243856168061	WBGene00019478				GO:1901164;GO:0046872;GO:0008270;GO:0008083;GO:0005615;GO:0010951;GO:0005515;GO:0005576;GO:0005581;GO:0005125;GO:0008191;GO:0031012;GO:0030414;GO:0010466;GO:0070062;GO:0044267;GO:0043687;GO:0002020;GO:0008284;GO:0002576;GO:0005788;GO:0031093;GO:0019221;GO:0022617;GO:2001044;GO:0004857;GO:0043086;GO:0010033;GO:0001775;GO:0002248;GO:0007568;GO:0009725;GO:0034097;GO:0042060;GO:0043066;GO:0043434;GO:0051045;GO:0051216;GO:1905049;GO:0005604	protein binding;metalloendopeptidase inhibitor activity;negative regulation of trophoblast cell migration;metal ion binding;zinc ion binding;growth factor activity;extracellular space;negative regulation of endopeptidase activity;extracellular region;collagen trimer;cytokine activity;extracellular matrix;peptidase inhibitor activity;negative regulation of peptidase activity;extracellular exosome;cellular protein metabolic process;post-translational protein modification;protease binding;positive regulation of cell population proliferation;platelet degranulation;endoplasmic reticulum lumen;platelet alpha granule lumen;cytokine-mediated signaling pathway;extracellular matrix disassembly;regulation of integrin-mediated signaling pathway;enzyme inhibitor activity;negative regulation of catalytic activity;response to organic substance;cell activation;connective tissue replacement involved in inflammatory response wound healing;aging;response to hormone;response to cytokine;wound healing;negative regulation of apoptotic process;response to peptide hormone;negative regulation of membrane protein ectodomain proteolysis;cartilage development;negative regulation of metallopeptidase activity;basement membrane	3D-structure;Direct protein sequencing;Disulfide bond;Glycoprotein;Growth factor;Metal-binding;Metalloenzyme inhibitor;Metalloprotease inhibitor;Phosphoprotein;Protease inhibitor;Reference proteome;Secreted;Signal;Zinc	R-HSA-109582;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-1280215;R-HSA-449147;R-HSA-1474228;R-HSA-1474244;R-HSA-76002;R-HSA-76005;R-HSA-114608;R-HSA-381426;R-HSA-8957275;R-HSA-6783783;R-HSA-6785807;R-HSA-1592389	Hemostasis;Immune System;Metabolism of proteins;Post-translational protein modification;Cytokine Signaling in Immune system;Signaling by Interleukins;Degradation of the extracellular matrix;Extracellular matrix organization;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Activation of Matrix Metalloproteinases
COQ7	negative	GIT1	ENSG00000108262	COQ7	1	COQ7	1	0.00441243856168061	WBGene00008805				GO:0005737;GO:0016020;GO:0046872;GO:0005829;GO:0005925;GO:0005096;GO:0043547;GO:0005515;GO:0048013;GO:0008277;GO:0032465;GO:0044877;GO:0099171;GO:2000300;GO:0044305	protein binding;GTPase activator activity;cytoplasm;membrane;metal ion binding;cytosol;mitochondrion;focal adhesion;positive regulation of GTPase activity;ephrin receptor signaling pathway;regulation of G protein-coupled receptor signaling pathway;regulation of cytokinesis;protein-containing complex binding;presynaptic modulation of chemical synaptic transmission;regulation of synaptic vesicle exocytosis;calyx of Held	ANK repeat;Alternative splicing;Cytoplasm;GTPase activation;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Zinc;Zinc-finger	R-HSA-1266738;R-HSA-422475;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-438064;R-HSA-442755;R-HSA-2682334;R-HSA-3928664;R-HSA-9619229	Developmental Biology;Axon guidance;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;EPH-Ephrin signaling;Ephrin signaling;Activation of RAC1 downstream of NMDARs
COQ7	negative	SLC6A4	ENSG00000108576	COQ7	1	COQ7	1	0.00441243856168061	WBGene00003387;WBGene00000934			ANXIETYHARM AVOIDANCE INCLUDED;Obsessive-compulsive disorder	GO:0016020;GO:0016021;GO:0005887;GO:0046872;GO:0015293;GO:0005886;GO:0005328;GO:0006836;GO:0055085;GO:0030054;GO:0045202;GO:0045121;GO:0005925;GO:0005768;GO:0005515;GO:0043005;GO:0051015;GO:0010008;GO:0012505;GO:0005335;GO:0051259;GO:0009636;GO:0042136;GO:0017137;GO:0051378;GO:0035176;GO:0008504;GO:0015844;GO:0046621;GO:0048854;GO:0051610;GO:0090067;GO:0098793;GO:0017022;GO:0017075;GO:0019811;GO:0042803;GO:0050998;GO:0001666;GO:0006837;GO:0007420;GO:0007584;GO:0007613;GO:0007623;GO:0010033;GO:0010628;GO:0014064;GO:0021941;GO:0032227;GO:0032355;GO:0042310;GO:0042493;GO:0042713;GO:0045665;GO:0045787;GO:0051260;GO:0071300;GO:0071310;GO:0071321;GO:0098810;GO:0099055;GO:0099056;GO:0099154	integral component of membrane;integral component of plasma membrane;neurotransmitter transport;neurotransmitter:sodium symporter activity;serotonin:sodium symporter activity;membrane;metal ion binding;endosome;focal adhesion;symporter activity;plasma membrane;cell junction;identical protein binding;transmembrane transport;membrane raft;synapse;protein binding;neuron projection;actin filament binding;endosome membrane;endomembrane system;response to toxic substance;neurotransmitter biosynthetic process;serotonin binding;social behavior;monoamine transmembrane transporter activity;monoamine transport;negative regulation of organ growth;brain morphogenesis;serotonin uptake;regulation of thalamus size;presynapse;syntaxin-1 binding;cocaine binding;nitric-oxide synthase binding;response to hypoxia;serotonin transport;brain development;response to nutrient;memory;circadian rhythm;response to organic substance;positive regulation of gene expression;positive regulation of serotonin secretion;negative regulation of cerebellar granule cell precursor proliferation;negative regulation of synaptic transmission, dopaminergic;response to estradiol;vasoconstriction;response to drug;sperm ejaculation;negative regulation of neuron differentiation;positive regulation of cell cycle;cellular response to retinoic acid;cellular response to organic substance;cellular response to cGMP;neurotransmitter reuptake;integral component of postsynaptic membrane;integral component of presynaptic membrane;serotonergic synapse	3D-structure;Alternative splicing;Cell junction;Cell membrane;Disulfide bond;Endosome;Glycoprotein;Membrane;Metal-binding;Neurotransmitter transport;Phosphoprotein;Polymorphism;Reference proteome;Sodium;Symport;Synapse;Transmembrane;Transmembrane helix;Transport	R-HSA-112315;R-HSA-112316;R-HSA-112311;R-HSA-380615	Transmission across Chemical Synapses;Neuronal System;Neurotransmitter clearance;Serotonin clearance from the synaptic cleft
COQ7	negative	PITPNM1	ENSG00000110697	COQ7	1	COQ7	1	0.00441243856168061	WBGene00010813				GO:0005737;GO:0016020;GO:0015031;GO:0046872;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0005515;GO:0005815;GO:0005548;GO:0015914;GO:0036464;GO:0005509;GO:0030496;GO:0032580;GO:0031210;GO:0035091;GO:0032154;GO:0006661;GO:0030971;GO:0008525;GO:0008526;GO:0070300;GO:0006629;GO:0007420;GO:0007602;GO:0005811;GO:0044297;GO:0005622	metal ion binding;phospholipid transporter activity;phospholipid transport;cytoplasm;membrane;protein transport;cytosol;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;protein binding;cytoplasmic ribonucleoprotein granule;calcium ion binding;midbody;Golgi cisterna membrane;phosphatidylcholine binding;phosphatidylinositol binding;cleavage furrow;phosphatidylinositol biosynthetic process;receptor tyrosine kinase binding;phosphatidylcholine transporter activity;phosphatidylinositol transfer activity;phosphatidic acid binding;lipid metabolic process;brain development;phototransduction;lipid droplet;cell body	Alternative splicing;Calcium;Cytoplasm;Endoplasmic reticulum;Golgi apparatus;Lipid droplet;Membrane;Metal-binding;Methylation;Phosphoprotein;Protein transport;Reference proteome;Transport	R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1483226	Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Synthesis of PI
COQ7	negative	GNAI2	ENSG00000114353	COQ7	1	COQ7	1	0.00441243856168061	WBGene00001666;WBGene00001678;WBGene00001648;WBGene00001669;WBGene00003850	WBGene00001664(0);WBGene00001675(0);WBGene00001665(0);WBGene00001745(0);WBGene00001670(0);WBGene00001671(0);WBGene00001673(0);WBGene00001668(0);WBGene00001676(0);WBGene00001667(0)		VENTRICULAR TACHYCARDIA FAMILIAL	GO:0008284;GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0007186;GO:0005829;GO:0005654;GO:0007165;GO:0003924;GO:0005525;GO:0005886;GO:0051301;GO:0005856;GO:0005515;GO:0005834;GO:0007049;GO:0019001;GO:0031683;GO:0007188;GO:0005813;GO:0005815;GO:0030496;GO:0070062;GO:0001664;GO:0006457;GO:0007193;GO:1903561;GO:0007584;GO:0007194;GO:0007214;GO:0001973;GO:0007189;GO:0007213;GO:0008283;GO:0030335;GO:0032930;GO:0033864;GO:0035810;GO:0035815;GO:0045955;GO:0046628;GO:0050805;GO:0051924;GO:0070374;GO:0140199;GO:1903614;GO:1904707;GO:2000179;GO:2001234;GO:0005634;GO:0030425;GO:0044297;GO:0045121	G protein-coupled receptor signaling pathway;signal transduction;GTP binding;GTPase activity;G-protein beta/gamma-subunit complex binding;guanyl nucleotide binding;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;positive regulation of cell population proliferation;cytoplasm;membrane;metal ion binding;nucleotide binding;nucleoplasm;cytosol;plasma membrane;cytoskeleton;cell division;protein binding;heterotrimeric G-protein complex;cell cycle;synapse;centrosome;microtubule organizing center;midbody;extracellular exosome;G protein-coupled receptor binding;protein folding;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;extracellular vesicle;response to nutrient;negative regulation of adenylate cyclase activity;gamma-aminobutyric acid signaling pathway;adenosine receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;G protein-coupled acetylcholine receptor signaling pathway;cell population proliferation;positive regulation of cell migration;positive regulation of superoxide anion generation;positive regulation of NAD(P)H oxidase activity;positive regulation of urine volume;positive regulation of renal sodium excretion;negative regulation of calcium ion-dependent exocytosis;positive regulation of insulin receptor signaling pathway;negative regulation of synaptic transmission;regulation of calcium ion transport;positive regulation of ERK1 and ERK2 cascade;negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process;negative regulation of protein tyrosine phosphatase activity;positive regulation of vascular smooth muscle cell proliferation;positive regulation of neural precursor cell proliferation;negative regulation of apoptotic signaling pathway;nucleus;dendrite;cell body;membrane raft	3D-structure;ADP-ribosylation;Alternative splicing;Cell cycle;Cell division;Cell membrane;Cytoplasm;Cytoskeleton;GTP-binding;Lipoprotein;Magnesium;Membrane;Metal-binding;Myristate;Nucleotide-binding;Palmitate;Reference proteome;Transducer	R-HSA-109582;R-HSA-392499;R-HSA-1430728;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418555;R-HSA-418594;R-HSA-418597;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-390466;R-HSA-391251;R-HSA-977443;R-HSA-111885;R-HSA-112040;R-HSA-112043;R-HSA-170670;R-HSA-202040;R-HSA-392170;R-HSA-392518;R-HSA-6814122;R-HSA-76002;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-977444;R-HSA-991365;R-HSA-163685;R-HSA-422356;R-HSA-400042	Hemostasis;Metabolism of proteins;Metabolism;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Chaperonin-mediated protein folding;Protein folding;GABA receptor activation;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Adenylate cyclase inhibitory pathway;G-protein activation;ADP signalling through P2Y purinoceptor 12;Signal amplification;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;GABA B receptor activation;Activation of GABAB receptors;Integration of energy metabolism;Regulation of insulin secretion;Adrenaline,noradrenaline inhibits insulin secretion
COQ7	negative	KIAA2013	ENSG00000116685	COQ7	1	COQ7	1	0.00441243856168061	WBGene00015928	WBGene00015928(0)			GO:0016020;GO:0016021	membrane;integral component of membrane	Alternative splicing;Glycoprotein;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ7	negative	PPDPF	ENSG00000125534	COQ7	1	COQ7	1	0.00441243856168061					GO:0007275;GO:0030154	multicellular organism development;cell differentiation	Alternative splicing;Developmental protein;Differentiation;Phosphoprotein;Reference proteome		
COQ7	negative	NR1D1	ENSG00000126368	COQ7	1	COQ7	1	0.00441243856168061	WBGene00003675	WBGene00044353(0);WBGene00013512(0);WBGene00011565(0);WBGene00011566(0);WBGene00008901(0);WBGene00011568(0);WBGene00022639(0);WBGene00022640(0);WBGene00022637(0);WBGene00008208(0);WBGene00012050(0);WBGene00010017(0);WBGene00006471(0);WBGene00014068(0);WBGene00010186(0);WBGene00012056(0);WBGene00003641(0);WBGene00008884(0);WBGene00010601(0);WBGene00010602(0);WBGene00010600(0);WBGene00003642(0);WBGene00010603(0);WBGene00018404(0);WBGene00016927(0);WBGene00016926(0);WBGene00010180(0);WBGene00018541(0);WBGene00003614(0);WBGene00018545(0);WBGene00018544(0);WBGene00003608(0);WBGene00003702(0);WBGene00011396(0);WBGene00007367(0);WBGene00003653(0);WBGene00003640(0);WBGene00016367(0);WBGene00016366(0);WBGene00016365(0);WBGene00016368(0);WBGene00020750(0);WBGene00018542(0);WBGene00003638(0);WBGene00015897(0);WBGene00003648(0);WBGene00020852(0);WBGene00003715(0);WBGene00020850(0);WBGene00020849(0);WBGene00003705(0);WBGene00020851(0);WBGene00020015(0);WBGene00017961(0);WBGene00003685(0);WBGene00003696(0);WBGene00003708(0);WBGene00003728(0);WBGene00022805(0);WBGene00003669(0);WBGene00021610(0);WBGene00003632(0);WBGene00003698(0);WBGene00008830(0);WBGene00021611(0);WBGene00018265(0);WBGene00018266(0);WBGene00003646(0);WBGene00003725(0);WBGene00044699(0);WBGene00003620(0);WBGene00021617(0);WBGene00003651(0);WBGene00003618(0);WBGene00015497(0);WBGene00016517(0);WBGene00008619(0);WBGene00008630(0);WBGene00003723(0);WBGene00018415(0);WBGene00018622(0);WBGene00012446(0);WBGene00003655(0);WBGene00013584(0);WBGene00015901(0);WBGene00015900(0);WBGene00015902(0);WBGene00018539(0);WBGene00003680(0);WBGene00010215(0);WBGene00003722(0);WBGene00006790(0);WBGene00021522(0);WBGene00020062(0);WBGene00003693(0);WBGene00003617(0);WBGene00003716(0);WBGene00003718(0);WBGene00003724(0);WBGene00003686(0);WBGene00003712(0);WBGene00003677(0);WBGene00003694(0);WBGene00011520(0);WBGene00003692(0);WBGene00011750(0);WBGene00020385(0);WBGene00014189(0);WBGene00003663(0);WBGene00003671(0);WBGene00003672(0);WBGene00010410(0);WBGene00008778(0);WBGene00003662(0);WBGene00003667(0);WBGene00008474(0);WBGene00008289(0);WBGene00008056(0);WBGene00011651(0);WBGene00009608(0);WBGene00008158(0);WBGene00016233(0);WBGene00022756(0);WBGene00015758(0);WBGene00001062(0);WBGene00022726(0);WBGene00012596(0);WBGene00003714(0);WBGene00016772(0);WBGene00003658(0);WBGene00003704(0);WBGene00012703(0);WBGene00018412(0);WBGene00019742(0);WBGene00019741(0);WBGene00019743(0);WBGene00003688(0);WBGene00003713(0);WBGene00003689(0);WBGene00003645(0);WBGene00003720(0);WBGene00020153(0);WBGene00020152(0);WBGene00021163(0);WBGene00003649(0);WBGene00003721(0);WBGene00019115(0);WBGene00020555(0);WBGene00003634(0);WBGene00019116(0);WBGene00003707(0);WBGene00017503(0);WBGene00017512(0);WBGene00003700(0);WBGene00016364(0);WBGene00003684(0);WBGene00016091(0);WBGene00003717(0);WBGene00008309(0);WBGene00012449(0);WBGene00013067(0);WBGene00003644(0);WBGene00020460(0);WBGene00003615(0);WBGene00003699(0);WBGene00003676(0);WBGene00003601(0);WBGene00003611(0);WBGene00011002(0);WBGene00003622(0);WBGene00010604(0);WBGene00003643(0);WBGene00004786(0);WBGene00003624(0);WBGene00003682(0);WBGene00003660(0);WBGene00014193(0);WBGene00045515(0);WBGene00011150(0);WBGene00013940(0);WBGene00022097(0);WBGene00018189(0);WBGene00013483(0)			GO:0071222;GO:0044212;GO:0005634;GO:0005737;GO:0008270;GO:0046872;GO:0006355;GO:0003677;GO:0003700;GO:0019216;GO:0043565;GO:0042995;GO:0005515;GO:0003707;GO:0030522;GO:0043401;GO:0016604;GO:0048511;GO:0032922;GO:0030154;GO:0045893;GO:0030425;GO:0020037;GO:0000981;GO:0000977;GO:0045944;GO:0000122;GO:0000790;GO:0008134;GO:0000978;GO:0001227;GO:0005654;GO:0090575;GO:0031648;GO:0038023;GO:0050728;GO:0071347;GO:0071356;GO:0009755;GO:0043197;GO:0000976;GO:0070888;GO:0005978;GO:0007623;GO:0010498;GO:0042632;GO:0042749;GO:0042752;GO:0043124;GO:0044321;GO:0045598;GO:0045892;GO:0060086;GO:0061178;GO:0061469;GO:0061889;GO:0070859;GO:0120163;GO:0150079;GO:1903979;GO:0007275;GO:0003714;GO:0006367;GO:0030374;GO:0001222;GO:0004879;GO:0033993;GO:0010871;GO:0034144;GO:0035947	DNA binding;steroid hormone receptor activity;zinc ion binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;sequence-specific DNA binding;cell;cellular response to lipopolysaccharide;transcription regulatory region DNA binding;cytoplasm;metal ion binding;regulation of lipid metabolic process;cell projection;protein binding;intracellular receptor signaling pathway;steroid hormone mediated signaling pathway;nuclear body;rhythmic process;cell junction;circadian regulation of gene expression;cell differentiation;positive regulation of transcription, DNA-templated;synapse;dendrite;heme binding;DNA-binding transcription factor activity, RNA polymerase II-specific;multicellular organism development;positive regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;nuclear chromatin;transcription factor binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;nucleoplasm;RNA polymerase II transcription factor complex;protein destabilization;signaling receptor activity;negative regulation of inflammatory response;cellular response to interleukin-1;cellular response to tumor necrosis factor;hormone-mediated signaling pathway;dendritic spine;transcription regulatory region sequence-specific DNA binding;E-box binding;glycogen biosynthetic process;circadian rhythm;proteasomal protein catabolic process;cholesterol homeostasis;regulation of circadian sleep/wake cycle;regulation of circadian rhythm;negative regulation of I-kappaB kinase/NF-kappaB signaling;response to leptin;regulation of fat cell differentiation;negative regulation of transcription, DNA-templated;circadian temperature homeostasis;regulation of insulin secretion involved in cellular response to glucose stimulus;regulation of type B pancreatic cell proliferation;negative regulation of astrocyte activation;positive regulation of bile acid biosynthetic process;negative regulation of cold-induced thermogenesis;negative regulation of neuroinflammatory response;negative regulation of microglial cell activation;transcription corepressor activity;transcription initiation from RNA polymerase II promoter;cellular glucose homeostasis;nuclear receptor transcription coactivator activity;ligand-activated transcription factor activity;response to lipid;transcription corepressor binding;nuclear receptor activity;negative regulation of receptor biosynthetic process;negative regulation of toll-like receptor 4 signaling pathway	3D-structure;Acetylation;Activator;Biological rhythms;Cell junction;Cell projection;Cytoplasm;DNA-binding;Differentiation;Heme;Iron;Metal-binding;Nucleus;Phosphoprotein;Receptor;Reference proteome;Repressor;Synapse;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1852241;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-400206;R-HSA-400253;R-HSA-1592230;R-HSA-2151201;R-HSA-1368071;R-HSA-383280	Organelle biogenesis and maintenance;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;NR1D1 (REV-ERBA) represses gene expression;Nuclear Receptor transcription pathway
COQ7	negative	ELK1	ENSG00000126767	COQ7	1	COQ7	1	0.00441243856168061	WBGene00002990;WBGene00022207;WBGene00017598;WBGene00017601		EIF2AK1;EZH2;FOSL1;MECOM;MUC4;PSEN1;TNFRSF10B		GO:0045944;GO:0005634;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0005515;GO:0045893;GO:0000981;GO:0030154;GO:0006357;GO:0000790;GO:0000978;GO:0001228;GO:0001085;GO:0071774;GO:0003682;GO:0003690;GO:0009416;GO:0071394;GO:0071396;GO:0071480;GO:1901216;GO:0005737;GO:0005739;GO:0030425;GO:0043025;GO:0043679	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II;nucleus;nucleoplasm;DNA binding;protein binding;positive regulation of transcription, DNA-templated;DNA-binding transcription factor activity, RNA polymerase II-specific;cell differentiation;regulation of transcription by RNA polymerase II;nuclear chromatin;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;RNA polymerase II transcription factor binding;response to fibroblast growth factor;chromatin binding;double-stranded DNA binding;response to light stimulus;cellular response to testosterone stimulus;cellular response to lipid;cellular response to gamma radiation;positive regulation of neuron death;cytoplasm;mitochondrion;dendrite;neuronal cell body;axon terminus	3D-structure;Activator;Alternative splicing;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-9006934;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-166520;R-HSA-187037;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-975871;R-HSA-9634638;R-HSA-198725;R-HSA-198753;R-HSA-450282	Innate Immune System;Immune System;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;MyD88 cascade initiated on plasma membrane;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;MAPK targets/ Nuclear events mediated by MAP kinases
COQ7	negative	ETV6	ENSG00000139083	COQ7	1	COQ7	1	0.00441243856168061			BBC3;CDKN1A;IGFBP5	Chronic myelomonocytic leukemia;Congenital mesoblastic nephroma;Differentiated thyroid carcinoma;Familial platelet disorder with associated myeloid malignancy;Fibrosarcoma;Precursor B-cell acute lymphoblastic leukemia;Primary hypereosinophilic syndrome;LEUKEMIA ACUTE MYELOID;Thrombocytopenia 5	GO:0005634;GO:0005730;GO:0005829;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0005515;GO:0000981;GO:0030154;GO:0000978;GO:0001228;GO:0007296;GO:0022008;GO:0045944;GO:0097152;GO:0006357;GO:0000790;GO:0001227;GO:0000122;GO:0019904;GO:0000977;GO:0071425;GO:0016020;GO:0016021	regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;sequence-specific DNA binding;nucleolus;cytosol;DNA binding;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cell differentiation;regulation of transcription by RNA polymerase II;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;vitellogenesis;neurogenesis;positive regulation of transcription by RNA polymerase II;mesenchymal cell apoptotic process;nuclear chromatin;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;protein domain specific binding;RNA polymerase II regulatory region sequence-specific DNA binding;hematopoietic stem cell proliferation;membrane;integral component of membrane	3D-structure;Acetylation;Chromosomal rearrangement;DNA-binding;Disease mutation;Isopeptide bond;Nucleus;Phosphoprotein;Proto-oncogene;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation		
COQ7	negative	PLCB3	ENSG00000149782	COQ7	1	COQ7	1	0.00441243856168061	WBGene00001177				GO:0016020;GO:0005654;GO:0016787;GO:0035556;GO:0005509;GO:0007165;GO:0006629;GO:0016042;GO:0005515;GO:0008081;GO:0004435;GO:0005829;GO:0045296;GO:0007186;GO:0032991;GO:0005516;GO:0048015;GO:0043647;GO:0007223;GO:0032959;GO:0051209;GO:0004629;GO:0003073;GO:0099524	signal transduction;calcium ion binding;intracellular signal transduction;lipid metabolic process;lipid catabolic process;phosphatidylinositol phospholipase C activity;phosphoric diester hydrolase activity;cell;membrane;nucleoplasm;hydrolase activity;protein binding;cytosol;cadherin binding;G protein-coupled receptor signaling pathway;protein-containing complex;calmodulin binding;phosphatidylinositol-mediated signaling;inositol phosphate metabolic process;Wnt signaling pathway, calcium modulating pathway;inositol trisphosphate biosynthetic process;release of sequestered calcium ion into cytosol;phospholipase C activity;regulation of systemic arterial blood pressure;postsynaptic cytosol	3D-structure;Acetylation;Alternative splicing;Calcium;Hydrolase;Lipid degradation;Lipid metabolism;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transducer	R-HSA-1430728;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-195721;R-HSA-3858494;R-HSA-416476;R-HSA-418594;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-111885;R-HSA-112040;R-HSA-112043;R-HSA-163685;R-HSA-422356;R-HSA-397795;R-HSA-4086398;R-HSA-418217;R-HSA-451326;R-HSA-500657;R-HSA-1483249;R-HSA-400451;R-HSA-434316;R-HSA-1855204;R-HSA-399997	Metabolism;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Signaling by WNT;Beta-catenin independent WNT signaling;G alpha (q) signalling events;G alpha (i) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Integration of energy metabolism;Regulation of insulin secretion;G-protein beta:gamma signalling;Ca2+ pathway;G beta:gamma signalling through PLC beta;Activation of kainate receptors upon glutamate binding;Presynaptic function of Kainate receptors;Inositol phosphate metabolism;Free fatty acids regulate insulin secretion;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Synthesis of IP3 and IP4 in the cytosol;Acetylcholine regulates insulin secretion
COQ7	negative	CITED4	ENSG00000179862	COQ7	1	COQ7	1	0.00441243856168061					GO:0005634;GO:0005737;GO:0006355;GO:0003713;GO:0005654;GO:0045944;GO:0043627;GO:0045893	regulation of transcription, DNA-templated;nucleus;cytoplasm;transcription coactivator activity;nucleoplasm;positive regulation of transcription by RNA polymerase II;response to estrogen;positive regulation of transcription, DNA-templated	Activator;Cytoplasm;Nucleus;Reference proteome;Transcription;Transcription regulation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260;R-HSA-8866907	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors
COQ7	negative	MXRA7	ENSG00000182534	COQ7	1	COQ7	1	0.00441243856168061	WBGene00007349				GO:0016020;GO:0016021;GO:0062023	membrane;integral component of membrane;endoplasmic reticulum;collagen-containing extracellular matrix	Alternative splicing;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
COQ7	negative	HGS	ENSG00000185359	COQ7	1	COQ7	1	0.00441243856168061	WBGene00004101	WBGene00004101(1)			GO:0005623;GO:0006886;GO:0016525;GO:0005737;GO:0016020;GO:0015031;GO:0043231;GO:0046872;GO:0016301;GO:0016310;GO:0005829;GO:0005515;GO:0005768;GO:0005764;GO:0070062;GO:0010628;GO:0072657;GO:0031901;GO:0016197;GO:0016236;GO:0036258;GO:0016579;GO:0007165;GO:0019904;GO:0006622;GO:0032585;GO:0061024;GO:1903543;GO:0044389;GO:0008285;GO:0042059;GO:0010324;GO:0010642;GO:0030948;GO:0042176;GO:0043405;GO:0046426;GO:0005769;GO:0033565	intracellular protein transport;metal ion binding;negative regulation of angiogenesis;negative regulation of vascular endothelial growth factor receptor signaling pathway;cytoplasm;membrane;protein transport;intracellular membrane-bounded organelle;kinase activity;phosphorylation;cytosol;endosome;protein binding;lysosome;extracellular exosome;positive regulation of gene expression;protein localization to membrane;early endosome membrane;endosomal transport;macroautophagy;multivesicular body assembly;protein deubiquitination;signal transduction;protein domain specific binding;protein targeting to lysosome;multivesicular body membrane;membrane organization;positive regulation of exosomal secretion;ubiquitin-like protein ligase binding;negative regulation of cell population proliferation;negative regulation of epidermal growth factor receptor signaling pathway;membrane invagination;negative regulation of platelet-derived growth factor receptor signaling pathway;regulation of protein catabolic process;regulation of MAP kinase activity;negative regulation of receptor signaling pathway via JAK-STAT;early endosome;ESCRT-0 complex	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Endosome;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport;Ubl conjugation;Zinc;Zinc-finger	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-199991;R-HSA-1643685;R-HSA-5663205;R-HSA-917729;R-HSA-5688426;R-HSA-5689880;R-HSA-9006934;R-HSA-199992;R-HSA-432720;R-HSA-8856828;R-HSA-8856825;R-HSA-177929;R-HSA-182971;R-HSA-6806834;R-HSA-6807004;R-HSA-8875360;R-HSA-8876384	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Signal Transduction;Membrane Trafficking;Disease;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);Deubiquitination;Ub-specific processing proteases;Signaling by Receptor Tyrosine Kinases;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Signaling by EGFR;EGFR downregulation;Signaling by MET;Negative regulation of MET activity;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
COQ7	negative	TCEAL3	ENSG00000196507	COQ7	1	COQ7	1	0.00441243856168061					GO:0005634;GO:0050699	nucleus;WW domain binding	Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation		
COQ7	negative	CPTP	ENSG00000224051	COQ7	1	COQ7	1	0.00441243856168061	WBGene00018632;WBGene00010666;WBGene00045433	WBGene00022347(0);WBGene00018632(0);WBGene00045433(0)			GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0005794;GO:0005886;GO:0006869;GO:0008289;GO:0120013;GO:0120009;GO:0005768;GO:0006687;GO:0010008;GO:1902387;GO:1902388;GO:0035627;GO:0005543;GO:1900226;GO:0010507;GO:0050713;GO:0005640;GO:1902389	cytoplasm;lipid transfer activity;intermembrane lipid transfer;nucleus;membrane;cytosol;endosome;Golgi apparatus;plasma membrane;lipid transport;lipid binding;glycosphingolipid metabolic process;phospholipid binding;endosome membrane;ceramide 1-phosphate binding;ceramide 1-phosphate transfer activity;ceramide transport;negative regulation of NLRP3 inflammasome complex assembly;negative regulation of autophagy;negative regulation of interleukin-1 beta secretion;nuclear outer membrane;ceramide 1-phosphate transport	3D-structure;Cell membrane;Cytoplasm;Endosome;Golgi apparatus;Lipid transport;Lipid-binding;Membrane;Nucleus;Reference proteome;Transport	R-HSA-1430728;R-HSA-1660662;R-HSA-428157;R-HSA-556833	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
COQ7	negative	MARK4	ENSG00000007047	COQ7	1	COQ7	1	0.00644143107344819	WBGene00003916				GO:0004672;GO:0005524;GO:0006468;GO:0005737;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0051301;GO:0005856;GO:0042995;GO:0005515;GO:0007049;GO:0030425;GO:0008017;GO:0005813;GO:0005815;GO:0007399;GO:0000226;GO:0035556;GO:0005829;GO:0015630;GO:0030030;GO:0001578;GO:0097711;GO:0043130;GO:0043005;GO:0048156;GO:0050321;GO:0043015;GO:0043068;GO:1904781;GO:0044782;GO:0036064;GO:0045724;GO:0046605;GO:0000930;GO:0030496;GO:0016055;GO:0005874;GO:0008284;GO:0000086;GO:0000082	ATP binding;protein phosphorylation;protein kinase activity;cytoplasm;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;cytosol;cytoskeleton;cell division;cell projection;protein binding;cell cycle;dendrite;microtubule binding;centrosome;microtubule organizing center;nervous system development;microtubule cytoskeleton organization;intracellular signal transduction;neuron projection;microtubule cytoskeleton;cell projection organization;microtubule bundle formation;ciliary basal body-plasma membrane docking;ubiquitin binding;tau protein binding;gamma-tubulin binding;cilium organization;tau-protein kinase activity;positive regulation of programmed cell death;positive regulation of protein localization to centrosome;ciliary basal body;positive regulation of cilium assembly;regulation of centrosome cycle;gamma-tubulin complex;midbody;Wnt signaling pathway;microtubule;positive regulation of cell population proliferation;G1/S transition of mitotic cell cycle;G2/M transition of mitotic cell cycle	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Cell projection;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Kinase;Mitosis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-1852241;R-HSA-5617833;R-HSA-5620912	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
COQ7	negative	RHBDF1	ENSG00000007384	COQ7	1	COQ7	1	0.00644143107344819	WBGene00004402;WBGene00004403				GO:0016020;GO:0016021;GO:0015031;GO:0005783;GO:0005789;GO:0005794;GO:0006508;GO:0000139;GO:0005515;GO:0016477;GO:0008283;GO:0061136;GO:0019838;GO:0050708;GO:0050709;GO:0042058;GO:0004252	integral component of membrane;serine-type endopeptidase activity;membrane;protein transport;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;proteolysis;Golgi membrane;protein binding;cell migration;regulation of proteasomal protein catabolic process;growth factor binding;cell population proliferation;regulation of protein secretion;negative regulation of protein secretion;regulation of epidermal growth factor receptor signaling pathway	Endoplasmic reticulum;Glycoprotein;Golgi apparatus;Growth factor binding;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ7	negative	SMOX	ENSG00000088826	COQ7	1	COQ7	1	0.00644143107344819	WBGene00000139;WBGene00016061	WBGene00000137(0);WBGene00011615(0);WBGene00005010(0)			GO:0005634;GO:0005737;GO:0043231;GO:0005654;GO:0016491;GO:0055114;GO:0031965;GO:0005829;GO:0006596;GO:0046592;GO:0052901;GO:0046208;GO:0052894;GO:0052895;GO:0006598	oxidation-reduction process;oxidoreductase activity;nucleus;cytoplasm;intracellular membrane-bounded organelle;nucleoplasm;nuclear membrane;cytosol;polyamine biosynthetic process;polyamine oxidase activity;spermine:oxygen oxidoreductase (spermidine-forming) activity;spermine catabolic process;norspermine:oxygen oxidoreductase activity;N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity;polyamine catabolic process	Alternative splicing;Cytoplasm;FAD;Flavoprotein;Nucleus;Oxidoreductase;Polymorphism;Reference proteome		
COQ7	negative	SLC4A11	ENSG00000088836	COQ7	1	COQ7	1	0.00644143107344819	WBGene00019018;WBGene00009929	WBGene00009929(1)		Congenital hereditary endothelial dystrophy type II;Corneal dystrophy-perceptive deafness syndrome;Fuchs endothelial corneal dystrophy;Corneal dystrophy fuchs endothelial 4;CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS;Corneal dystrophy fuchs endothelial 4;Corneal endothelial dystrophy	GO:0016020;GO:0016021;GO:0015293;GO:0006811;GO:0005886;GO:0035725;GO:0006820;GO:0098656;GO:0005452;GO:0046983;GO:0015301;GO:0051453;GO:1902600;GO:0016323;GO:0005272;GO:0015106;GO:0015252;GO:0046715;GO:0006814;GO:0015701;GO:0030003;GO:0035445;GO:0042044;GO:0046713;GO:0050801;GO:0015698	integral component of membrane;membrane;inorganic anion exchanger activity;anion transport;plasma membrane;cell;symporter activity;ion transport;sodium ion transmembrane transport;anion transmembrane transport;apical plasma membrane;basolateral plasma membrane;protein dimerization activity;anion:anion antiporter activity;regulation of intracellular pH;proton transmembrane transport;sodium channel activity;bicarbonate transmembrane transporter activity;proton channel activity;active borate transmembrane transporter activity;sodium ion transport;bicarbonate transport;cellular cation homeostasis;borate transmembrane transport;fluid transport;borate transport;vesicle membrane;ion homeostasis;inorganic anion transport	Alternative splicing;Anion exchange;Cell membrane;Corneal dystrophy;Deafness;Disease mutation;Glycoprotein;Ion transport;Membrane;Polymorphism;Reference proteome;Symport;Transmembrane;Transmembrane helix;Transport		
COQ7	negative	BCKDK	ENSG00000103507	COQ7	1	COQ7	1	0.00644143107344819				Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency;Branched-chain keto acid dehydrogenase kinase deficiency	GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005739;GO:0004674;GO:0016772;GO:0047323;GO:0006468;GO:0009083;GO:0005759;GO:0005947;GO:0005515;GO:0009063	transferase activity, transferring phosphorus-containing groups;protein kinase activity;phosphorylation;nucleotide binding;ATP binding;kinase activity;transferase activity;mitochondrion;protein serine/threonine kinase activity;[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity;protein phosphorylation;branched-chain amino acid catabolic process;mitochondrial matrix;mitochondrial alpha-ketoglutarate dehydrogenase complex;protein binding;glucose homeostasis;cellular amino acid catabolic process;negative regulation of pyruvate dehydrogenase activity	ATP-binding;Acetylation;Alternative splicing;Autism;Autism spectrum disorder;Disease mutation;Epilepsy;Kinase;Mental retardation;Mitochondrion;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-70895	Metabolism;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism
COQ7	negative	PLA2G4C	ENSG00000105499	COQ7	1	COQ7	1	0.00644143107344819					GO:0016020;GO:0016787;GO:0004620;GO:0006629;GO:0009395;GO:0016042;GO:0005829;GO:0006954;GO:0004623;GO:0102567;GO:0102568;GO:0005737;GO:0005789;GO:0005509;GO:0005544;GO:0005635;GO:0005654;GO:0047498;GO:0005543;GO:0035556;GO:0006644;GO:0019369;GO:0036149;GO:0036151;GO:0036152;GO:0007567;GO:0046475;GO:0004622;GO:0047499;GO:0008970;GO:0005938	phospholipase activity;phospholipid catabolic process;membrane;hydrolase activity;lipid metabolic process;lipid catabolic process;cytosol;inflammatory response;phospholipase A2 activity;phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine);phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);cytoplasm;nucleoplasm;endoplasmic reticulum membrane;calcium ion binding;calcium-dependent phospholipid binding;phospholipid binding;nuclear envelope;calcium-dependent phospholipase A2 activity;intracellular signal transduction;phospholipid metabolic process;arachidonic acid metabolic process;phosphatidylinositol acyl-chain remodeling;phosphatidylcholine acyl-chain remodeling;phosphatidylethanolamine acyl-chain remodeling;parturition;glycerophospholipid catabolic process;calcium-independent phospholipase A2 activity;lysophospholipase activity;phospholipase A1 activity;cell cortex	Alternative splicing;Hydrolase;Lipid degradation;Lipid metabolism;Lipoprotein;Membrane;Methylation;Phosphoprotein;Polymorphism;Prenylation;Reference proteome	R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1482788;R-HSA-1482839;R-HSA-1482922;R-HSA-1483115;R-HSA-1483152	Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Acyl chain remodelling of PC;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Hydrolysis of LPC;Hydrolysis of LPE
COQ7	negative	DNM1	ENSG00000106976	COQ7	1	COQ7	1	0.00644143107344819	WBGene00001130;WBGene00001093			Lennox-Gastaut syndrome;Undetermined early-onset epileptic encephalopathy;Epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 31	GO:0003723;GO:0005737;GO:0005634;GO:0000166;GO:0005654;GO:0016787;GO:0003924;GO:0005525;GO:0005856;GO:0005515;GO:0005874;GO:0005886;GO:0042802;GO:0016020;GO:0045202;GO:0006897;GO:0070062;GO:0008017;GO:0014069;GO:0045211;GO:0030424;GO:0031410;GO:0048013;GO:0000266;GO:0006898;GO:0019901;GO:0016185;GO:0043197;GO:0031623;GO:0050803;GO:0098884;GO:0044327;GO:0098844;GO:0008022;GO:0017124;GO:0031749;GO:0044877;GO:0050998;GO:0002031;GO:0007032;GO:0048488;GO:0050804;GO:1900242;GO:1900244;GO:1901998;GO:1903423;GO:1904645;GO:0001917;GO:0005794;GO:0008021;GO:0030117;GO:0032991;GO:0043196;GO:0098684;GO:0098835;GO:0098978;GO:0072583	GTP binding;GTPase activity;RNA binding;cytoplasm;nucleotide binding;nucleoplasm;hydrolase activity;cytoskeleton;protein binding;microtubule;plasma membrane;identical protein binding;endocytosis;membrane;synapse;membrane fusion;extracellular exosome;microtubule binding;postsynaptic density;postsynaptic membrane;mitochondrial membrane;microtubule cytoskeleton;axon;cytoplasmic vesicle;ephrin receptor signaling pathway;organelle fission;mitochondrial fission;receptor-mediated endocytosis;protein kinase binding;synaptic vesicle budding from presynaptic endocytic zone membrane;dendritic spine;receptor internalization;regulation of synapse structure or activity;postsynaptic neurotransmitter receptor internalization;dendritic spine head;postsynaptic endocytic zone membrane;protein C-terminus binding;SH3 domain binding;D2 dopamine receptor binding;protein-containing complex binding;nitric-oxide synthase binding;G protein-coupled receptor internalization;endosome organization;synaptic vesicle endocytosis;modulation of chemical synaptic transmission;regulation of synaptic vesicle endocytosis;positive regulation of synaptic vesicle endocytosis;toxin transport;positive regulation of synaptic vesicle recycling;response to amyloid-beta;photoreceptor inner segment;Golgi apparatus;synaptic vesicle;membrane coat;protein-containing complex;varicosity;photoreceptor ribbon synapse;presynaptic endocytic zone membrane;glutamatergic synapse	3D-structure;Alternative splicing;Cytoplasm;Cytoskeleton;Disease mutation;Endocytosis;Epilepsy;GTP-binding;Hydrolase;Methylation;Microtubule;Motor protein;Nitration;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-162582;R-HSA-199991;R-HSA-157858;R-HSA-190828;R-HSA-2132295;R-HSA-9006934;R-HSA-166016;R-HSA-168898;R-HSA-8856828;R-HSA-2682334;R-HSA-166520;R-HSA-187037;R-HSA-3928665;R-HSA-177504;R-HSA-190873;R-HSA-196025	Adaptive Immune System;Innate Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Signal Transduction;Membrane Trafficking;Gap junction trafficking and regulation;Gap junction trafficking;MHC class II antigen presentation;Signaling by Receptor Tyrosine Kinases;Toll Like Receptor 4 (TLR4) Cascade;Toll-like Receptor Cascades;Clathrin-mediated endocytosis;EPH-Ephrin signaling;Signaling by NTRKs;Signaling by NTRK1 (TRKA);EPH-ephrin mediated repulsion of cells;Retrograde neurotrophin signalling;Gap junction degradation;Formation of annular gap junctions
COQ7	negative	ENG	ENSG00000106991	COQ7	1	COQ7	1	0.00644143107344819				Familial cerebral saccular aneurysm;Generalized juvenile polyposis/juvenile polyposis coli;HEREDITARY HEMORRHAGIC TELANGIECTASIA;Heritable pulmonary arterial hypertension;TELANGIECTASIA HEREDITARY HEMORRHAGIC TYPE 1	GO:0005615;GO:0010629;GO:0051897;GO:0045944;GO:0001934;GO:1905065;GO:0030336;GO:0030513;GO:0030509;GO:0016020;GO:0016021;GO:0007155;GO:0005886;GO:0005515;GO:0005114;GO:0042803;GO:0050431;GO:0001300;GO:0001525;GO:0001569;GO:0001570;GO:0001947;GO:0003148;GO:0003198;GO:0003203;GO:0003208;GO:0003209;GO:0003222;GO:0003273;GO:0007507;GO:0010628;GO:0017015;GO:0031960;GO:0032967;GO:0035912;GO:0042493;GO:0045766;GO:0048745;GO:0048844;GO:0048845;GO:0055009;GO:0060348;GO:0070278;GO:0071260;GO:0071559;GO:0097084;GO:1905007;GO:1905222;GO:0009986;GO:0072563;GO:0005925;GO:0042802;GO:0009897;GO:0043235;GO:0034713;GO:0048185;GO:0036122;GO:0010862;GO:0004888;GO:0005539;GO:0006355;GO:0005072;GO:0005534;GO:0022009;GO:0031953	extracellular space;negative regulation of gene expression;negative regulation of cell migration;positive regulation of protein kinase B signaling;positive regulation of transcription by RNA polymerase II;positive regulation of protein phosphorylation;positive regulation of vascular smooth muscle cell differentiation;positive regulation of BMP signaling pathway;BMP signaling pathway;branching involved in blood vessel morphogenesis;membrane;integral component of membrane;plasma membrane;cell adhesion;focal adhesion;protein binding;nuclear body;type II transforming growth factor beta receptor binding;protein homodimerization activity;transforming growth factor beta binding;chronological cell aging;angiogenesis;vasculogenesis;heart looping;outflow tract septum morphogenesis;epithelial to mesenchymal transition involved in endocardial cushion formation;endocardial cushion morphogenesis;cardiac ventricle morphogenesis;cardiac atrium morphogenesis;ventricular trabecula myocardium morphogenesis;cell migration involved in endocardial cushion formation;heart development;positive regulation of gene expression;regulation of transforming growth factor beta receptor signaling pathway;response to corticosteroid;positive regulation of collagen biosynthetic process;dorsal aorta morphogenesis;response to drug;positive regulation of angiogenesis;smooth muscle tissue development;artery morphogenesis;venous blood vessel morphogenesis;atrial cardiac muscle tissue morphogenesis;bone development;extracellular matrix constituent secretion;cellular response to mechanical stimulus;response to transforming growth factor beta;vascular smooth muscle cell development;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;atrioventricular canal morphogenesis;cell surface;endothelial microparticle;identical protein binding;external side of plasma membrane;receptor complex;type I transforming growth factor beta receptor binding;activin binding;BMP binding;positive regulation of pathway-restricted SMAD protein phosphorylation;transmembrane signaling receptor activity;glycosaminoglycan binding;regulation of transcription, DNA-templated;transforming growth factor beta receptor, cytoplasmic mediator activity;galactose binding;central nervous system vasculogenesis;negative regulation of protein autophosphorylation	3D-structure;Alternative splicing;Angiogenesis;Cell adhesion;Cell membrane;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ7	negative	SH3PXD2A	ENSG00000107957	COQ7	1	COQ7	1	0.00644143107344819				Malignant peripheral nerve sheath tumor	GO:0005737;GO:0043085;GO:0042995;GO:0005515;GO:0030054;GO:0035091;GO:0005829;GO:0016176;GO:0006801;GO:0002102;GO:0030198;GO:0072675;GO:0002020;GO:0005546;GO:0010314;GO:0032266;GO:0043325;GO:0070273;GO:0001701;GO:0072593	protein binding;phosphatidylinositol binding;cytoplasm;positive regulation of catalytic activity;cell projection;cell junction;cytosol;superoxide-generating NADPH oxidase activator activity;superoxide metabolic process;podosome;extracellular matrix organization;osteoclast fusion;protease binding;phosphatidylinositol-4,5-bisphosphate binding;phosphatidylinositol-5-phosphate binding;phosphatidylinositol-3-phosphate binding;phosphatidylinositol-3,4-bisphosphate binding;phosphatidylinositol-4-phosphate binding;in utero embryonic development;reactive oxygen species metabolic process	3D-structure;Alternative splicing;Cell junction;Cell projection;Coiled coil;Cytoplasm;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3 domain	R-HSA-1474244;R-HSA-8941237	Extracellular matrix organization;Invadopodia formation
COQ7	negative	ST3GAL4	ENSG00000110080	COQ7	1	COQ7	1	0.00644143107344819					GO:0016020;GO:0016021;GO:0016740;GO:0008373;GO:0016757;GO:0006486;GO:0097503;GO:0005794;GO:0005576;GO:0032580;GO:0000139;GO:0050890;GO:0016266;GO:0018146;GO:0009312;GO:0009247;GO:0003836;GO:0047288;GO:0009101;GO:0030259;GO:1990743	protein glycosylation;sialyltransferase activity;membrane;integral component of membrane;transferase activity;transferase activity, transferring glycosyl groups;sialylation;Golgi apparatus;extracellular region;Golgi cisterna membrane;Golgi membrane;cognition;O-glycan processing;keratan sulfate biosynthetic process;oligosaccharide biosynthetic process;glycolipid biosynthetic process;beta-galactoside (CMP) alpha-2,3-sialyltransferase activity;monosialoganglioside sialyltransferase activity;glycoprotein biosynthetic process;lipid glycosylation;protein sialylation	Alternative splicing;Disulfide bond;Glycoprotein;Glycosyltransferase;Golgi apparatus;Membrane;Reference proteome;Secreted;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-1430728;R-HSA-162582;R-HSA-446193;R-HSA-446203;R-HSA-446219;R-HSA-5173105;R-HSA-71387;R-HSA-948021;R-HSA-157118;R-HSA-1630316;R-HSA-1912420;R-HSA-1912422;R-HSA-4085001;R-HSA-975576;R-HSA-975577;R-HSA-1638074;R-HSA-2022854;R-HSA-913709;R-HSA-9033658;R-HSA-9037629;R-HSA-977068	Metabolism of proteins;Post-translational protein modification;Metabolism;Signal Transduction;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Metabolism of carbohydrates;Transport to the Golgi and subsequent modification;Signaling by NOTCH;Glycosaminoglycan metabolism;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Sialic acid metabolism;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;O-linked glycosylation of mucins;Blood group systems biosynthesis;Lewis blood group biosynthesis;Termination of O-glycan biosynthesis
COQ7	negative	ARHGDIB	ENSG00000111348	COQ7	1	COQ7	1	0.00644143107344819	WBGene00004356	WBGene00004356(1)			GO:0005737;GO:0005829;GO:0050790;GO:0043547;GO:0005856;GO:0005096;GO:0005094;GO:0071461;GO:0016020;GO:0005515;GO:0070062;GO:0051056;GO:0007266;GO:0007275;GO:2000249;GO:0048365;GO:0031410;GO:0035023;GO:0007162;GO:0003924;GO:1901164	cytoplasm;Rho GDP-dissociation inhibitor activity;cytoskeleton;cytosol;regulation of catalytic activity;positive regulation of GTPase activity;GTPase activator activity;cellular response to redox state;membrane;protein binding;extracellular exosome;regulation of small GTPase mediated signal transduction;Rho protein signal transduction;multicellular organism development;regulation of actin cytoskeleton reorganization;Rac GTPase binding;cytoplasmic vesicle;regulation of Rho protein signal transduction;negative regulation of cell adhesion;GTPase activity;negative regulation of trophoblast cell migration	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;GTPase activation;Phosphoprotein;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-194840	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
COQ7	negative	LOXL3	ENSG00000115318	COQ7	1	COQ7	1	0.00644143107344819					GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0016491;GO:0055114;GO:0005615;GO:0005576;GO:0005044;GO:0006897;GO:0006954;GO:0005507;GO:0005515;GO:0001968;GO:0016641;GO:0045892;GO:0030199;GO:0060021;GO:0021510;GO:0001837;GO:2001046;GO:0030324;GO:0004720;GO:0018057;GO:0061053;GO:1905590;GO:2000329	membrane;oxidation-reduction process;copper ion binding;scavenger receptor activity;oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor;nucleus;cytoplasm;metal ion binding;oxidoreductase activity;extracellular space;extracellular region;inflammatory response;protein binding;endocytosis;fibronectin binding;negative regulation of transcription, DNA-templated;roof of mouth development;spinal cord development;epithelial to mesenchymal transition;collagen fibril organization;positive regulation of integrin-mediated signaling pathway;lung development;protein-lysine 6-oxidase activity;peptidyl-lysine oxidation;somite development;fibronectin fibril organization;negative regulation of T-helper 17 cell lineage commitment	Alternative splicing;Copper;Cytoplasm;Deafness;Disulfide bond;Glycoprotein;Inflammatory response;LTQ;Metal-binding;Nucleus;Oxidoreductase;Polymorphism;Reference proteome;Repeat;Secreted;Signal;Stickler syndrome;TPQ	R-HSA-1474244;R-HSA-1474290;R-HSA-2022090;R-HSA-2243919;R-HSA-1566948	Extracellular matrix organization;Collagen formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils;Elastic fibre formation
COQ7	negative	BMP8B	ENSG00000116985	COQ7	1	COQ7	1	0.00644143107344819	WBGene00000936				GO:0008083;GO:0005615;GO:0005576;GO:0007275;GO:0005125;GO:0030154;GO:0051216;GO:0042981;GO:0060395;GO:0001503;GO:0005160;GO:0010862;GO:0043408;GO:0048468;GO:0001501	growth factor activity;extracellular space;extracellular region;multicellular organism development;cytokine activity;cell differentiation;cartilage development;SMAD protein signal transduction;ossification;BMP signaling pathway;positive regulation of pathway-restricted SMAD protein phosphorylation;skeletal system development;BMP receptor binding	Alternative splicing;Chondrogenesis;Cytokine;Developmental protein;Differentiation;Disulfide bond;Glycoprotein;Growth factor;Osteogenesis;Polymorphism;Reference proteome;Secreted;Signal		
COQ7	negative	MMP24OS	ENSG00000126005	COQ7	1	COQ7	1	0.00644143107344819							Direct protein sequencing;Reference proteome		
COQ7	negative	TMEM8A	ENSG00000129925	COQ7	1	COQ7	1	0.00644143107344819					GO:0016020;GO:0016021;GO:0016787;GO:0005765;GO:0005886;GO:0005515;GO:0004623;GO:0102567;GO:0102568;GO:0005764;GO:0005887;GO:0070062;GO:0003674;GO:0008150	integral component of membrane;membrane;hydrolase activity;lysosomal membrane;plasma membrane;protein binding;phospholipase A2 activity;phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine);phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine);lysosome;integral component of plasma membrane;extracellular exosome;molecular_function;biological_process	Cell membrane;Disulfide bond;EGF-like domain;Glycoprotein;Hydrolase;Lysosome;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ7	negative	MAP1S	ENSG00000130479	COQ7	1	COQ7	1	0.00644143107344819	WBGene00007966;WBGene00009113;WBGene00009306				GO:0051015;GO:0006915;GO:0008017;GO:0000226;GO:0005874;GO:0005634;GO:0005737;GO:0005730;GO:0005829;GO:0003677;GO:0030054;GO:0005856;GO:0042995;GO:0005515;GO:0006259;GO:0045202;GO:0005819;GO:0016358;GO:0043025;GO:0015631;GO:0030425;GO:0003779;GO:0048471;GO:0005875;GO:0007399;GO:0001578;GO:0007409;GO:0007420;GO:0048487;GO:0047497;GO:0031114;GO:0006914;GO:0042802;GO:0010848;GO:0048812;GO:0015630	microtubule;actin filament binding;microtubule binding;apoptotic process;microtubule cytoskeleton organization;nucleus;cytoplasm;nucleoplasm;nucleolus;cytosol;DNA binding;cytoskeleton;DNA metabolic process;cell projection;protein binding;synapse;spindle;dendrite development;neuronal cell body;tubulin binding;dendrite;actin binding;perinuclear region of cytoplasm;microtubule associated complex;nervous system development;microtubule bundle formation;axonogenesis;brain development;beta-tubulin binding;mitochondrion transport along microtubule;regulation of microtubule depolymerization;autophagy;identical protein binding;regulation of chromatin disassembly;neuron projection morphogenesis;microtubule cytoskeleton	Alternative splicing;Apoptosis;Cytoplasm;Cytoskeleton;DNA-binding;Microtubule;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ7	negative	PRR7	ENSG00000131188	COQ7	1	COQ7	1	0.00644143107344819					GO:0016020;GO:0016021;GO:0005634;GO:0005737;GO:0005886;GO:0042995;GO:0048471;GO:0030054;GO:0045202;GO:0045211;GO:0044877;GO:0030217;GO:0031397;GO:0099527;GO:0014069;GO:0043005;GO:0098978;GO:0099092;GO:0002376;GO:0030425;GO:0002250;GO:0005515;GO:0043065;GO:2001269;GO:0044389;GO:0010942;GO:1990782;GO:0036041	membrane;integral component of membrane;nucleus;cytoplasm;plasma membrane;cell projection;perinuclear region of cytoplasm;cell junction;protein-containing complex binding;negative regulation of protein ubiquitination;T cell differentiation in thymus;alpha-beta T cell differentiation;postsynapse to nucleus signaling pathway;postsynaptic density;neuron projection;synapse;glutamatergic synapse;postsynaptic density, intracellular component;postsynaptic membrane;immune system process;dendrite;adaptive immune response;protein binding;postsynaptic density membrane;positive regulation of apoptotic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;ubiquitin-like protein ligase binding;positive regulation of cell death;protein tyrosine kinase binding;long-chain fatty acid binding	Adaptive immunity;Alternative splicing;Cell junction;Cell membrane;Cell projection;Cytoplasm;Immunity;Lipoprotein;Membrane;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Postsynaptic cell membrane;Reference proteome;Signal-anchor;Synapse;Transmembrane;Transmembrane helix		
COQ7	negative	RBM38	ENSG00000132819	COQ7	1	COQ7	1	0.00644143107344819	WBGene00006321	WBGene00006321(1)			GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005829;GO:0007049;GO:0030154;GO:0003729;GO:1990904;GO:0043484;GO:0003730;GO:0070935;GO:0010830	nucleic acid binding;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;cytosol;cell cycle;cell differentiation;mRNA binding;regulation of RNA metabolic process;ribonucleoprotein complex;viral process;regulation of RNA splicing;mRNA 3'-UTR binding;3'-UTR-mediated mRNA stabilization;regulation of myotube differentiation	3D-structure;Alternative splicing;Cell cycle;Cytoplasm;Differentiation;Host-virus interaction;Nucleus;Polymorphism;RNA-binding;Reference proteome;mRNA processing;mRNA splicing		
COQ7	negative	LCP1	ENSG00000136167	COQ7	1	COQ7	1	0.00644143107344819	WBGene00022425;WBGene00022223	WBGene00022425(1);WBGene00022223(0)			GO:0005737;GO:0016020;GO:0046872;GO:0005829;GO:0005509;GO:0003779;GO:0051015;GO:0005886;GO:0005615;GO:0015629;GO:0005856;GO:0042995;GO:0030054;GO:0051017;GO:0005925;GO:0042802;GO:0031100;GO:0001726;GO:0001891;GO:0005884;GO:0030175;GO:0070062;GO:0022617;GO:0002102;GO:0016477;GO:0001725;GO:0032587;GO:0035722;GO:0051020;GO:0005178;GO:0048471;GO:0032432;GO:0002286;GO:0010737;GO:0033157;GO:0051639;GO:0071803;GO:0005515	protein binding;calcium ion binding;actin filament binding;actin filament bundle assembly;cytoplasm;membrane;metal ion binding;cytosol;plasma membrane;actin binding;cytoskeleton;focal adhesion;extracellular space;actin cytoskeleton;cell projection;cell junction;identical protein binding;animal organ regeneration;ruffle;phagocytic cup;actin filament;filopodium;extracellular exosome;extracellular matrix disassembly;podosome;cell migration;stress fiber;ruffle membrane;interleukin-12-mediated signaling pathway;GTPase binding;perinuclear region of cytoplasm;integrin binding;actin filament bundle;T cell activation involved in immune response;protein kinase A signaling;regulation of intracellular protein transport;actin filament network formation;positive regulation of podosome assembly	3D-structure;Acetylation;Actin-binding;Alternative splicing;Calcium;Cell junction;Cell membrane;Cell projection;Chromosomal rearrangement;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-168256;R-HSA-1280215;R-HSA-449147;R-HSA-447115;R-HSA-8950505;R-HSA-9020591	Immune System;Cytokine Signaling in Immune system;Signaling by Interleukins;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
COQ7	negative	IGF1R	ENSG00000140443	COQ7	1	COQ7	1	0.00644143107344819	WBGene00000898			Growth delay due to insulin-like growth factor I resistance;INSULIN-LIKE GROWTH FACTOR I RESISTANCE TO;INSULIN-LIKE GROWTH FACTOR I RESISTANCE TO	GO:0008284;GO:1904646;GO:0030335;GO:0016020;GO:0016021;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0043066;GO:0004713;GO:0004714;GO:0007169;GO:0005886;GO:0046777;GO:0005515;GO:0042802;GO:0005887;GO:0043235;GO:0042593;GO:0043548;GO:0043560;GO:0048856;GO:0030424;GO:0007165;GO:0120162;GO:0043231;GO:0014068;GO:0043410;GO:0006955;GO:0051262;GO:0046328;GO:0097242;GO:0005158;GO:0008286;GO:0097062;GO:0014065;GO:0048009;GO:0048015;GO:0035867;GO:0031994;GO:0005009;GO:0043559;GO:0043243;GO:0051897;GO:0005899;GO:0005010;GO:0005520;GO:0140318;GO:0038083;GO:0045056;GO:0051389;GO:0071333;GO:0018108	integral component of membrane;ATP binding;protein binding;membrane;protein phosphorylation;protein kinase activity;transmembrane receptor protein tyrosine kinase signaling pathway;transmembrane receptor protein tyrosine kinase activity;protein tyrosine kinase activity;phosphatidylinositol 3-kinase binding;insulin receptor substrate binding;protein autophosphorylation;positive regulation of cell population proliferation;cellular response to amyloid-beta;positive regulation of cell migration;cell;nucleotide binding;kinase activity;transferase activity;phosphorylation;negative regulation of apoptotic process;plasma membrane;identical protein binding;integral component of plasma membrane;multicellular organism development;positive regulation of kinase activity;receptor complex;glucose homeostasis;anatomical structure development;axon;signal transduction;positive regulation of cold-induced thermogenesis;intracellular membrane-bounded organelle;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of MAPK cascade;immune response;regulation of JNK cascade;amyloid-beta clearance;insulin receptor binding;insulin receptor signaling pathway;dendritic spine maintenance;phosphatidylinositol 3-kinase signaling;insulin-like growth factor receptor signaling pathway;phosphatidylinositol-mediated signaling;alphav-beta3 integrin-IGF-1-IGF1R complex;insulin-like growth factor I binding;insulin-activated receptor activity;insulin binding;positive regulation of protein-containing complex disassembly;positive regulation of protein kinase B signaling;insulin receptor complex;insulin-like growth factor-activated receptor activity;insulin-like growth factor binding;protein transporter activity;peptidyl-tyrosine autophosphorylation;transcytosis;inactivation of MAPKK activity;cellular response to glucose stimulus;protein kinase complex;peptidyl-tyrosine phosphorylation	3D-structure;ATP-binding;Cell membrane;Cleavage on pair of basic residues;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Isopeptide bond;Kinase;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transferase;Transmembrane;Transmembrane helix;Tyrosine-protein kinase;Ubl conjugation	R-HSA-162582;R-HSA-9006934;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-2404192;R-HSA-2428924;R-HSA-2428928;R-HSA-2428933	Signal Transduction;Signaling by Receptor Tyrosine Kinases;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R
COQ7	negative	PPP1R18	ENSG00000146112	COQ7	1	COQ7	1	0.00644143107344819					GO:0005737;GO:0003779;GO:0005856;GO:0005515;GO:0019902	phosphatase binding;cytoplasm;actin binding;cytoskeleton;protein binding	Acetylation;Actin-binding;Alternative splicing;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome		
COQ7	negative	ADIPOR1	ENSG00000159346	COQ7	1	COQ7	1	0.00644143107344819	WBGene00016610;WBGene00021313	WBGene00019643(0);WBGene00016610(0)			GO:0010719;GO:1901223;GO:0016020;GO:0016021;GO:0046872;GO:0006629;GO:0019216;GO:0006631;GO:0005886;GO:0038023;GO:0009755;GO:0031226;GO:0120162;GO:0046426;GO:0019901;GO:0042593;GO:0042304;GO:0010906;GO:0019395;GO:0010633;GO:0033211;GO:0055100;GO:0097003;GO:0042802;GO:0046982;GO:0030308;GO:0033210;GO:0046427;GO:0046628	integral component of membrane;negative regulation of epithelial to mesenchymal transition;negative regulation of NIK/NF-kappaB signaling;membrane;metal ion binding;lipid metabolic process;regulation of lipid metabolic process;fatty acid metabolic process;plasma membrane;signaling receptor activity;hormone-mediated signaling pathway;intrinsic component of plasma membrane;positive regulation of cold-induced thermogenesis;negative regulation of receptor signaling pathway via JAK-STAT;protein kinase binding;glucose homeostasis;regulation of fatty acid biosynthetic process;regulation of glucose metabolic process;fatty acid oxidation;negative regulation of epithelial cell migration;adiponectin-activated signaling pathway;adiponectin binding;adipokinetic hormone receptor activity;identical protein binding;negative regulation of cell growth;leptin-mediated signaling pathway;positive regulation of receptor signaling pathway via JAK-STAT;positive regulation of insulin receptor signaling pathway	3D-structure;Cell membrane;Fatty acid metabolism;Lipid metabolism;Membrane;Metal-binding;Receptor;Reference proteome;Transmembrane;Transmembrane helix;Zinc	R-HSA-1430728;R-HSA-163685;R-HSA-163680	Metabolism;Integration of energy metabolism;AMPK inhibits chREBP transcriptional activation activity
COQ7	negative	LMNA	ENSG00000160789	COQ7	1	COQ7	1	0.00644143107344819	WBGene00003052;WBGene00002050;WBGene00002051;WBGene00002052;WBGene00003485;WBGene00002053;WBGene00002054			Atypical Werner syndrome;Autosomal dominant Emery-Dreifuss muscular dystrophy;Autosomal dominant limb-girdle muscular dystrophy type 1B;Autosomal recessive Emery-Dreifuss muscular dystrophy;Autosomal semi-dominant severe lipodystrophic laminopathy;Charcot-Marie-Tooth disease type 2B1;Congenital muscular dystrophy due to LMNA mutation;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Familial dilated cardiomyopathy with conduction defect due to LMNA mutation;Familial isolated arrhythmogenic ventricular dysplasia biventricular form;Familial isolated arrhythmogenic ventricular dysplasia left dominant form;Familial isolated arrhythmogenic ventricular dysplasia right dominant form;Familial partial lipodystrophy Dunnigan type;Familial partial lipodystrophy Kobberling type;HEART-HAND SYNDROME SLOVENIAN TYPE;HUTCHINSON-GILFORD PROGERIA SYNDROME;LMNA-related cardiocutaneous progeria syndrome;Left ventricular noncompaction;MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY;Restrictive dermopathy;CARDIOMYOPATHY DILATED TYPE 1A;CARDIOMYOPATHY DILATED WITH HYPERGONADOTROPIC HYPOGONADISM;Charcot-Marie-Tooth disease type 2B1;Emery-Dreifuss muscular dystrophy type 2;FAMILIAL PARTIAL LIPODYSTROPHY TYPE 2;HEART-HAND SYNDROME SLOVENIAN TYPE;HUTCHINSON-GILFORD PROGERIA SYNDROME;Lethal tight skin contracture syndrome;LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1B;MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY;MUSCULAR DYSTROPHY CONGENITAL LMNA-RELATED;CARDIOMYOPATHY DILATED 1A;CARDIOMYOPATHY DILATED WITH HYPERGONADOTROPIC HYPOGONADISM;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2B1;EMERY-DREIFUSS MUSCULAR DYSTROPHY 2 AUTOSOMAL DOMINANT;EMERY-DREIFUSS MUSCULAR DYSTROPHY 3 AUTOSOMAL RECESSIVE;HEART-HAND SYNDROME SLOVENIAN TYPE;HUTCHINSON-GILFORD PROGERIA SYNDROME;LIPODYSTROPHY FAMILIAL PARTIAL TYPE 2;MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY;MUSCULAR DYSTROPHY CONGENITAL LMNA-RELATED;RESTRICTIVE DERMOPATHY LETHAL	GO:0030334;GO:0005634;GO:0016607;GO:0005515;GO:0005882;GO:0005654;GO:0005829;GO:0005635;GO:0031965;GO:0036498;GO:0034504;GO:0071456;GO:0005652;GO:0007084;GO:0008285;GO:0030951;GO:0090343;GO:1903243;GO:0006606;GO:0006997;GO:0006998;GO:0010628;GO:0031647;GO:0055015;GO:0072201;GO:0090201;GO:1900114;GO:1900180;GO:2001237;GO:0005638	regulation of cell migration;nucleus;nuclear speck;nucleoplasm;cytosol;protein binding;nuclear body;intermediate filament;nuclear envelope;nuclear membrane;IRE1-mediated unfolded protein response;protein localization to nucleus;cellular response to hypoxia;nuclear lamina;mitotic nuclear envelope reassembly;negative regulation of cell population proliferation;establishment or maintenance of microtubule cytoskeleton polarity;positive regulation of cell aging;negative regulation of cardiac muscle hypertrophy in response to stress;protein import into nucleus;nucleus organization;nuclear envelope organization;positive regulation of gene expression;regulation of protein stability;ventricular cardiac muscle cell development;negative regulation of mesenchymal cell proliferation;negative regulation of release of cytochrome c from mitochondria;positive regulation of histone H3-K9 trimethylation;regulation of protein localization to nucleus;negative regulation of extrinsic apoptotic signaling pathway;lamin filament	3D-structure;Acetylation;Alternative splicing;Cardiomyopathy;Charcot-Marie-Tooth disease;Coiled coil;Congenital muscular dystrophy;Direct protein sequencing;Disease mutation;Emery-Dreifuss muscular dystrophy;Intermediate filament;Isopeptide bond;Limb-girdle muscular dystrophy;Lipoprotein;Methylation;Neurodegeneration;Neuropathy;Nucleus;Phosphoprotein;Polymorphism;Prenylation;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-1643685;R-HSA-5663202;R-HSA-6802952;R-HSA-6802957;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;Disease;Diseases of signal transduction;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
COQ7	negative	CARD19	ENSG00000165233	COQ7	1	COQ7	1	0.00644143107344819					GO:0005634;GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0005739;GO:0005829;GO:0031966;GO:0050700;GO:0043124	nucleus;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;mitochondrion;cytosol;mitochondrial membrane;CARD domain binding;negative regulation of I-kappaB kinase/NF-kappaB signaling	3D-structure;Alternative splicing;Disulfide bond;Endoplasmic reticulum;Membrane;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
COQ7	negative	CKB	ENSG00000166165	COQ7	1	COQ7	1	0.00644143107344819	WBGene00009706;WBGene00013894;WBGene00017975;WBGene00018519;WBGene00021128;WBGene00017388	WBGene00013894(1);WBGene00009706(1);WBGene00018519(1);WBGene00017975(1);WBGene00021128(1)			GO:0005737;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005829;GO:0003824;GO:0016772;GO:0005515;GO:0004111;GO:0046314;GO:0005615;GO:0070062;GO:0021762;GO:0031625;GO:0006600;GO:0007420;GO:0021549;GO:0030644;GO:0005634;GO:0030425;GO:0043025	catalytic activity;transferase activity, transferring phosphorus-containing groups;creatine kinase activity;phosphocreatine biosynthetic process;kinase activity;cell;cytoplasm;nucleotide binding;ATP binding;transferase activity;phosphorylation;cytosol;protein binding;extracellular space;extracellular exosome;substantia nigra development;ubiquitin protein ligase binding;creatine metabolic process;brain development;cerebellum development;cellular chloride ion homeostasis;nucleus;dendrite;neuronal cell body	3D-structure;ATP-binding;Cytoplasm;Direct protein sequencing;Kinase;Nitration;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-1430728;R-HSA-71291;R-HSA-71288	Metabolism;Metabolism of amino acids and derivatives;Creatine metabolism
COQ7	negative	LAMB2	ENSG00000172037	COQ7	1	COQ7	1	0.00644143107344819	WBGene00002247			LAMB-2-related infantile-onset nephrotic syndrome;PIERSON SYNDROME;Synaptic congenital myasthenic syndromes;Nephrotic syndrome type 5 with or without ocular abnormalities;PIERSON SYNDROME	GO:0007155;GO:0005576;GO:0009887;GO:0009888;GO:0005201;GO:0070062;GO:0044267;GO:0016477;GO:0034446;GO:0070831;GO:0005604;GO:0043256;GO:0043687;GO:0062023;GO:0005178;GO:0005788;GO:0030198;GO:0005198;GO:0043260;GO:0005608;GO:0000904;GO:0007411;GO:0007528;GO:0007601;GO:0014002;GO:0014044;GO:0031175;GO:0048677;GO:0050808;GO:0060041;GO:0072249;GO:0072274;GO:0031594;GO:0043083;GO:0045202	cell adhesion;extracellular region;animal organ morphogenesis;tissue development;extracellular matrix structural constituent;extracellular exosome;cellular protein metabolic process;cell migration;substrate adhesion-dependent cell spreading;basement membrane assembly;basement membrane;laminin complex;post-translational protein modification;collagen-containing extracellular matrix;integrin binding;endoplasmic reticulum lumen;extracellular matrix organization;structural molecule activity;laminin-11 complex;laminin-3 complex;cell morphogenesis involved in differentiation;axon guidance;neuromuscular junction development;visual perception;astrocyte development;Schwann cell development;neuron projection development;axon extension involved in regeneration;synapse organization;retina development in camera-type eye;metanephric glomerular visceral epithelial cell development;metanephric glomerular basement membrane development;neuromuscular junction;synaptic cleft;synapse	Basement membrane;Cell adhesion;Coiled coil;Disease mutation;Disulfide bond;Extracellular matrix;Glycoprotein;Laminin EGF-like domain;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Secreted;Signal	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-1474244;R-HSA-3000178;R-HSA-9006934;R-HSA-381426;R-HSA-8957275;R-HSA-3000171;R-HSA-6806834;R-HSA-3000157;R-HSA-8874081;R-HSA-8875878	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Extracellular matrix organization;ECM proteoglycans;Signaling by Receptor Tyrosine Kinases;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation;Non-integrin membrane-ECM interactions;Signaling by MET;Laminin interactions;MET activates PTK2 signaling;MET promotes cell motility
COQ7	negative	NRROS	ENSG00000174004	COQ7	1	COQ7	1	0.00644143107344819					GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0005886;GO:0006955;GO:0006954;GO:0005576;GO:0009986;GO:0006801;GO:0007179;GO:0019838;GO:0050431;GO:0035583;GO:0014005;GO:0036364;GO:0005515	protein binding;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;immune response;inflammatory response;extracellular region;cell surface;superoxide metabolic process;transforming growth factor beta receptor signaling pathway;growth factor binding;transforming growth factor beta binding;sequestering of TGFbeta in extracellular matrix;microglia development;transforming growth factor beta1 activation	Cell membrane;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Growth factor binding;Leucine-rich repeat;Membrane;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		
COQ7	negative	CLDN5	ENSG00000184113	COQ7	1	COQ7	1	0.00644143107344819					GO:0016020;GO:0016021;GO:0005198;GO:0005886;GO:0030054;GO:0005923;GO:0042552;GO:0045471;GO:0016328;GO:0033270;GO:0043220;GO:0010629;GO:0030336;GO:0010628;GO:0042802;GO:0030864;GO:0005515;GO:0003151;GO:0007043;GO:0007179;GO:0007612;GO:0016338;GO:0016525;GO:0032092;GO:0060021;GO:0060325;GO:1903142;GO:1903348;GO:1990963;GO:2000810;GO:0005911;GO:0016327	integral component of membrane;structural molecule activity;bicellular tight junction;membrane;plasma membrane;cell junction;positive regulation of gene expression;negative regulation of gene expression;myelination;response to ethanol;tight junction assembly;cell-cell junction;lateral plasma membrane;paranode region of axon;Schmidt-Lanterman incisure;tight junction;negative regulation of cell migration;protein binding;identical protein binding;cortical actin cytoskeleton;outflow tract morphogenesis;cell-cell junction assembly;transforming growth factor beta receptor signaling pathway;learning;positive regulation of cell population proliferation;calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules;negative regulation of angiogenesis;positive regulation of protein binding;maintenance of permeability of blood-brain barrier;negative regulation of vascular permeability;roof of mouth development;face morphogenesis;positive regulation of establishment of endothelial barrier;establishment of blood-retinal barrier;regulation of bicellular tight junction assembly;apicolateral plasma membrane	Cell junction;Cell membrane;Membrane;Reference proteome;Tight junction;Transmembrane;Transmembrane helix	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8878171;R-HSA-1500931;R-HSA-420029;R-HSA-421270;R-HSA-446728;R-HSA-8935964	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization;RUNX1 regulates expression of components of tight junctions
COQ7	negative	SRC	ENSG00000197122	COQ7	1	COQ7	1	0.00644143107344819	WBGene00005077;WBGene00005078			Hereditary thrombocytopenia with early-onset myelofibrosis;Colorectal Cancer;THROMBOCYTOPENIA 6	GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0043066;GO:0005829;GO:0005743;GO:0007155;GO:0004713;GO:0005739;GO:0005886;GO:0005856;GO:0005515;GO:0007049;GO:0004715;GO:0048471;GO:0007229;GO:0002376;GO:0005764;GO:0038096;GO:0050900;GO:0020037;GO:0030154;GO:0007169;GO:0045296;GO:0031234;GO:0070062;GO:0071902;GO:0042169;GO:0002223;GO:0016032;GO:0005770;GO:0007186;GO:0051902;GO:0005102;GO:0044325;GO:0007165;GO:0019899;GO:0005178;GO:0030168;GO:0007411;GO:0014068;GO:0051897;GO:0048013;GO:0046777;GO:0048010;GO:0007179;GO:0043154;GO:2001243;GO:0005070;GO:0038128;GO:0097110;GO:0035556;GO:0032463;GO:0070851;GO:0045453;GO:0007173;GO:0051219;GO:2001237;GO:0010634;GO:0050731;GO:0031295;GO:0019900;GO:0051895;GO:0070555;GO:0016236;GO:0033625;GO:0005901;GO:0035635;GO:2000641;GO:0036035;GO:0010632;GO:0018108;GO:0008022;GO:0042127;GO:0051974;GO:0045124;GO:2000811;GO:0038083;GO:0046875;GO:0007172;GO:0032211;GO:0043114;GO:2000394;GO:0005080;GO:0005158;GO:0019901;GO:0019904;GO:0030331;GO:0031625;GO:0044877;GO:0050839;GO:0070700;GO:0071253;GO:0001545;GO:0008283;GO:0009612;GO:0009615;GO:0010447;GO:0010628;GO:0010641;GO:0010907;GO:0010954;GO:0014911;GO:0016477;GO:0018105;GO:0022407;GO:0030900;GO:0031648;GO:0031667;GO:0031954;GO:0032148;GO:0032869;GO:0033146;GO:0034332;GO:0034446;GO:0034614;GO:0035306;GO:0036120;GO:0042476;GO:0042493;GO:0042542;GO:0043065;GO:0043149;GO:0043393;GO:0043406;GO:0043552;GO:0045056;GO:0045737;GO:0045785;GO:0045892;GO:0045893;GO:0046628;GO:0048011;GO:0048477;GO:0050715;GO:0050847;GO:0051057;GO:0051222;GO:0051385;GO:0051602;GO:0060065;GO:0060444;GO:0060491;GO:0070301;GO:0070374;GO:0070542;GO:0071222;GO:0071375;GO:0071393;GO:0071398;GO:0071456;GO:0071498;GO:0071560;GO:0071803;GO:0086098;GO:0090263;GO:0098609;GO:0098962;GO:1900182;GO:1902533;GO:1903997;GO:2000386;GO:2000573;GO:2000588;GO:2001286;GO:0002102;GO:0005884;GO:0014069;GO:0032587;GO:0043005;GO:0098978;GO:0099091	ATP binding;protein binding;protein phosphorylation;protein kinase activity;protein tyrosine kinase activity;nucleus;cytoplasm;membrane;nucleotide binding;kinase activity;transferase activity;phosphorylation;negative regulation of apoptotic process;cytosol;plasma membrane;mitochondrial inner membrane;cell adhesion;mitochondrion;cytoskeleton;focal adhesion;cell junction;cell cycle;non-membrane spanning protein tyrosine kinase activity;perinuclear region of cytoplasm;integrin-mediated signaling pathway;immune system process;lysosome;Fc-gamma receptor signaling pathway involved in phagocytosis;leukocyte migration;heme binding;cell differentiation;transmembrane receptor protein tyrosine kinase signaling pathway;cadherin binding;extrinsic component of cytoplasmic side of plasma membrane;extracellular exosome;positive regulation of protein serine/threonine kinase activity;SH2 domain binding;stimulatory C-type lectin receptor signaling pathway;viral process;late endosome;G protein-coupled receptor signaling pathway;regulation of cell population proliferation;negative regulation of mitochondrial depolarization;stress fiber assembly;signaling receptor binding;ion channel binding;signal transduction;enzyme binding;focal adhesion assembly;integrin binding;platelet activation;axon guidance;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of protein kinase B signaling;ephrin receptor signaling pathway;protein autophosphorylation;vascular endothelial growth factor receptor signaling pathway;transforming growth factor beta receptor signaling pathway;negative regulation of protein-containing complex assembly;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of intrinsic apoptotic signaling pathway;SH3/SH2 adaptor activity;ERBB2 signaling pathway;scaffold protein binding;intracellular signal transduction;growth factor receptor binding;bone resorption;epidermal growth factor receptor signaling pathway;phosphoprotein binding;negative regulation of extrinsic apoptotic signaling pathway;positive regulation of epithelial cell migration;positive regulation of peptidyl-tyrosine phosphorylation;T cell costimulation;kinase binding;negative regulation of focal adhesion assembly;response to interleukin-1;membrane raft;macroautophagy;positive regulation of integrin activation;caveola;entry of bacterium into host cell;regulation of early endosome to late endosome transport;regulation of epithelial cell migration;peptidyl-tyrosine phosphorylation;ATPase binding;protein C-terminus binding;negative regulation of telomerase activity;regulation of bone resorption;negative regulation of anoikis;peptidyl-tyrosine autophosphorylation;ephrin receptor binding;signal complex assembly;negative regulation of telomere maintenance via telomerase;regulation of vascular permeability;positive regulation of lamellipodium morphogenesis;protein kinase C binding;insulin receptor binding;protein kinase binding;protein domain specific binding;estrogen receptor binding;ubiquitin protein ligase binding;protein-containing complex binding;cell adhesion molecule binding;BMP receptor binding;connexin binding;primary ovarian follicle growth;cell population proliferation;response to mechanical stimulus;response to virus;response to acidic pH;positive regulation of gene expression;positive regulation of platelet-derived growth factor receptor signaling pathway;positive regulation of glucose metabolic process;positive regulation of protein processing;positive regulation of smooth muscle cell migration;cell migration;peptidyl-serine phosphorylation;regulation of cell-cell adhesion;forebrain development;protein destabilization;response to nutrient levels;positive regulation of protein autophosphorylation;activation of protein kinase B activity;cellular response to insulin stimulus;regulation of intracellular estrogen receptor signaling pathway;adherens junction organization;substrate adhesion-dependent cell spreading;cellular response to reactive oxygen species;positive regulation of dephosphorylation;osteoclast development;cellular response to platelet-derived growth factor stimulus;odontogenesis;response to drug;response to hydrogen peroxide;positive regulation of apoptotic process;regulation of protein binding;positive regulation of MAP kinase activity;positive regulation of phosphatidylinositol 3-kinase activity;transcytosis;positive regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of cell adhesion;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of insulin receptor signaling pathway;neurotrophin TRK receptor signaling pathway;oogenesis;positive regulation of cytokine secretion;progesterone receptor signaling pathway;positive regulation of small GTPase mediated signal transduction;positive regulation of protein transport;response to mineralocorticoid;response to electrical stimulus;uterus development;branching involved in mammary gland duct morphogenesis;regulation of cell projection assembly;cellular response to hydrogen peroxide;positive regulation of ERK1 and ERK2 cascade;response to fatty acid;cellular response to lipopolysaccharide;cellular response to peptide hormone stimulus;cellular response to progesterone stimulus;cellular response to fatty acid;cellular response to hypoxia;cellular response to fluid shear stress;cellular response to transforming growth factor beta stimulus;positive regulation of podosome assembly;angiotensin-activated signaling pathway involved in heart process;positive regulation of canonical Wnt signaling pathway;cell-cell adhesion;regulation of postsynaptic neurotransmitter receptor activity;positive regulation of protein localization to nucleus;positive regulation of intracellular signal transduction;positive regulation of non-membrane spanning protein tyrosine kinase activity;positive regulation of ovarian follicle development;positive regulation of DNA biosynthetic process;positive regulation of platelet-derived growth factor receptor-beta signaling pathway;regulation of caveolin-mediated endocytosis;podosome;actin filament;postsynaptic density;ruffle membrane;neuron projection;glutamatergic synapse;postsynaptic specialization, intracellular component	3D-structure;ATP-binding;Alternative splicing;Cell adhesion;Cell cycle;Cell junction;Cell membrane;Cytoplasm;Cytoskeleton;Disease mutation;Host-virus interaction;Immunity;Kinase;Lipoprotein;Membrane;Mitochondrion;Mitochondrion inner membrane;Myristate;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;SH2 domain;SH3 domain;Transferase;Tyrosine-protein kinase;Ubl conjugation	R-HSA-109582;R-HSA-168256;R-HSA-1266738;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-422475;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-1643685;R-HSA-418555;R-HSA-5663205;R-HSA-1257604;R-HSA-1280215;R-HSA-376176;R-HSA-449147;R-HSA-449836;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-8878166;R-HSA-8878171;R-HSA-9006925;R-HSA-9607240;R-HSA-418594;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-438064;R-HSA-442755;R-HSA-186797;R-HSA-9006934;R-HSA-76002;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-2219528;R-HSA-6802952;R-HSA-6802957;R-HSA-8878159;R-HSA-8941858;R-HSA-199418;R-HSA-2219530;R-HSA-6811558;R-HSA-373752;R-HSA-418885;R-HSA-166520;R-HSA-186763;R-HSA-1227986;R-HSA-1236394;R-HSA-1251985;R-HSA-177929;R-HSA-180292;R-HSA-6806834;R-HSA-8876384;R-HSA-8874081;R-HSA-8875878;R-HSA-8940973;R-HSA-8941326;R-HSA-9620244;R-HSA-354192;R-HSA-76009;R-HSA-9006921;R-HSA-6802949;R-HSA-9006115;R-HSA-5673000;R-HSA-6802946;R-HSA-6802955;R-HSA-8876493;R-HSA-428542;R-HSA-418886;R-HSA-5674135;R-HSA-6802948;R-HSA-9034015;R-HSA-354194;R-HSA-372708;R-HSA-1253288;R-HSA-8934593;R-HSA-9032500;R-HSA-9603381	Hemostasis;Immune System;Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Axon guidance;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Disease;G alpha (s) signalling events;Infectious disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signaling by ROBO receptors;Signaling by Interleukins;Other interleukin signaling;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;Intracellular signaling by second messengers;FLT3 Signaling;G alpha (i) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;PI3K/AKT Signaling in Cancer;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Negative regulation of the PI3K/AKT network;Constitutive Signaling by Aberrant PI3K in Cancer;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Netrin-1 signaling;DCC mediated attractive signaling;Signaling by NTRKs;Downstream signal transduction;Signaling by ERBB2;Signaling by ERBB4;Nuclear signaling by ERBB4;Signaling by EGFR;GAB1 signalosome;Signaling by MET;Listeria monocytogenes entry into host cells;MET activates PTK2 signaling;MET promotes cell motility;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Long-term potentiation;Integrin signaling;Platelet Aggregation (Plug Formation);;Signaling by RAS mutants;Signaling by NTRK2 (TRKB);RAF activation;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;InlA-mediated entry of Listeria monocytogenes into host cells;Regulation of commissural axon pathfinding by SLIT and ROBO;Netrin mediated repulsion signals;MAP2K and MAPK activation;Signaling by high-kinase activity BRAF mutants;Signaling by NTRK3 (TRKC);GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Downregulation of ERBB4 signaling;Regulation of RUNX1 Expression and Activity;Activated NTRK2 signals through FYN;Activated NTRK3 signals through PI3K
COQ7	negative	INF2	ENSG00000203485	COQ7	1	COQ7	1	0.00644143107344819	WBGene00019030	WBGene00018976(0);WBGene00021473(0);WBGene00019030(0)		Autosomal dominant intermediate Charcot-Marie-Tooth disease type E;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;CHARCOT-MARIE-TOOTH DISEASE DOMINANT INTERMEDIATE E;FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5	GO:0005737;GO:0003779;GO:0030036;GO:0048471;GO:0016043;GO:0017048;GO:0090140	actin binding;actin cytoskeleton organization;cellular component organization;Rho GTPase binding;cytoplasm;perinuclear region of cytoplasm;regulation of mitochondrial fission	Acetylation;Actin-binding;Alternative splicing;Charcot-Marie-Tooth disease;Coiled coil;Cytoplasm;Direct protein sequencing;Disease mutation;Neurodegeneration;Neuropathy;Phosphoprotein;Polymorphism;Reference proteome		
COQ7	negative	HLA-G	ENSG00000204632	COQ7	1	COQ7	1	0.00644143107344819				ASTHMA SUSCEPTIBILITY TO	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0042803;GO:0005886;GO:0042995;GO:0005515;GO:0005576;GO:0002376;GO:0006955;GO:0005615;GO:0009897;GO:0050776;GO:0042802;GO:0005768;GO:0005769;GO:0042605;GO:0002474;GO:0042612;GO:0031901;GO:0002479;GO:0005102;GO:0030670;GO:0045953;GO:0032735;GO:0000139;GO:0016525;GO:0060333;GO:0012507;GO:0051898;GO:0060337;GO:0045591;GO:0071556;GO:0006968;GO:0060907;GO:0031527;GO:0002729;GO:2000353;GO:0002480;GO:0042270;GO:0055038;GO:0001916;GO:0002476;GO:0002486;GO:0042610;GO:0050777;GO:0001915;GO:0070207;GO:2000774;GO:0002451;GO:0002645;GO:0002666;GO:0002767;GO:0042130;GO:0070317;GO:2001199;GO:0033106	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;endosome;protein homodimerization activity;plasma membrane;cell projection;protein binding;extracellular region;immune system process;extracellular space;external side of plasma membrane;regulation of immune response;identical protein binding;early endosome;peptide antigen binding;early endosome membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of peptide antigen via MHC class I;MHC class I protein complex;signaling receptor binding;phagocytic vesicle membrane;negative regulation of natural killer cell mediated cytotoxicity;positive regulation of interleukin-12 production;Golgi membrane;negative regulation of angiogenesis;interferon-gamma-mediated signaling pathway;ER to Golgi transport vesicle membrane;negative regulation of protein kinase B signaling;type I interferon signaling pathway;positive regulation of regulatory T cell differentiation;integral component of lumenal side of endoplasmic reticulum membrane;cellular defense response;positive regulation of macrophage cytokine production;filopodium membrane;positive regulation of natural killer cell cytokine production;positive regulation of endothelial cell apoptotic process;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;protection from natural killer cell mediated cytotoxicity;recycling endosome membrane;negative regulation of immune response;CD8 receptor binding;positive regulation of T cell mediated cytotoxicity;negative regulation of T cell mediated cytotoxicity;antigen processing and presentation of endogenous peptide antigen via MHC class Ib;protein homotrimerization;positive regulation of cellular senescence;peripheral B cell tolerance induction;positive regulation of tolerance induction;positive regulation of T cell tolerance induction;immune response-inhibiting cell surface receptor signaling pathway;negative regulation of T cell proliferation;negative regulation of G0 to G1 transition;negative regulation of dendritic cell differentiation;cis-Golgi network membrane	3D-structure;Alternative splicing;Cell membrane;Cell projection;Disulfide bond;Endoplasmic reticulum;Endosome;Glycoprotein;Immunity;MHC I;Membrane;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix	R-HSA-1280218;R-HSA-168256;R-HSA-198933;R-HSA-983169;R-HSA-1236974;R-HSA-1236975;R-HSA-1280215;R-HSA-913531;R-HSA-877300;R-HSA-909733;R-HSA-983170;R-HSA-1236977	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Class I MHC mediated antigen processing & presentation;ER-Phagosome pathway;Antigen processing-Cross presentation;Cytokine Signaling in Immune system;Interferon Signaling;Interferon gamma signaling;Interferon alpha/beta signaling;Antigen Presentation: Folding, assembly and peptide loading of class I MHC;Endosomal/Vacuolar pathway
COQ7	negative	SIPA1	ENSG00000213445	COQ7	1	COQ7	1	0.00644143107344819	WBGene00012100	WBGene00018734(0)			GO:0005634;GO:0005737;GO:0016020;GO:0005096;GO:0043547;GO:0005515;GO:0048471;GO:0051056;GO:0005829;GO:0012505;GO:0007010;GO:0007165;GO:0030308;GO:0045786;GO:0035556;GO:0007162;GO:0008022;GO:0042631;GO:0030133;GO:0032991	protein binding;GTPase activator activity;regulation of small GTPase mediated signal transduction;nucleus;cytoplasm;membrane;positive regulation of GTPase activity;perinuclear region of cytoplasm;cytosol;endomembrane system;cytoskeleton organization;signal transduction;negative regulation of cell growth;negative regulation of cell cycle;intracellular signal transduction;negative regulation of cell adhesion;protein C-terminus binding;cellular response to water deprivation;transport vesicle;protein-containing complex	Coiled coil;Cytoplasm;GTPase activation;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1280218;R-HSA-168256;R-HSA-392517	Adaptive Immune System;Immune System;Rap1 signalling
COQ7	negative	FYN	ENSG00000010810	COQ7	1	COQ7	1	0.00925593571352712	WBGene00005077;WBGene00005078				GO:0005829;GO:0005886;GO:0005515;GO:1904646;GO:1904645;GO:0005634;GO:1902951;GO:1903202;GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0004713;GO:0004715;GO:0006816;GO:0007275;GO:0002376;GO:0002250;GO:0038096;GO:0050900;GO:0042802;GO:0030154;GO:0007169;GO:0031234;GO:0000165;GO:0002223;GO:0016032;GO:0007631;GO:0030168;GO:0044297;GO:0007411;GO:0019221;GO:0050852;GO:0051897;GO:0048013;GO:0048010;GO:0005102;GO:0048156;GO:0035556;GO:0070851;GO:0005768;GO:0007596;GO:0031295;GO:0045121;GO:0050690;GO:1901216;GO:0050321;GO:0014069;GO:0097718;GO:0030425;GO:0018108;GO:0042127;GO:0031802;GO:0050730;GO:0090314;GO:0097062;GO:1900449;GO:1905664;GO:0048471;GO:0097386;GO:0038083;GO:0019899;GO:0043014;GO:0046875;GO:0000304;GO:0003015;GO:0007612;GO:0008360;GO:0010730;GO:0042542;GO:1903997;GO:1905232;GO:1905430;GO:1905477;GO:2001056;GO:0005739;GO:0097038;GO:0001664;GO:0015631;GO:0042608;GO:0042609;GO:0042610;GO:0043548;GO:0044325;GO:0044877;GO:0051428;GO:0001764;GO:0007166;GO:0010629;GO:0010976;GO:0014068;GO:0030900;GO:0031397;GO:0036120;GO:0042177;GO:0042493;GO:0042531;GO:0043123;GO:0043524;GO:0045471;GO:0046777;GO:0048813;GO:0050798;GO:0050804;GO:0050966;GO:0071363;GO:0071375;GO:0071560;GO:1900182;GO:2001240;GO:0005884;GO:0043231;GO:0071944;GO:0098685;GO:0098978;GO:0099092	ATP binding;protein binding;protein phosphorylation;protein kinase activity;protein tyrosine kinase activity;cellular response to amyloid-beta;response to amyloid-beta;nucleus;negative regulation of dendritic spine maintenance;negative regulation of oxidative stress-induced cell death;cytoplasm;membrane;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytosol;plasma membrane;non-membrane spanning protein tyrosine kinase activity;calcium ion transport;multicellular organism development;immune system process;adaptive immune response;Fc-gamma receptor signaling pathway involved in phagocytosis;leukocyte migration;identical protein binding;cell differentiation;transmembrane receptor protein tyrosine kinase signaling pathway;extrinsic component of cytoplasmic side of plasma membrane;MAPK cascade;stimulatory C-type lectin receptor signaling pathway;viral process;regulation of cell population proliferation;feeding behavior;platelet activation;cell body;axon guidance;cytokine-mediated signaling pathway;T cell receptor signaling pathway;positive regulation of protein kinase B signaling;ephrin receptor signaling pathway;vascular endothelial growth factor receptor signaling pathway;signaling receptor binding;tau protein binding;intracellular signal transduction;growth factor receptor binding;endosome;blood coagulation;T cell costimulation;membrane raft;regulation of defense response to virus by virus;positive regulation of neuron death;tau-protein kinase activity;postsynaptic density;disordered domain specific binding;dendrite;peptidyl-tyrosine phosphorylation;perinuclear region of cytoplasm;type 5 metabotropic glutamate receptor binding;regulation of peptidyl-tyrosine phosphorylation;positive regulation of protein targeting to membrane;dendritic spine maintenance;regulation of glutamate receptor signaling pathway;regulation of calcium ion import across plasma membrane;glial cell projection;peptidyl-tyrosine autophosphorylation;enzyme binding;alpha-tubulin binding;ephrin receptor binding;response to singlet oxygen;heart process;learning;regulation of cell shape;negative regulation of hydrogen peroxide biosynthetic process;response to hydrogen peroxide;positive regulation of non-membrane spanning protein tyrosine kinase activity;cellular response to L-glutamate;cellular response to glycine;positive regulation of protein localization to membrane;positive regulation of cysteine-type endopeptidase activity;mitochondrion;perinuclear endoplasmic reticulum;G protein-coupled receptor binding;tubulin binding;T cell receptor binding;CD4 receptor binding;CD8 receptor binding;phosphatidylinositol 3-kinase binding;ion channel binding;protein-containing complex binding;peptide hormone receptor binding;neuron migration;cell surface receptor signaling pathway;negative regulation of gene expression;positive regulation of neuron projection development;positive regulation of phosphatidylinositol 3-kinase signaling;forebrain development;negative regulation of protein ubiquitination;cellular response to platelet-derived growth factor stimulus;negative regulation of protein catabolic process;response to drug;positive regulation of tyrosine phosphorylation of STAT protein;positive regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of neuron apoptotic process;response to ethanol;protein autophosphorylation;dendrite morphogenesis;activated T cell proliferation;modulation of chemical synaptic transmission;detection of mechanical stimulus involved in sensory perception of pain;cellular response to growth factor stimulus;cellular response to peptide hormone stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of protein localization to nucleus;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;actin filament;intracellular membrane-bounded organelle;cell periphery;Schaffer collateral - CA1 synapse;glutamatergic synapse;postsynaptic density, intracellular component	3D-structure;ATP-binding;Adaptive immunity;Alternative splicing;Cell membrane;Cytoplasm;Developmental protein;Host-virus interaction;Immunity;Kinase;Lipoprotein;Manganese;Membrane;Metal-binding;Myristate;Nucleotide-binding;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;SH2 domain;SH3 domain;Transferase;Tyrosine-protein kinase	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-202733;R-HSA-2029480;R-HSA-2029481;R-HSA-2454202;R-HSA-2730905;R-HSA-983695;R-HSA-983705;R-HSA-388841;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-449147;R-HSA-449836;R-HSA-5621481;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9006925;R-HSA-9607240;R-HSA-2172127;R-HSA-375165;R-HSA-9006934;R-HSA-76002;R-HSA-2219528;R-HSA-1500931;R-HSA-199418;R-HSA-2219530;R-HSA-512988;R-HSA-6811558;R-HSA-912631;R-HSA-2682334;R-HSA-373753;R-HSA-3928662;R-HSA-114604;R-HSA-1433557;R-HSA-194138;R-HSA-2424491;R-HSA-389356;R-HSA-389357;R-HSA-4420097;R-HSA-3928664;R-HSA-1433559;R-HSA-1227986;R-HSA-373755;R-HSA-399956;R-HSA-3928665;R-HSA-399954;R-HSA-399955;R-HSA-3928663;R-HSA-164952;R-HSA-8866376;R-HSA-75892;R-HSA-5621575;R-HSA-389359;R-HSA-210990;R-HSA-164944;R-HSA-389513;R-HSA-5621480	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR);Costimulation by the CD28 family;Developmental Biology;Axon guidance;Signal Transduction;Disease;HIV Infection;Infectious disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Signaling by Interleukins;Other interleukin signaling;C-type lectin receptors (CLRs);Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Intracellular signaling by second messengers;FLT3 Signaling;DAP12 interactions;NCAM signaling for neurite out-growth;Signaling by Receptor Tyrosine Kinases;Platelet activation, signaling and aggregation;PI3K/AKT Signaling in Cancer;Cell-Cell communication;Negative regulation of the PI3K/AKT network;Constitutive Signaling by Aberrant PI3K in Cancer;Interleukin-3, Interleukin-5 and GM-CSF signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Regulation of signaling by CBL;EPH-Ephrin signaling;Nephrin family interactions;EPHB-mediated forward signaling;GPVI-mediated activation cascade;Signaling by SCF-KIT;Signaling by VEGF;DAP12 signaling;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;VEGFA-VEGFR2 Pathway;Ephrin signaling;Regulation of KIT signaling;Signaling by ERBB2;Semaphorin interactions;CRMPs in Sema3A signaling;EPH-ephrin mediated repulsion of cells;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;EPHA-mediated growth cone collapse;The role of Nef in HIV-1 replication and disease pathogenesis;Reelin signalling pathway;Platelet Adhesion to exposed collagen;CD209 (DC-SIGN) signaling;CD28 dependent Vav1 pathway;PECAM1 interactions;Nef and signal transduction;CTLA4 inhibitory signaling;Dectin-2 family
COQ7	negative	SLC38A5	ENSG00000017483	COQ7	1	COQ7	1	0.00925593571352712	WBGene00021765	WBGene00006783(0);WBGene00012804(0);WBGene00020837(0);WBGene00019837(0);WBGene00012487(0);WBGene00012629(0);WBGene00010421(0)			GO:0016020;GO:0016021;GO:0005886;GO:0005887;GO:0015171;GO:0003333;GO:0006865;GO:0015187;GO:0015816	membrane;integral component of membrane;plasma membrane;integral component of plasma membrane;amino acid transmembrane transporter activity;amino acid transmembrane transport;amino acid transport;L-serine transmembrane transporter activity;glycine transmembrane transporter activity;glycine transport;L-histidine transmembrane transporter activity;L-asparagine transmembrane transporter activity;L-glutamine transmembrane transporter activity;alanine transmembrane transporter activity;serine transmembrane transporter activity;glutamine transport;L-serine transport;serine transport;L-histidine transmembrane transport;asparagine transmembrane transport;L-alanine transmembrane transport	Acetylation;Alternative splicing;Cell membrane;Disulfide bond;Glycoprotein;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-382551;R-HSA-425407;R-HSA-425393;R-HSA-352230	Transport of small molecules;SLC-mediated transmembrane transport;Transport of inorganic cations/anions and amino acids/oligopeptides;Amino acid transport across the plasma membrane
COQ7	negative	MAP2K3	ENSG00000034152	COQ7	1	COQ7	1	0.00925593571352712	WBGene00004758;WBGene00003368;WBGene00012162				GO:0043536;GO:0035924;GO:0016020;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0004713;GO:0018108;GO:0005515;GO:0045893;GO:0005737;GO:0005654;GO:0005829;GO:0019901;GO:0007165;GO:0023014;GO:0032147;GO:0004708;GO:0000187;GO:0045860;GO:0000165;GO:0006954;GO:0038066;GO:0042035;GO:0060048	ATP binding;protein phosphorylation;protein kinase activity;positive regulation of blood vessel endothelial cell migration;cellular response to vascular endothelial growth factor stimulus;membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;protein tyrosine kinase activity;peptidyl-tyrosine phosphorylation;protein binding;positive regulation of transcription, DNA-templated;cytoplasm;nucleoplasm;cytosol;protein kinase binding;signal transduction;regulation of mitotic cell cycle;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;MAP kinase kinase activity;activation of MAPK activity;positive regulation of protein kinase activity;MAPK cascade;inflammatory response;p38MAPK cascade;regulation of cytokine biosynthetic process;cardiac muscle contraction	ATP-binding;Acetylation;Alternative splicing;Disease mutation;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Tyrosine-protein kinase	R-HSA-168249;R-HSA-168256;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-8953897;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-2559580;R-HSA-2559583;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-975871;R-HSA-450302	Innate Immune System;Immune System;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;Cellular responses to external stimuli;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Oxidative Stress Induced Senescence;Cellular Senescence;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;MyD88 cascade initiated on plasma membrane;activated TAK1 mediates p38 MAPK activation
COQ7	negative	TUBG2	ENSG00000037042	COQ7	1	COQ7	1	0.00925593571352712	WBGene00006540	WBGene00006539(0);WBGene00000248(0);WBGene00006536(0);WBGene00006537(0);WBGene00006530(0);WBGene00012489(0);WBGene00006529(0);WBGene00006528(0);WBGene00006532(0)			GO:0005737;GO:0000166;GO:0003924;GO:0005525;GO:0005856;GO:0005874;GO:0005815;GO:0005634;GO:0007017;GO:0007020;GO:0005200;GO:0000226;GO:0000278;GO:0031122;GO:0005829;GO:0005813;GO:0005819;GO:0000930;GO:0005198;GO:0007052;GO:0000070;GO:0000212;GO:0015630;GO:0000242;GO:0005876;GO:0005881	GTP binding;microtubule-based process;microtubule;GTPase activity;microtubule nucleation;cytoplasmic microtubule organization;gamma-tubulin complex;cytoplasm;nucleotide binding;cytoskeleton;microtubule organizing center;nucleus;structural constituent of cytoskeleton;microtubule cytoskeleton organization;mitotic cell cycle;cytosol;centrosome;spindle;structural molecule activity;mitotic spindle organization;mitotic sister chromatid segregation;meiotic spindle organization;microtubule cytoskeleton;pericentriolar material;spindle microtubule;cytoplasmic microtubule	Cytoplasm;Cytoskeleton;GTP-binding;Microtubule;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-380270;R-HSA-380287	Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation
COQ7	negative	AP2S1	ENSG00000042753	COQ7	1	COQ7	1	0.00925593571352712	WBGene00000157	WBGene00000157(0)		Familial hypocalciuric hypercalcemia type 3;HYPOCALCIURIC HYPERCALCEMIA FAMILIAL TYPE III	GO:0016020;GO:0006886;GO:0015031;GO:0016192;GO:0030117;GO:0072583;GO:0035615;GO:0030122;GO:0008565;GO:0005886;GO:0005515;GO:0005905;GO:0043231;GO:0005829;GO:0006897;GO:0060071;GO:0019886;GO:0048268;GO:0061024;GO:0048013;GO:0030666;GO:0034383;GO:0036020;GO:0050690;GO:0032802;GO:0030669;GO:0045334;GO:0030100	intracellular protein transport;vesicle-mediated transport;membrane coat;protein transport;clathrin adaptor activity;clathrin-dependent endocytosis;AP-2 adaptor complex;membrane;plasma membrane;protein binding;clathrin-coated pit;endocytosis;intracellular membrane-bounded organelle;regulation of endocytosis;cytosol;Wnt signaling pathway, planar cell polarity pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;clathrin coat assembly;membrane organization;ephrin receptor signaling pathway;endocytic vesicle membrane;low-density lipoprotein particle clearance;endolysosome membrane;regulation of defense response to virus by virus;low-density lipoprotein particle receptor catabolic process;clathrin-coated endocytic vesicle membrane;clathrin-coated endocytic vesicle	Alternative splicing;Cell membrane;Coated pit;Disease mutation;Endocytosis;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport	R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-382551;R-HSA-162582;R-HSA-199991;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-195721;R-HSA-3858494;R-HSA-4086400;R-HSA-2132295;R-HSA-9006934;R-HSA-8856828;R-HSA-2682334;R-HSA-166520;R-HSA-187037;R-HSA-8856825;R-HSA-5099900;R-HSA-3928665;R-HSA-174824;R-HSA-8964038;R-HSA-8964043;R-HSA-164938;R-HSA-164952;R-HSA-167590;R-HSA-177504;R-HSA-182218;R-HSA-5140745;R-HSA-8866427	Adaptive Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Transport of small molecules;Signal Transduction;Membrane Trafficking;Disease;HIV Infection;Infectious disease;Host Interactions of HIV factors;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway;MHC class II antigen presentation;Signaling by Receptor Tyrosine Kinases;Clathrin-mediated endocytosis;EPH-Ephrin signaling;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Cargo recognition for clathrin-mediated endocytosis;WNT5A-dependent internalization of FZD4;EPH-ephrin mediated repulsion of cells;Plasma lipoprotein assembly, remodeling, and clearance;LDL clearance;Plasma lipoprotein clearance;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Nef Mediated CD4 Down-regulation;Retrograde neurotrophin signalling;Nef Mediated CD8 Down-regulation;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;VLDLR internalisation and degradation
COQ7	negative	NDST1	ENSG00000070614	COQ7	1	COQ7	1	0.00925593571352712	WBGene00002028			Autosomal recessive non-syndromic intellectual disability;Autosomal Recessive Mental Retardation;Mental retardation autosomal recessive 46	GO:0016020;GO:0016021;GO:0016787;GO:0015016;GO:0008146;GO:0016740;GO:0005794;GO:0003824;GO:0008152;GO:0000139;GO:0006954;GO:0005515;GO:0019213;GO:0006024;GO:0015012;GO:0030210;GO:0042328;GO:0015014	membrane;integral component of membrane;hydrolase activity;[heparan sulfate]-glucosamine N-sulfotransferase activity;sulfotransferase activity;transferase activity;Golgi apparatus;catalytic activity;metabolic process;inflammatory response;Golgi membrane;protein binding;deacetylase activity;glycosaminoglycan biosynthetic process;heparan sulfate proteoglycan biosynthetic process;heparin biosynthetic process;heparan sulfate N-acetylglucosaminyltransferase activity;heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process;heparan sulfate N-deacetylase activity;polysaccharide biosynthetic process;cardiac septum development;protein sulfation;heart development;respiratory gaseous exchange by respiratory system;fibroblast growth factor receptor signaling pathway;animal organ morphogenesis;glycosaminoglycan metabolic process;forebrain development;midbrain development;aorta development;positive regulation of MAPK cascade;positive regulation of smoothened signaling pathway;embryonic neurocranium morphogenesis;embryonic viscerocranium morphogenesis;coronary vasculature development	3D-structure;Alternative splicing;Disease mutation;Disulfide bond;Glycoprotein;Golgi apparatus;Hydrolase;Inflammatory response;Membrane;Mental retardation;Multifunctional enzyme;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-71387;R-HSA-1630316;R-HSA-1638091;R-HSA-2022928	Metabolism;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis
COQ7	negative	FAM50A	ENSG00000071859	COQ7	1	COQ7	1	0.00925593571352712	WBGene00008143	WBGene00008143(1)			GO:0005634;GO:0003723;GO:0005654;GO:0007283	nucleus;RNA binding;nucleoplasm;spermatogenesis;chromatin organization	Acetylation;Direct protein sequencing;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation		
COQ7	negative	SYNJ2	ENSG00000078269	COQ7	1	COQ7	1	0.00925593571352712	WBGene00006763	WBGene00006763(0);WBGene00012353(0)			GO:0003676;GO:0003723;GO:0005737;GO:0016020;GO:0016787;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0045121;GO:0046856;GO:0034595;GO:0042578;GO:0030424;GO:0005829;GO:0061024;GO:0098793;GO:0006661;GO:0048471;GO:0007420;GO:0046855;GO:0004439;GO:0017124	phosphatidylinositol dephosphorylation;nucleic acid binding;phosphoric ester hydrolase activity;phosphatidylinositol phosphate 5-phosphatase activity;RNA binding;cytoplasm;membrane;hydrolase activity;cytoskeleton;plasma membrane;cell projection;protein binding;cell junction;membrane raft;synapse;cytosol;membrane organization;presynapse;phosphatidylinositol biosynthetic process;perinuclear region of cytoplasm;brain development;inositol phosphate dephosphorylation;phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;SH3 domain binding	3D-structure;Alternative splicing;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Hydrolase;Membrane;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Synapse	R-HSA-5653656;R-HSA-1430728;R-HSA-556833;R-HSA-199991;R-HSA-8856828;R-HSA-1483255;R-HSA-1483257;R-HSA-1660499	Vesicle-mediated transport;Metabolism;Metabolism of lipids;Membrane Trafficking;Clathrin-mediated endocytosis;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane
COQ7	negative	ITGB5	ENSG00000082781	COQ7	1	COQ7	1	0.00925593571352712	WBGene00003930				GO:0016020;GO:0016021;GO:0007155;GO:0005515;GO:0007229;GO:0009986;GO:0008305;GO:0046718;GO:0005925;GO:0005886;GO:0038023;GO:0070062;GO:0016477;GO:0002479;GO:0016032;GO:0005178;GO:0007160;GO:0033627;GO:0030198;GO:0007179;GO:0006936;GO:0001618;GO:0043235;GO:0035987;GO:0034684;GO:0045335;GO:0043149;GO:0090136	integrin complex;signaling receptor activity;integrin-mediated signaling pathway;membrane;integral component of membrane;cell adhesion;focal adhesion;protein binding;cell surface;viral entry into host cell;plasma membrane;extracellular exosome;cell migration;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;viral process;integrin binding;cell-matrix adhesion;cell adhesion mediated by integrin;stress fiber assembly;extracellular matrix organization;transforming growth factor beta receptor signaling pathway;muscle contraction;virus receptor activity;receptor complex;endodermal cell differentiation;integrin alphav-beta5 complex;phagocytic vesicle;epithelial cell-cell adhesion	Cell adhesion;Disulfide bond;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Integrin;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-1280218;R-HSA-168256;R-HSA-983169;R-HSA-1236975;R-HSA-1474244;R-HSA-216083;R-HSA-3000178;R-HSA-397014;R-HSA-3000171;R-HSA-3000170;R-HSA-445355;R-HSA-1566948;R-HSA-2129379;R-HSA-1236973	Adaptive Immune System;Immune System;Class I MHC mediated antigen processing & presentation;Antigen processing-Cross presentation;Extracellular matrix organization;Integrin cell surface interactions;ECM proteoglycans;Muscle contraction;Non-integrin membrane-ECM interactions;Syndecan interactions;Smooth Muscle Contraction;Elastic fibre formation;Molecules associated with elastic fibres;Cross-presentation of particulate exogenous antigens (phagosomes)
COQ7	negative	GNAO1	ENSG00000087258	COQ7	1	COQ7	1	0.00925593571352712	WBGene00001648;WBGene00001666;WBGene00001669;WBGene00001678;WBGene00003850	WBGene00001648(1)		Early infantile epileptic encephalopathy;Epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 17;NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS	GO:0016020;GO:0046872;GO:0000166;GO:0007186;GO:0007165;GO:0003924;GO:0005525;GO:0005886;GO:0005834;GO:0019001;GO:0031683;GO:0007188;GO:0001664;GO:0006457;GO:0006936;GO:0007223;GO:0031821;GO:0031852;GO:0051430;GO:0007212;GO:0005102;GO:0032794;GO:0044877;GO:0007568;GO:0007626;GO:0008016;GO:0009987;GO:0010243;GO:0014070;GO:0030900;GO:0031175;GO:0034097;GO:0042475;GO:0042493;GO:0042542;GO:0043278;GO:0043547;GO:0051926;GO:0030425;GO:0032991;GO:0043005;GO:0043209;GO:0044297	G protein-coupled receptor signaling pathway;signal transduction;GTP binding;GTPase activity;G-protein beta/gamma-subunit complex binding;guanyl nucleotide binding;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;membrane;metal ion binding;nucleotide binding;plasma membrane;heterotrimeric G-protein complex;G protein-coupled receptor binding;protein folding;muscle contraction;Wnt signaling pathway, calcium modulating pathway;G protein-coupled serotonin receptor binding;mu-type opioid receptor binding;corticotropin-releasing hormone receptor 1 binding;dopamine receptor signaling pathway;locomotory behavior;regulation of heart contraction;cellular process;dendrite;cell body	3D-structure;ADP-ribosylation;Alternative splicing;Cell membrane;Disease mutation;Epilepsy;GTP-binding;Lipoprotein;Magnesium;Membrane;Metal-binding;Myristate;Nucleotide-binding;Palmitate;Reference proteome;Transducer	R-HSA-392499;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-195721;R-HSA-3858494;R-HSA-418594;R-HSA-390466;R-HSA-391251;R-HSA-111885;R-HSA-112040;R-HSA-112043;R-HSA-202040;R-HSA-6814122;R-HSA-4086398	Metabolism of proteins;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Signaling by WNT;Beta-catenin independent WNT signaling;G alpha (i) signalling events;Chaperonin-mediated protein folding;Protein folding;Opioid Signalling;G-protein mediated events;PLC beta mediated events;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Ca2+ pathway
COQ7	negative	ARHGAP4	ENSG00000089820	COQ7	1	COQ7	1	0.00925593571352712	WBGene00006406	WBGene00006406(1)			GO:0007165;GO:0043547;GO:0005096;GO:0005515;GO:0005737;GO:0009967;GO:0005829;GO:0051056;GO:0007266;GO:0005070;GO:0007010;GO:0048365;GO:0030336;GO:0007399;GO:0010764;GO:0030517;GO:0005794;GO:0005874;GO:0030426	protein binding;signal transduction;positive regulation of GTPase activity;GTPase activator activity;cytoplasm;positive regulation of signal transduction;cytosol;regulation of small GTPase mediated signal transduction;Rho protein signal transduction;SH3/SH2 adaptor activity;cytoskeleton organization;Rac GTPase binding;negative regulation of cell migration;nervous system development;negative regulation of fibroblast migration;negative regulation of axon extension;Golgi apparatus;microtubule;growth cone	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;GTPase activation;Phosphoprotein;Polymorphism;Reference proteome;SH3 domain	R-HSA-162582;R-HSA-194315;R-HSA-194840	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
COQ7	negative	NAT14	ENSG00000090971	COQ7	1	COQ7	1	0.00925593571352712					GO:0005634;GO:0016020;GO:0016021;GO:0016740;GO:0003677;GO:0016746;GO:0008080;GO:0045893;GO:0006352	N-acetyltransferase activity;nucleus;membrane;integral component of membrane;transferase activity;DNA binding;transferase activity, transferring acyl groups;positive regulation of transcription, DNA-templated;DNA-templated transcription, initiation	Activator;Acyltransferase;DNA-binding;Membrane;Reference proteome;Transcription;Transcription regulation;Transferase;Transmembrane;Transmembrane helix		
COQ7	negative	ABHD4	ENSG00000100439	COQ7	1	COQ7	1	0.00925593571352712	WBGene00016506;WBGene00016507;WBGene00007711	WBGene00022260(0);WBGene00022259(0);WBGene00018077(0);WBGene00007854(0);WBGene00022258(0);WBGene00019525(0);WBGene00017335(0)			GO:0016787;GO:0006629;GO:0016042;GO:0005789;GO:0052689;GO:0055088;GO:0036152;GO:0005811;GO:0070292	hydrolase activity;lipid metabolic process;lipid catabolic process;endoplasmic reticulum membrane;carboxylic ester hydrolase activity;lipid homeostasis;phosphatidylethanolamine acyl-chain remodeling;lipid droplet;N-acylphosphatidylethanolamine metabolic process	Alternative splicing;Hydrolase;Lipid degradation;Lipid metabolism;Reference proteome	R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1482839	Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Acyl chain remodelling of PE
COQ7	negative	PORCN	ENSG00000102312	COQ7	1	COQ7	1	0.00925593571352712	WBGene00003394	WBGene00003394(0)		FOCAL DERMAL HYPOPLASIA;FOCAL DERMAL HYPOPLASIA;FOCAL DERMAL HYPOPLASIA	GO:0016020;GO:0016021;GO:0016740;GO:0005783;GO:0005789;GO:0016746;GO:0016055;GO:0006497;GO:1990698;GO:0045234;GO:0017147;GO:0009100;GO:0060070;GO:0099072;GO:0030176;GO:0032281;GO:0098978	membrane;integral component of membrane;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;transferase activity, transferring acyl groups;Wnt signaling pathway;protein lipidation;palmitoleoyltransferase activity;protein palmitoleylation;Wnt-protein binding;glycoprotein metabolic process;canonical Wnt signaling pathway;regulation of postsynaptic membrane neurotransmitter receptor levels;integral component of endoplasmic reticulum membrane;AMPA glutamate receptor complex;glutamatergic synapse	Acyltransferase;Alternative splicing;Disease mutation;Endoplasmic reticulum;Lipoprotein;Membrane;Palmitate;Reference proteome;Transferase;Transmembrane;Transmembrane helix;Wnt signaling pathway	R-HSA-162582;R-HSA-1643685;R-HSA-195721;R-HSA-5663202;R-HSA-3238698;R-HSA-4791275;R-HSA-5340573	Signal Transduction;Disease;Signaling by WNT;Diseases of signal transduction;WNT ligand biogenesis and trafficking;Signaling by WNT in cancer;WNT ligand secretion is abrogated by the PORCN inhibitor LGK974
COQ7	negative	CRYM	ENSG00000103316	COQ7	1	COQ7	1	0.00925593571352712				Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 40	GO:0005737;GO:0005829;GO:0016491;GO:0055114;GO:0042803;GO:0005515;GO:0000122;GO:0003714;GO:0070062;GO:0006554;GO:0007605;GO:0005782;GO:0042562;GO:0050661;GO:0070324;GO:0070327;GO:0042403;GO:0047127;GO:0005634;GO:0005739	cytoplasm;cytosol;oxidoreductase activity;oxidation-reduction process;protein homodimerization activity;protein binding;negative regulation of transcription by RNA polymerase II;transcription corepressor activity;extracellular exosome;lysine catabolic process;sensory perception of sound;peroxisomal matrix;hormone binding;NADP binding;thyroid hormone binding;thyroid hormone transport;thyroid hormone metabolic process;oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor;thiomorpholine-carboxylate dehydrogenase activity;nucleus;mitochondrion	3D-structure;Cytoplasm;Deafness;Direct protein sequencing;Disease mutation;NAD;NADP;Non-syndromic deafness;Oxidoreductase;Reference proteome	R-HSA-1430728;R-HSA-71064;R-HSA-71291	Metabolism;Lysine catabolism;Metabolism of amino acids and derivatives
COQ7	negative	PLD3	ENSG00000105223	COQ7	1	COQ7	1	0.00925593571352712	WBGene00017316;WBGene00013080;WBGene00017124;WBGene00020256	WBGene00020256(1);WBGene00017316(1);WBGene00017124(0);WBGene00013080(1)		SPINOCEREBELLAR ATAXIA 46	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0016787;GO:0003824;GO:0006629;GO:0016042;GO:0005515;GO:0070062;GO:0004630;GO:0070290	membrane;integral component of membrane;catalytic activity;endoplasmic reticulum;endoplasmic reticulum membrane;hydrolase activity;endosome;Golgi apparatus;DNA metabolic process;nucleic acid phosphodiester bond hydrolysis;protein binding;exonuclease activity;nuclease activity;inflammatory response;Golgi membrane;immune system process;lysosome;late endosome membrane;extracellular exosome;early endosome membrane;endosome membrane;lysosomal lumen;phospholipase D activity;regulation of cytokine production involved in inflammatory response;myotube differentiation;single-stranded DNA 5'-3' exodeoxyribonuclease activity;lysosomal membrane	Disease mutation;Endoplasmic reticulum;Endosome;Exonuclease;Glycoprotein;Golgi apparatus;Hydrolase;Immunity;Inflammatory response;Lysosome;Membrane;Neurodegeneration;Nuclease;Polymorphism;Reference proteome;Repeat;Signal-anchor;Spinocerebellar ataxia;Transmembrane;Transmembrane helix;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029485;R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1483148	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Synthesis of PG
COQ7	negative	LSR	ENSG00000105699	COQ7	1	COQ7	1	0.00925593571352712					GO:0016020;GO:0016021;GO:0005886;GO:0034361;GO:0042627;GO:0070062;GO:0034362;GO:0001889;GO:0060856;GO:0061436;GO:0061833;GO:1904274;GO:0061689;GO:0019216	membrane;integral component of membrane;plasma membrane;chylomicron;very-low-density lipoprotein particle;extracellular exosome;low-density lipoprotein particle;liver development;establishment of blood-brain barrier;establishment of skin barrier;protein localization to tricellular tight junction;tricellular tight junction assembly;tricellular tight junction;regulation of lipid metabolic process	Alternative splicing;Cell membrane;Chylomicron;Disulfide bond;Immunoglobulin domain;LDL;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Transmembrane;Transmembrane helix;VLDL	R-HSA-382551;R-HSA-174824;R-HSA-8964038;R-HSA-8964043;R-HSA-8964046	Transport of small molecules;Plasma lipoprotein assembly, remodeling, and clearance;LDL clearance;Plasma lipoprotein clearance;VLDL clearance
COQ7	negative	SPARC	ENSG00000113140	COQ7	1	COQ7	1	0.00925593571352712	WBGene00003893	WBGene00003893(1)		Osteogenesis imperfecta type 4;OSTEOGENESIS IMPERFECTA TYPE XVII;OSTEOGENESIS IMPERFECTA TYPE XVII	GO:0005737;GO:0005615;GO:0046872;GO:0005509;GO:0005515;GO:0005576;GO:0005518;GO:0009986;GO:0062023;GO:0006898;GO:0005604;GO:0022604;GO:0031091;GO:0002576;GO:0016363;GO:0031093;GO:0005201;GO:0030198;GO:0001937;GO:0016525;GO:0010595;GO:0071682;GO:0050840;GO:0001503;GO:0007507;GO:0009629;GO:0010288;GO:0030324;GO:0032496;GO:0033591;GO:0034097;GO:0042060;GO:0042127;GO:0043434;GO:0043473;GO:0045471;GO:0046686;GO:0048839;GO:0050807;GO:0051384;GO:0051591;GO:0051592;GO:0060348;GO:0071363;GO:0005634;GO:0031012;GO:0031092;GO:0031982;GO:0045202;GO:0098978	protein binding;extracellular space;calcium ion binding;collagen-containing extracellular matrix;collagen binding;cytoplasm;intracellular membrane-bounded organelle;metal ion binding;extracellular region;cell surface;receptor-mediated endocytosis;basement membrane;regulation of cell morphogenesis;anatomical structure development;platelet alpha granule;platelet degranulation;nuclear matrix;platelet alpha granule lumen;extracellular matrix structural constituent;extracellular matrix organization;negative regulation of endothelial cell proliferation;negative regulation of angiogenesis;positive regulation of endothelial cell migration;endocytic vesicle lumen;extracellular matrix binding;ossification;heart development;response to gravity;response to lead ion;lung development;response to lipopolysaccharide;response to L-ascorbic acid;response to cytokine;wound healing;regulation of cell population proliferation;response to peptide hormone;pigmentation;response to ethanol;response to cadmium ion;inner ear development;regulation of synapse organization;response to glucocorticoid;response to cAMP;response to calcium ion;bone development;cellular response to growth factor stimulus;nucleus;extracellular matrix;platelet alpha granule membrane;vesicle;synapse;glutamatergic synapse	3D-structure;Basement membrane;Calcium;Copper;Direct protein sequencing;Disease mutation;Disulfide bond;Extracellular matrix;Glycoprotein;Metal-binding;Osteogenesis imperfecta;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-109582;R-HSA-2173782;R-HSA-5653656;R-HSA-162582;R-HSA-1474244;R-HSA-3000178;R-HSA-9006934;R-HSA-76002;R-HSA-76005;R-HSA-114608;R-HSA-1236394;R-HSA-1251985;R-HSA-3000497	Hemostasis;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport;Signal Transduction;Extracellular matrix organization;ECM proteoglycans;Signaling by Receptor Tyrosine Kinases;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Signaling by ERBB4;Nuclear signaling by ERBB4;Scavenging by Class H Receptors
COQ7	negative	HPCAL1	ENSG00000115756	COQ7	1	COQ7	1	0.00925593571352712	WBGene00003563	WBGene00015867(0);WBGene00003564(0)			GO:0005509;GO:0016020;GO:0046872;GO:0005515	calcium ion binding;membrane;metal ion binding;protein binding	3D-structure;Calcium;Lipoprotein;Membrane;Metal-binding;Myristate;Reference proteome;Repeat		
COQ7	negative	RAP1A	ENSG00000116473	COQ7	1	COQ7	1	0.00925593571352712	WBGene00004307			Kabuki syndrome	GO:0005737;GO:0016020;GO:0000166;GO:0007165;GO:0003924;GO:0005525;GO:0005886;GO:0005515;GO:0048471;GO:0030054;GO:0032486;GO:0005768;GO:0005769;GO:0007399;GO:0043547;GO:0005829;GO:0070062;GO:0070374;GO:0005770;GO:0043312;GO:0035579;GO:0044877;GO:0061028;GO:0071320;GO:0050796;GO:0098978;GO:0072659;GO:0019003;GO:0045860;GO:0010976;GO:0017034;GO:0098696;GO:0038180;GO:1990090;GO:2001214;GO:1901888;GO:2000301;GO:0017016;GO:0007264;GO:0009743;GO:0032966;GO:0035690;GO:0046326;GO:0071333;GO:0071407;GO:0097327;GO:0097421;GO:1905451;GO:0032045;GO:0043005;GO:0045335	signal transduction;membrane;GTP binding;GTPase activity;Rap protein signal transduction;cytoplasm;nucleotide binding;endosome;plasma membrane;protein binding;perinuclear region of cytoplasm;cell junction;early endosome;nervous system development;positive regulation of GTPase activity;cytosol;extracellular exosome;positive regulation of ERK1 and ERK2 cascade;late endosome;neutrophil degranulation;specific granule membrane;protein-containing complex binding;establishment of endothelial barrier;cellular response to cAMP;regulation of insulin secretion;glutamatergic synapse;protein localization to plasma membrane;GDP binding;positive regulation of protein kinase activity;positive regulation of neuron projection development;Rap guanyl-nucleotide exchange factor activity;regulation of neurotransmitter receptor localization to postsynaptic specialization membrane;nerve growth factor signaling pathway;cellular response to nerve growth factor stimulus;positive regulation of vasculogenesis;regulation of cell junction assembly;negative regulation of synaptic vesicle exocytosis;Ras GTPase binding;small GTPase mediated signal transduction;response to carbohydrate;negative regulation of collagen biosynthetic process;cellular response to drug;positive regulation of glucose import;cellular response to organic cyclic compound;response to antineoplastic agent;liver regeneration;positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;guanyl-nucleotide exchange factor complex;neuron projection;phagocytic vesicle	3D-structure;Cell junction;Cell membrane;Cytoplasm;Direct protein sequencing;Endosome;GTP-binding;Lipoprotein;Membrane;Methylation;Neurogenesis;Nucleotide-binding;Prenylation;Reference proteome;Tumor suppressor	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-162582;R-HSA-1643685;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-9006934;R-HSA-76002;R-HSA-6798695;R-HSA-6802952;R-HSA-6802957;R-HSA-163685;R-HSA-422356;R-HSA-166520;R-HSA-187037;R-HSA-381676;R-HSA-6806834;R-HSA-8875878;R-HSA-187687;R-HSA-354192;R-HSA-76009;R-HSA-9006921;R-HSA-6802949;R-HSA-6802946;R-HSA-6802955;R-HSA-392517;R-HSA-5674135;R-HSA-6802948;R-HSA-169893;R-HSA-170968;R-HSA-170984;R-HSA-354194;R-HSA-372708;R-HSA-8875555	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Metabolism;Signal Transduction;Disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Signaling by Receptor Tyrosine Kinases;Platelet activation, signaling and aggregation;Neutrophil degranulation;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Integration of energy metabolism;Regulation of insulin secretion;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Signaling by MET;MET promotes cell motility;Signalling to ERKs;Integrin signaling;Platelet Aggregation (Plug Formation);;Signaling by RAS mutants;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Rap1 signalling;MAP2K and MAPK activation;Signaling by high-kinase activity BRAF mutants;Prolonged ERK activation events;Frs2-mediated activation;ARMS-mediated activation;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;MET activates RAP1 and RAC1
COQ7	negative	P3H1	ENSG00000117385	COQ7	1	COQ7	1	0.00925593571352712	WBGene00013531			Osteogenesis imperfecta type 2;Osteogenesis imperfecta type 3;OSTEOGENESIS IMPERFECTA TYPE VIII;OSTEOGENESIS IMPERFECTA TYPE VIII	GO:0010976;GO:0016020;GO:0046872;GO:0016491;GO:0055114;GO:0005783;GO:0005506;GO:0016705;GO:0031418;GO:0005576;GO:0051213;GO:0060348;GO:0005515;GO:0070062;GO:0003674;GO:0050821;GO:0008285;GO:0032991;GO:0062023;GO:0019511;GO:0019797;GO:0032963;GO:0006457;GO:0005788;GO:0061077;GO:0005518;GO:1901874;GO:0050708;GO:0018126	protein binding;oxidation-reduction process;oxidoreductase activity;iron ion binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;L-ascorbic acid binding;collagen metabolic process;procollagen-proline 3-dioxygenase activity;positive regulation of neuron projection development;membrane;metal ion binding;endoplasmic reticulum;extracellular region;bone development;dioxygenase activity;extracellular exosome;molecular_function;protein stabilization;negative regulation of cell population proliferation;protein-containing complex;collagen-containing extracellular matrix;peptidyl-proline hydroxylation;protein folding;endoplasmic reticulum lumen;chaperone-mediated protein folding;collagen binding;negative regulation of post-translational protein modification;regulation of protein secretion;protein hydroxylation	Alternative splicing;Coiled coil;Dioxygenase;Dwarfism;Endoplasmic reticulum;Extracellular matrix;Glycoprotein;Iron;Metal-binding;Osteogenesis imperfecta;Oxidoreductase;Polymorphism;Reference proteome;Repeat;Secreted;Signal;TPR repeat;Vitamin C	R-HSA-1474244;R-HSA-1474290;R-HSA-1650814	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
COQ7	negative	FAM210B	ENSG00000124098	COQ7	1	COQ7	1	0.00925593571352712					GO:0016020;GO:0016021;GO:0005739;GO:0005741;GO:0030154;GO:0043249;GO:0031224;GO:0071392;GO:0045648	membrane;integral component of membrane;mitochondrion;mitochondrial outer membrane;cell differentiation;erythrocyte maturation;intrinsic component of membrane;cellular response to estradiol stimulus;positive regulation of erythrocyte differentiation	Differentiation;Erythrocyte maturation;Membrane;Mitochondrion;Mitochondrion outer membrane;Polymorphism;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Tumor suppressor		
COQ7	negative	LRRFIP1	ENSG00000124831	COQ7	1	COQ7	1	0.00925593571352712	WBGene00018998	WBGene00018998(0)			GO:0005634;GO:0005737;GO:0005829;GO:0006355;GO:0003677;GO:0005886;GO:0042803;GO:0005515;GO:0000978;GO:0001227;GO:0000122;GO:0045296;GO:0045892;GO:0005856;GO:0006357;GO:0032481;GO:0003725;GO:0051092	regulation of transcription, DNA-templated;nucleus;cytoplasm;cytosol;plasma membrane;DNA binding;protein homodimerization activity;protein binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;cadherin binding;negative regulation of transcription, DNA-templated;cytoskeleton;regulation of transcription by RNA polymerase II;positive regulation of type I interferon production;double-stranded RNA binding;positive regulation of NF-kappaB transcription factor activity	3D-structure;Acetylation;Alternative splicing;Coiled coil;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1643685;R-HSA-5663202;R-HSA-1834949;R-HSA-1226099;R-HSA-1839117;R-HSA-1839124;R-HSA-5655302;R-HSA-3134973	Innate Immune System;Immune System;Disease;Diseases of signal transduction;Cytosolic sensors of pathogen-associated DNA ;Signaling by FGFR in disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
COQ7	negative	RRAS	ENSG00000126458	COQ7	1	COQ7	1	0.00925593571352712	WBGene00004310;WBGene00004309	WBGene00004310(1)		Juvenile myelomonocytic leukemia;Noonan Syndrome;Atypical Noonan syndrome	GO:0016020;GO:0000166;GO:0007165;GO:0003924;GO:0005525;GO:0030336;GO:0005886;GO:0005515;GO:0005925;GO:0070062;GO:0019003;GO:0044877;GO:0060325;GO:0045766;GO:0007265;GO:0070372;GO:0002521;GO:0051896	signal transduction;membrane;GTP binding;GTPase activity;nucleotide binding;focal adhesion;negative regulation of cell migration;plasma membrane;protein binding;extracellular exosome;GDP binding;protein-containing complex binding;face morphogenesis;positive regulation of angiogenesis;Ras protein signal transduction;regulation of ERK1 and ERK2 cascade;leukocyte differentiation;positive regulation of endothelial cell migration;regulation of protein kinase B signaling;positive regulation of endothelial cell-matrix adhesion via fibronectin;positive regulation of vasculogenesis	3D-structure;Cell membrane;Direct protein sequencing;GTP-binding;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Palmitate;Prenylation;Reference proteome	R-HSA-1266738;R-HSA-422475;R-HSA-373755;R-HSA-399955;R-HSA-400685;R-HSA-416550	Developmental Biology;Axon guidance;Semaphorin interactions;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Sema4D in semaphorin signaling;Sema4D mediated inhibition of cell attachment and migration
COQ7	negative	PRRG2	ENSG00000126460	COQ7	1	COQ7	1	0.00925593571352712					GO:0005509;GO:0005576;GO:0016020;GO:0016021;GO:0005515;GO:0005615;GO:0005887	extracellular region;calcium ion binding;membrane;integral component of membrane;protein binding;extracellular space;integral component of plasma membrane	Disulfide bond;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ7	negative	SLC10A3	ENSG00000126903	COQ7	1	COQ7	1	0.00925593571352712	WBGene00044650	WBGene00044650(0)			GO:0016020;GO:0016021;GO:0055085;GO:0015293;GO:0015721;GO:0008508;GO:0010033;GO:0032526	integral component of membrane;membrane;transmembrane transport;symporter activity;bile acid and bile salt transport;bile acid:sodium symporter activity;response to organic substance;response to retinoic acid	Alternative splicing;Membrane;Polymorphism;Reference proteome;Symport;Transmembrane;Transmembrane helix;Transport		
COQ7	negative	SLC35E1	ENSG00000127526	COQ7	1	COQ7	1	0.00925593571352712					GO:0016020;GO:0016021;GO:0005794;GO:0055085;GO:0015297;GO:0022857	membrane;integral component of membrane;Golgi apparatus;transmembrane transport;antiporter activity;transmembrane transporter activity	Alternative splicing;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ7	negative	TPST2	ENSG00000128294	COQ7	1	COQ7	1	0.00925593571352712	WBGene00013737;WBGene00018365	WBGene00018365(1);WBGene00013737(1)			GO:0016020;GO:0016021;GO:0016740;GO:0005794;GO:0042803;GO:0008476;GO:0006478;GO:0000139;GO:0005783;GO:0050427	protein-tyrosine sulfotransferase activity;peptidyl-tyrosine sulfation;membrane;integral component of membrane;transferase activity;Golgi apparatus;protein homodimerization activity;Golgi membrane;endoplasmic reticulum;3'-phosphoadenosine 5'-phosphosulfate metabolic process;sulfotransferase activity	3D-structure;Disulfide bond;Glycoprotein;Golgi apparatus;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-156580;R-HSA-211859;R-HSA-156584	Metabolism;Phase II - Conjugation of compounds;Biological oxidations;Cytosolic sulfonation of small molecules
COQ7	negative	NECTIN2	ENSG00000130202	COQ7	1	COQ7	1	0.00925593571352712					GO:0016020;GO:0016021;GO:0007155;GO:0005886;GO:0005515;GO:0042803;GO:0005925;GO:0007286;GO:0050776;GO:0042802;GO:0005911;GO:0070062;GO:0050862;GO:0016032;GO:0050839;GO:0009986;GO:0015026;GO:0045954;GO:0001618;GO:0034332;GO:0044406;GO:0007156;GO:0005915;GO:0002860;GO:0042271;GO:0060370;GO:0002891;GO:0019062;GO:0033005;GO:0019064;GO:0046596;GO:0046814;GO:0001675;GO:0007010;GO:0007289;GO:0009566;GO:0030382;GO:0032990;GO:0044782;GO:0051654;GO:0043296;GO:0044291	membrane;integral component of membrane;cell adhesion;focal adhesion;plasma membrane;protein binding;protein homodimerization activity;spermatid development;regulation of immune response;identical protein binding;cell-cell junction;extracellular exosome;positive regulation of T cell receptor signaling pathway;viral process;cell adhesion molecule binding;cell surface;coreceptor activity;positive regulation of natural killer cell mediated cytotoxicity;virus receptor activity;adherens junction organization;adhesion of symbiont to host;homophilic cell adhesion via plasma membrane adhesion molecules;zonula adherens;positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;susceptibility to natural killer cell mediated cytotoxicity;susceptibility to T cell mediated cytotoxicity;positive regulation of immunoglobulin mediated immune response;virion attachment to host cell;positive regulation of mast cell activation;fusion of virus membrane with host plasma membrane;regulation of viral entry into host cell;coreceptor-mediated virion attachment to host cell;acrosome assembly;cytoskeleton organization;spermatid nucleus differentiation;fertilization;sperm mitochondrion organization;cell part morphogenesis;cilium organization;establishment of mitochondrion localization;apical junction complex;cell-cell contact zone	3D-structure;Alternative splicing;Cell adhesion;Cell membrane;Disulfide bond;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Immunoglobulin domain;Membrane;Phosphoprotein;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-1280218;R-HSA-168256;R-HSA-198933;R-HSA-1500931;R-HSA-421270;R-HSA-446728;R-HSA-418990;R-HSA-420597	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell-Cell communication;Cell-cell junction organization;Cell junction organization;Adherens junctions interactions;Nectin/Necl  trans heterodimerization
COQ7	negative	ACAP3	ENSG00000131584	COQ7	1	COQ7	1	0.00925593571352712	WBGene00000565				GO:0046872;GO:0005096;GO:0043547;GO:0001764;GO:0010975;GO:0030426;GO:0005515	protein binding;GTPase activator activity;metal ion binding;positive regulation of GTPase activity;neuron migration;regulation of neuron projection development;growth cone	ANK repeat;Alternative splicing;GTPase activation;Metal-binding;Reference proteome;Repeat;Zinc;Zinc-finger		
COQ7	negative	STARD3	ENSG00000131748	COQ7	1	COQ7	1	0.00925593571352712	WBGene00017826	WBGene00017826(0)			GO:0016020;GO:0016021;GO:0005789;GO:0005765;GO:0042803;GO:0005515;GO:0008289;GO:0006869;GO:0005768;GO:0031902;GO:0120020;GO:0005829;GO:0044232;GO:0015485;GO:0030301;GO:0005737;GO:0006629;GO:0008203;GO:0006839;GO:0008202;GO:0140284;GO:0006700;GO:0099044;GO:0006701;GO:0005739;GO:0005770	lipid binding;cholesterol transfer activity;cholesterol binding;late endosome;cell;membrane;integral component of membrane;intracellular membrane-bounded organelle;nucleoplasm;endoplasmic reticulum membrane;endosome;lysosomal membrane;protein homodimerization activity;protein binding;lipid transport;late endosome membrane;cytosol;organelle membrane contact site;cholesterol transport;cytoplasm;lipid metabolic process;cholesterol metabolic process;mitochondrial transport;steroid metabolic process;endoplasmic reticulum-endosome membrane contact site;C21-steroid hormone biosynthetic process;vesicle tethering to endoplasmic reticulum;progesterone biosynthetic process;mitochondrion	3D-structure;Alternative splicing;Endosome;Lipid transport;Lipid-binding;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-556833;R-HSA-196071;R-HSA-8957322;R-HSA-196108	Metabolism;Metabolism of lipids;Metabolism of steroid hormones;Metabolism of steroids;Pregnenolone biosynthesis
COQ7	negative	BEX1	ENSG00000133169	COQ7	1	COQ7	1	0.00925593571352712					GO:0051091;GO:0045944;GO:0005634;GO:0005737;GO:0005515;GO:0007275;GO:0030154;GO:0007399;GO:0005667;GO:0001102	positive regulation of DNA-binding transcription factor activity;positive regulation of transcription by RNA polymerase II;nucleus;cytoplasm;protein binding;multicellular organism development;cell differentiation;nervous system development;transcription factor complex;RNA polymerase II activating transcription factor binding	Cytoplasm;Developmental protein;Differentiation;Neurogenesis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation		
COQ7	negative	DNAJB2	ENSG00000135924	COQ7	1	COQ7	1	0.00925593571352712	WBGene00001042	WBGene00001019(0);WBGene00001044(0)		DNAJB2-related Charcot-Marie-Tooth disease type 2;Young adult-onset distal hereditary motor neuropathy;SPINAL MUSCULAR ATROPHY DISTAL AUTOSOMAL RECESSIVE 5	GO:0005634;GO:0005737;GO:0016020;GO:0005783;GO:0005789;GO:0031965;GO:0005829;GO:0051082;GO:0042026;GO:0005515;GO:0031227;GO:0008285;GO:0032436;GO:0030308;GO:0051087;GO:0061077;GO:0006986;GO:0032091;GO:0032781;GO:0030433;GO:0001671;GO:0090084;GO:0030544;GO:0070050;GO:0000502;GO:0043130;GO:0140036;GO:0031396;GO:1903644	cell;nucleus;cytoplasm;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;nuclear membrane;cytosol;unfolded protein binding;protein refolding;protein binding;intrinsic component of endoplasmic reticulum membrane;negative regulation of cell population proliferation;negative regulation of cell growth;chaperone binding;chaperone-mediated protein folding;response to unfolded protein;negative regulation of protein binding;positive regulation of ATPase activity;ubiquitin-dependent ERAD pathway;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;ATPase activator activity;negative regulation of inclusion body assembly;Hsp70 protein binding;neuron cellular homeostasis;proteasome complex;ubiquitin binding;ubiquitin-dependent protein binding;regulation of protein ubiquitination;regulation of chaperone-mediated protein folding	3D-structure;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Endoplasmic reticulum;Lipoprotein;Membrane;Methylation;Neurodegeneration;Nucleus;Phosphoprotein;Polymorphism;Prenylation;Reference proteome;Repeat;Ubl conjugation		
COQ7	negative	SEMA7A	ENSG00000138623	COQ7	1	COQ7	1	0.00925593571352712	WBGene00003111;WBGene00004890	WBGene00004889(0)		BLOOD GROUP JOHN MILTON HAGEN SYSTEM	GO:0016020;GO:0005886;GO:0005515;GO:0007275;GO:0006954;GO:0030154;GO:0007229;GO:0005615;GO:0009897;GO:0031225;GO:0030215;GO:0007399;GO:0005887;GO:0070374;GO:0045773;GO:0062023;GO:0005178;GO:0006955;GO:0045499;GO:0001755;GO:0030335;GO:0048843;GO:0050919;GO:0071526;GO:0001649;GO:0050727;GO:0001934;GO:0021988;GO:0031175;GO:0048675;GO:0060907	protein binding;semaphorin receptor binding;membrane;plasma membrane;multicellular organism development;inflammatory response;cell differentiation;integrin-mediated signaling pathway;extracellular space;external side of plasma membrane;anchored component of membrane;nervous system development;integral component of plasma membrane;positive regulation of ERK1 and ERK2 cascade;positive regulation of axon extension;collagen-containing extracellular matrix;integrin binding;immune response;regulation of inflammatory response;chemorepellent activity;neural crest cell migration;positive regulation of cell migration;negative regulation of axon extension involved in axon guidance;negative chemotaxis;semaphorin-plexin signaling pathway;osteoblast differentiation;positive regulation of protein phosphorylation;olfactory lobe development;neuron projection development;axon extension;positive regulation of macrophage cytokine production	3D-structure;Alternative splicing;Cell membrane;Developmental protein;Differentiation;Disulfide bond;GPI-anchor;Glycoprotein;Immunoglobulin domain;Inflammatory response;Lipoprotein;Membrane;Methylation;Neurogenesis;Polymorphism;Reference proteome;Signal	R-HSA-1266738;R-HSA-422475;R-HSA-373755;R-HSA-416700	Developmental Biology;Axon guidance;Semaphorin interactions;Other semaphorin interactions
COQ7	negative	PFKL	ENSG00000141959	COQ7	1	COQ7	1	0.00925593571352712	WBGene00022199;WBGene00008230	WBGene00022199(0)			GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0006096;GO:0005829;GO:0005515;GO:0003824;GO:0003872;GO:0006002;GO:0008152;GO:0005576;GO:0042802;GO:0070062;GO:0043312;GO:0034774;GO:1904813;GO:0030388;GO:0061621;GO:0019900;GO:0070061;GO:0048029;GO:0016208;GO:0070095;GO:0006007;GO:0051289;GO:0005945;GO:0005975;GO:0009749;GO:0046676;GO:0061615	6-phosphofructokinase activity;glycolytic process;ATP binding;cytoplasm;fructose 6-phosphate metabolic process;membrane;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytosol;protein binding;catalytic activity;metabolic process;extracellular region;identical protein binding;extracellular exosome;neutrophil degranulation;secretory granule lumen;ficolin-1-rich granule lumen;fructose 1,6-bisphosphate metabolic process;canonical glycolysis;kinase binding;fructose binding;monosaccharide binding;AMP binding;fructose-6-phosphate binding;glucose catabolic process;protein homotetramerization;6-phosphofructokinase complex;carbohydrate metabolic process;response to glucose;negative regulation of insulin secretion;glycolytic process through fructose-6-phosphate	ATP-binding;Acetylation;Allosteric enzyme;Alternative splicing;Cytoplasm;Direct protein sequencing;Glycolysis;Glycoprotein;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-6798695	Innate Immune System;Immune System;Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Neutrophil degranulation
COQ7	negative	RNPEPL1	ENSG00000142327	COQ7	1	COQ7	1	0.00925593571352712		WBGene00010999(0);WBGene00011000(0);WBGene00011587(0);WBGene00012776(0);WBGene00009865(0)			GO:0006508;GO:0070006;GO:0008270;GO:0046872;GO:0016787;GO:0008233;GO:0008237;GO:0004177	metalloaminopeptidase activity;proteolysis;zinc ion binding;metallopeptidase activity;metal ion binding;hydrolase activity;peptidase activity;aminopeptidase activity	Aminopeptidase;Hydrolase;Metal-binding;Metalloprotease;Polymorphism;Protease;Reference proteome;Zinc		
COQ7	negative	SH3KBP1	ENSG00000147010	COQ7	1	COQ7	1	0.00925593571352712	WBGene00021549	WBGene00021549(0)		IMMUNODEFICIENCY 61	GO:0005737;GO:0016020;GO:0016301;GO:0016310;GO:0007015;GO:0005856;GO:0005515;GO:0006915;GO:0030054;GO:0031410;GO:0045202;GO:0030659;GO:0005925;GO:0005886;GO:0005829;GO:0006897;GO:0016477;GO:0007010;GO:0017124;GO:0008360;GO:0043005;GO:0061024;GO:0007411;GO:0007267;GO:0042059;GO:0030139;GO:0005911;GO:0050871	protein binding;actin filament organization;cytoplasm;membrane;kinase activity;phosphorylation;cytoskeleton;focal adhesion;apoptotic process;cell junction;cytoplasmic vesicle;cytoplasmic vesicle membrane;synapse;plasma membrane;endocytosis;neuron projection;cytosol;cell migration;cytoskeleton organization;SH3 domain binding;regulation of cell shape;membrane organization;axon guidance;cell-cell signaling;negative regulation of epidermal growth factor receptor signaling pathway;endocytic vesicle;cell-cell junction;positive regulation of B cell activation	3D-structure;Alternative splicing;Apoptosis;Cell junction;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Endocytosis;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3 domain;SH3-binding;Synapse;Synaptosome;Ubl conjugation	R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-983695;R-HSA-983705;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-199991;R-HSA-1643685;R-HSA-5663205;R-HSA-9006934;R-HSA-8856828;R-HSA-8856825;R-HSA-177929;R-HSA-182971;R-HSA-6806834;R-HSA-6807004;R-HSA-8875360;R-HSA-8876384;R-HSA-8866376	Adaptive Immune System;Immune System;Vesicle-mediated transport;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR);Developmental Biology;Axon guidance;Signal Transduction;Membrane Trafficking;Disease;Infectious disease;Signaling by Receptor Tyrosine Kinases;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Signaling by EGFR;EGFR downregulation;Signaling by MET;Negative regulation of MET activity;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Reelin signalling pathway
COQ7	negative	TGOLN2	ENSG00000152291	COQ7	1	COQ7	1	0.00925593571352712	WBGene00022615				GO:0016020;GO:0016021;GO:0005794;GO:0005654;GO:0005886;GO:0005515;GO:0044267;GO:0043687;GO:0005802;GO:0005768;GO:0005788;GO:0061024;GO:0030665;GO:0030133;GO:0030140	membrane;integral component of membrane;Golgi apparatus;nucleoplasm;plasma membrane;protein binding;cellular protein metabolic process;post-translational protein modification;trans-Golgi network;endosome;endoplasmic reticulum lumen;membrane organization;clathrin-coated vesicle membrane;transport vesicle;trans-Golgi network transport vesicle	Alternative splicing;Cell membrane;Glycoprotein;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811442;R-HSA-199992;R-HSA-432722;R-HSA-381426;R-HSA-8957275;R-HSA-8856828;R-HSA-8856825;R-HSA-6811440	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Retrograde transport at the Trans-Golgi-Network
COQ7	negative	ANKRD9	ENSG00000156381	COQ7	1	COQ7	1	0.00925593571352712					GO:0005829;GO:0043687;GO:0005515	protein binding;cytosol;post-translational protein modification	ANK repeat;Reference proteome;Repeat	R-HSA-392499;R-HSA-597592;R-HSA-8951664	Metabolism of proteins;Post-translational protein modification;Neddylation
COQ7	negative	ZBTB7B	ENSG00000160685	COQ7	1	COQ7	1	0.00925593571352712	WBGene00021846				GO:0003676;GO:0005634;GO:0046872;GO:0005654;GO:0003677;GO:0042803;GO:0005515;GO:0007275;GO:0030154;GO:0000122;GO:0000978;GO:0000981;GO:0010628;GO:0010629;GO:0006366;GO:0120162;GO:0001158;GO:0001865;GO:0007398;GO:0007595;GO:0031065;GO:0032868;GO:0043372;GO:0043377;GO:0046628;GO:0051141;GO:0060850;GO:0072615;GO:0090336;GO:1990845;GO:2000640;GO:0001228;GO:0003700;GO:0042826;GO:0010468;GO:0043370;GO:0043376;GO:0045944;GO:2000320	protein binding;nucleic acid binding;nucleus;metal ion binding;nucleoplasm;DNA binding;protein homodimerization activity;multicellular organism development;cell differentiation;RNA polymerase II cis-regulatory region sequence-specific DNA binding;negative regulation of transcription by RNA polymerase II;cis-regulatory region sequence-specific DNA binding;positive regulation of gene expression;negative regulation of gene expression;transcription by RNA polymerase II;positive regulation of cold-induced thermogenesis;NK T cell differentiation;ectoderm development;lactation;positive regulation of histone deacetylation;response to insulin;positive regulation of CD4-positive, alpha-beta T cell differentiation;negative regulation of CD8-positive, alpha-beta T cell differentiation;positive regulation of insulin receptor signaling pathway;negative regulation of NK T cell proliferation;regulation of transcription involved in cell fate commitment;interleukin-17 secretion;positive regulation of brown fat cell differentiation;adaptive thermogenesis;positive regulation of SREBP signaling pathway;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;identical protein binding;histone deacetylase binding;regulation of gene expression;regulation of CD4-positive, alpha-beta T cell differentiation;regulation of CD8-positive, alpha-beta T cell differentiation;positive regulation of transcription by RNA polymerase II;negative regulation of T-helper 17 cell differentiation	Acetylation;Alternative splicing;DNA-binding;Developmental protein;Differentiation;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ7	negative	NBEAL2	ENSG00000160796	COQ7	1	COQ7	1	0.00925593571352712		WBGene00004760(0);WBGene00007752(0)		GRAY PLATELET SYNDROME;GRAY PLATELET SYNDROME	GO:0005783;GO:0005515;GO:0005886;GO:0043312;GO:0070821;GO:0101003;GO:0030220	protein binding;endoplasmic reticulum;plasma membrane;neutrophil degranulation;tertiary granule membrane;ficolin-1-rich granule membrane;platelet formation	Alternative splicing;Direct protein sequencing;Endoplasmic reticulum;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ7	negative	INPPL1	ENSG00000165458	COQ7	1	COQ7	1	0.00925593571352712	WBGene00012016	WBGene00006763(0)		Opsismodysplasia;SCHNECKENBECKEN DYSPLASIA;Opsismodysplasia;Opsismodysplasia	GO:0005634;GO:0005737;GO:0016607;GO:0016020;GO:0005794;GO:0005829;GO:0016787;GO:0003779;GO:0007155;GO:0005856;GO:0042995;GO:0005515;GO:0002376;GO:0046856;GO:0006897;GO:0030027;GO:0030175;GO:0042169;GO:0007015;GO:0017124;GO:0006661;GO:0019221;GO:0043647;GO:0001958;GO:0006006;GO:0008285;GO:0009791;GO:0010629;GO:0032868;GO:0044255;GO:0097178;GO:0005886	protein binding;phosphatidylinositol dephosphorylation;nucleus;cytoplasm;nuclear speck;membrane;Golgi apparatus;cytosol;hydrolase activity;actin binding;cell adhesion;cytoskeleton;cell projection;immune system process;endocytosis;lamellipodium;filopodium;SH2 domain binding;actin filament organization;SH3 domain binding;phosphatidylinositol biosynthetic process;cytokine-mediated signaling pathway;inositol phosphate metabolic process;endochondral ossification;glucose metabolic process;negative regulation of cell population proliferation;post-embryonic development;negative regulation of gene expression;response to insulin;cellular lipid metabolic process;ruffle assembly;plasma membrane	3D-structure;Actin-binding;Alternative splicing;Cell adhesion;Cell projection;Cytoplasm;Cytoskeleton;Diabetes mellitus;Disease mutation;Hydrolase;Immunity;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;SH2 domain;SH3-binding	R-HSA-168256;R-HSA-1430728;R-HSA-556833;R-HSA-1280215;R-HSA-449147;R-HSA-451927;R-HSA-1483255;R-HSA-1483257;R-HSA-1660499;R-HSA-512988;R-HSA-912526;R-HSA-1483249;R-HSA-1855204	Immune System;Metabolism;Metabolism of lipids;Cytokine Signaling in Immune system;Signaling by Interleukins;Interleukin-2 family signaling;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Interleukin-3, Interleukin-5 and GM-CSF signaling;Interleukin receptor SHC signaling;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
COQ7	negative	STAT3	ENSG00000168610	COQ7	1	COQ7	1	0.00925593571352712	WBGene00013111	WBGene00010251(0);WBGene00013111(0)	AKAP12;BCL2;BCL2L1;BCL6;BIRC5;CCL11;CCL2;CCND1;CCND3;CD46;CDK4;CDKN1A;CFB;CHI3L1;CISH;CRP;CSRP1;DNMT1;EGFR;ESR2;ETV6;F2R;FAAH;FAS;FGF2;FGG;FLT3;FOS;GAST;GFAP;HAMP;HGF;HIF1A;HMOX1;HSPA4;HSPB1;IFNAR1;IKBKE;IL10;IL1RN;IL2;IL21;IL6;IRF1;JAK2;JUNB;KLF11;KRT17;LEP;MCL1;MMP2;MMP7;MUC1;MUC4;MYC;NANOG;NME1;NOX5;OPRM1;OSM;PIAS3;PIM1;PPARA;PRDM1;PSMB5;PTEN;PTGS2;PTPN13;S100A11;S1PR1;SALL4;SHH;SOCS1;SOCS3;STAT1;STS;TERT;TGFB1;TIMP1;TP63;TWIST1;VEGFA;ZFP36	Autosomal dominant hyper IgE syndrome;Chronic lymphoproliferative disorder of natural killer cells;Permanent neonatal diabetes mellitus;STAT3-related early-onset multisystem autoimmune disease;T-cell large granular lymphocyte leukemia;AUTOIMMUNE DISEASE MULTISYSTEM INFANTILE-ONSET 1;HYPER-IgE RECURRENT INFECTION SYNDROME 1 AUTOSOMAL DOMINANT	GO:0035278;GO:0010628;GO:0045944;GO:0005737;GO:1904685;GO:0005634;GO:0044212;GO:0045893;GO:0030335;GO:0016310;GO:0005829;GO:0005654;GO:0006355;GO:0007165;GO:0003677;GO:0003700;GO:0031490;GO:0042803;GO:0005886;GO:0005515;GO:0006954;GO:0042802;GO:0001228;GO:0000978;GO:0000981;GO:0000790;GO:0019901;GO:0006952;GO:0006357;GO:0016032;GO:0019221;GO:0006606;GO:0051726;GO:0007399;GO:0019903;GO:0051092;GO:0008134;GO:0060259;GO:0090575;GO:0045747;GO:0097009;GO:0007259;GO:0032355;GO:0032870;GO:0038111;GO:0060396;GO:0042531;GO:0070102;GO:1902895;GO:0000122;GO:0001103;GO:0035019;GO:0060019;GO:0042593;GO:0046983;GO:0045410;GO:0010507;GO:0038155;GO:0060397;GO:0070106;GO:0070757;GO:0001659;GO:0043066;GO:0071345;GO:0004879;GO:0042127;GO:0043434;GO:0005667;GO:0072540;GO:0042755;GO:0019953;GO:0045648;GO:0030522;GO:0035723;GO:0038113;GO:0044321;GO:0038114;GO:0033210;GO:0031730;GO:0035259;GO:0043565;GO:0001754;GO:0006366;GO:0006953;GO:0007568;GO:0008283;GO:0008284;GO:0008285;GO:0010033;GO:0010730;GO:0014070;GO:0019827;GO:0034097;GO:0040014;GO:0042493;GO:0042789;GO:0044320;GO:0045471;GO:0045766;GO:0045820;GO:0046902;GO:0048708;GO:0050804;GO:0060548;GO:0071407;GO:0099527;GO:1901215;GO:1902728;GO:1905564;GO:2000637;GO:2000737;GO:2001171;GO:2001223;GO:0005739;GO:0005743;GO:0014069;GO:0044798;GO:0098685;GO:0098978	DNA binding;regulation of transcription, DNA-templated;nucleus;signal transduction;DNA-binding transcription factor activity;miRNA mediated inhibition of translation;positive regulation of gene expression;positive regulation of transcription by RNA polymerase II;cytoplasm;positive regulation of metalloendopeptidase activity;transcription regulatory region DNA binding;positive regulation of transcription, DNA-templated;positive regulation of cell migration;phosphorylation;nucleoplasm;cytosol;chromatin DNA binding;protein homodimerization activity;plasma membrane;protein binding;inflammatory response;identical protein binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;protein kinase binding;defense response;DNA-binding transcription activator activity, RNA polymerase II-specific;regulation of transcription by RNA polymerase II;viral process;regulation of cell cycle;cytokine-mediated signaling pathway;protein import into nucleus;regulation of cell population proliferation;nervous system development;protein phosphatase binding;positive regulation of NF-kappaB transcription factor activity;transcription factor binding;regulation of feeding behavior;RNA polymerase II transcription factor complex;positive regulation of Notch signaling pathway;energy homeostasis;receptor signaling pathway via JAK-STAT;response to estradiol;cellular response to hormone stimulus;interleukin-7-mediated signaling pathway;growth hormone receptor signaling pathway;positive regulation of tyrosine phosphorylation of STAT protein;interleukin-6-mediated signaling pathway;positive regulation of pri-miRNA transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;RNA polymerase II repressing transcription factor binding;somatic stem cell population maintenance;radial glial cell differentiation;glucose homeostasis;protein dimerization activity;positive regulation of interleukin-6 biosynthetic process;negative regulation of autophagy;interleukin-23-mediated signaling pathway;growth hormone receptor signaling pathway via JAK-STAT;interleukin-27-mediated signaling pathway;interleukin-35-mediated signaling pathway;temperature homeostasis;positive regulation of erythrocyte differentiation;cellular response to cytokine stimulus;nuclear receptor activity;response to peptide hormone;transcription factor complex;T-helper 17 cell lineage commitment;eating behavior;sexual reproduction;intracellular receptor signaling pathway;interleukin-15-mediated signaling pathway;interleukin-9-mediated signaling pathway;response to leptin;interleukin-21-mediated signaling pathway;leptin-mediated signaling pathway;CCR5 chemokine receptor binding;glucocorticoid receptor binding;sequence-specific DNA binding;eye photoreceptor cell differentiation;transcription by RNA polymerase II;acute-phase response;aging;cell population proliferation;positive regulation of cell population proliferation;negative regulation of cell population proliferation;response to organic substance;negative regulation of hydrogen peroxide biosynthetic process;response to organic cyclic compound;stem cell population maintenance;response to cytokine;regulation of multicellular organism growth;response to drug;mRNA transcription by RNA polymerase II;cellular response to leptin stimulus;response to ethanol;positive regulation of angiogenesis;negative regulation of glycolytic process;regulation of mitochondrial membrane permeability;astrocyte differentiation;modulation of chemical synaptic transmission;negative regulation of cell death;cellular response to organic cyclic compound;postsynapse to nucleus signaling pathway;negative regulation of neuron death;positive regulation of growth factor dependent skeletal muscle satellite cell proliferation;positive regulation of vascular endothelial cell proliferation;positive regulation of gene silencing by miRNA;negative regulation of stem cell differentiation;positive regulation of ATP biosynthetic process;negative regulation of neuron migration;mitochondrion;mitochondrial inner membrane;postsynaptic density;nuclear transcription factor complex;Schaffer collateral - CA1 synapse;glutamatergic synapse	3D-structure;Acetylation;Activator;Alternative splicing;Cytoplasm;DNA-binding;Diabetes mellitus;Disease mutation;Dwarfism;Host-virus interaction;Lipoprotein;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Reference proteome;SH2 domain;Transcription;Transcription regulation	R-HSA-168256;R-HSA-1266738;R-HSA-392499;R-HSA-109581;R-HSA-162582;R-HSA-5357801;R-HSA-1643685;R-HSA-1280215;R-HSA-2262752;R-HSA-446652;R-HSA-449147;R-HSA-5663202;R-HSA-8953897;R-HSA-390466;R-HSA-391251;R-HSA-186797;R-HSA-9006934;R-HSA-447115;R-HSA-451927;R-HSA-2559583;R-HSA-1266695;R-HSA-1433557;R-HSA-166520;R-HSA-186763;R-HSA-187037;R-HSA-390471;R-HSA-6783783;R-HSA-6785807;R-HSA-2559582;R-HSA-982772;R-HSA-8848021;R-HSA-9006927;R-HSA-1059683;R-HSA-2586552;R-HSA-6783589;R-HSA-8849474;R-HSA-109606;R-HSA-6806834;R-HSA-1226099;R-HSA-1839117;R-HSA-1839124;R-HSA-5655302;R-HSA-452723;R-HSA-111453;R-HSA-2892247;R-HSA-8854691;R-HSA-8984722;R-HSA-9020933;R-HSA-9020956;R-HSA-9616222;R-HSA-9008059;R-HSA-198745;R-HSA-8875791;R-HSA-8983432;R-HSA-8985947;R-HSA-9020958	Immune System;Developmental Biology;Metabolism of proteins;Apoptosis;Signal Transduction;Programmed Cell Death;Disease;Cytokine Signaling in Immune system;Cellular responses to stress;Interleukin-1 family signaling;Signaling by Interleukins;Diseases of signal transduction;Cellular responses to external stimuli;Chaperonin-mediated protein folding;Protein folding;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases;Interleukin-12 family signaling;Interleukin-2 family signaling;Cellular Senescence;Interleukin-7 signaling;Signaling by SCF-KIT;Signaling by NTRKs;Downstream signal transduction;Signaling by NTRK1 (TRKA);Association of TriC/CCT with target proteins during biosynthesis;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Senescence-Associated Secretory Phenotype (SASP);Growth hormone receptor signaling;Signaling by PTK6;Signaling by Non-Receptor Tyrosine Kinases;Interleukin-6 signaling;Signaling by Leptin;Interleukin-6 family signaling;PTK6 Activates STAT3;Intrinsic Pathway for Apoptosis;Signaling by MET;Signaling by FGFR in disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Transcriptional regulation of pluripotent stem cells;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Interleukin-20 family signaling;Interleukin-35 Signalling;Interleukin-23 signaling;Interleukin-27 signaling;Transcriptional regulation of granulopoiesis;Interleukin-37 signaling;Signalling to STAT3;MET activates STAT3;Interleukin-15 signaling;Interleukin-9 signaling;Interleukin-21 signaling
COQ7	negative	RFNG	ENSG00000169733	COQ7	1	COQ7	1	0.00925593571352712					GO:0016020;GO:0016021;GO:0046872;GO:0016740;GO:0016757;GO:0005794;GO:0005576;GO:0000139;GO:0007275;GO:0030154;GO:0007399;GO:0030173;GO:0003674;GO:0033829;GO:0007389;GO:0008593;GO:0036066;GO:0009887;GO:0032092;GO:0045747	membrane;transferase activity, transferring glycosyl groups;integral component of Golgi membrane;O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity;pattern specification process;integral component of membrane;metal ion binding;transferase activity;Golgi apparatus;extracellular region;multicellular organism development;Golgi membrane;cell differentiation;nervous system development;molecular_function;acetylglucosaminyltransferase activity;regulation of Notch signaling pathway;protein O-linked fucosylation;animal organ morphogenesis;positive regulation of protein binding;positive regulation of Notch signaling pathway	Developmental protein;Differentiation;Disulfide bond;Glycoprotein;Glycosyltransferase;Golgi apparatus;Manganese;Membrane;Metal-binding;Neurogenesis;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-157118;R-HSA-1912420;R-HSA-1912422	Signal Transduction;Signaling by NOTCH;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing
COQ7	negative	TM4SF1	ENSG00000169908	COQ7	1	COQ7	1	0.00925593571352712					GO:0016020;GO:0016021;GO:0005515;GO:0005887;GO:0003674;GO:0008150;GO:0001825	integral component of membrane;membrane;protein binding;integral component of plasma membrane;molecular_function;biological_process;blastocyst formation	Glycoprotein;Membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ7	negative	C9orf16	ENSG00000171159	COQ7	1	COQ7	1	0.00925593571352712					GO:0005515;GO:0003674;GO:0008150;GO:0005575	protein binding;molecular_function;biological_process;cellular_component	Coiled coil;Phosphoprotein;Reference proteome		
COQ7	negative	SCAND1	ENSG00000171222	COQ7	1	COQ7	1	0.00925593571352712		WBGene00003033(0);WBGene00001824(0);WBGene00012385(0)			GO:0005634;GO:0006355;GO:0003700;GO:1903508;GO:0005515;GO:0042802;GO:0003713	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleus;positive regulation of nucleic acid-templated transcription;protein binding;identical protein binding;transcription coactivator activity	Nucleus;Reference proteome		
COQ7	negative	LPL	ENSG00000175445	COQ7	1	COQ7	1	0.00925593571352712				Familial lipoprotein lipase deficiency;HYPERLIPIDEMIA FAMILIAL COMBINED 3;Hyperlipoproteinemia type I	GO:0006629;GO:0005576;GO:0004465;GO:0052689;GO:0005615;GO:0042632;GO:0050729;GO:0070328;GO:0050718;GO:1904469;GO:2000778;GO:0010744;GO:0016020;GO:0046872;GO:0016787;GO:0016042;GO:0006631;GO:0042803;GO:0005886;GO:0005509;GO:0005515;GO:0004806;GO:0008201;GO:0017129;GO:0009409;GO:0009617;GO:0019432;GO:0019433;GO:0031670;GO:0042493;GO:0071398;GO:1900077;GO:1904209;GO:0009986;GO:0034361;GO:0042627;GO:0010890;GO:0043395;GO:0001523;GO:0005102;GO:0004620;GO:0034185;GO:0090197;GO:0034371;GO:0006641;GO:0034372;GO:0006633;GO:0010886;GO:0006644;GO:0016298;GO:0043495;GO:0071813;GO:0009749;GO:0010884;GO:0045600;GO:0051004;GO:0055096	carboxylic ester hydrolase activity;lipid metabolic process;lipoprotein lipase activity;extracellular region;protein binding;extracellular space;cholesterol homeostasis;positive regulation of inflammatory response;triglyceride homeostasis;positive regulation of interleukin-1 beta secretion;positive regulation of tumor necrosis factor secretion;positive regulation of interleukin-6 secretion;positive regulation of macrophage derived foam cell differentiation;membrane;metal ion binding;hydrolase activity;lipid catabolic process;fatty acid metabolic process;protein homodimerization activity;plasma membrane;calcium ion binding;chylomicron;triglyceride lipase activity;heparin binding;triglyceride binding;response to cold;response to bacterium;triglyceride biosynthetic process;triglyceride catabolic process;cellular response to nutrient;response to drug;cellular response to fatty acid;negative regulation of cellular response to insulin stimulus;positive regulation of chemokine (C-C motif) ligand 2 secretion;cell surface;very-low-density lipoprotein particle;positive regulation of sequestering of triglyceride;heparan sulfate proteoglycan binding;retinoid metabolic process;signaling receptor binding;phospholipase activity;apolipoprotein binding;positive regulation of chemokine secretion;chylomicron remodeling;triglyceride metabolic process;very-low-density lipoprotein particle remodeling;fatty acid biosynthetic process;positive regulation of cholesterol storage;phospholipid metabolic process;lipase activity;protein membrane adaptor;lipoprotein particle binding;response to glucose;positive regulation of lipid storage;positive regulation of fat cell differentiation;regulation of lipoprotein lipase activity;low-density lipoprotein particle mediated signaling	3D-structure;Calcium;Cell membrane;Chylomicron;Direct protein sequencing;Disease mutation;Disulfide bond;Extracellular matrix;Glycoprotein;Heparin-binding;Hydrolase;Hyperlipidemia;Lipid degradation;Lipid metabolism;Membrane;Metal-binding;Nitration;Polymorphism;Reference proteome;Secreted;Signal;VLDL	R-HSA-1266738;R-HSA-1430728;R-HSA-381340;R-HSA-382551;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-196854;R-HSA-2187338;R-HSA-6806667;R-HSA-975634;R-HSA-174824;R-HSA-8963889;R-HSA-8963899;R-HSA-8963901	Developmental Biology;Metabolism;Transcriptional regulation of white adipocyte differentiation;Transport of small molecules;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of vitamins and cofactors;Visual phototransduction;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport;Plasma lipoprotein assembly, remodeling, and clearance;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling;Chylomicron remodeling
COQ7	negative	PJA1	ENSG00000181191	COQ7	1	COQ7	1	0.00925593571352712	WBGene00021842				GO:0046872;GO:0016740;GO:0005515;GO:0016567;GO:0061630;GO:0005737;GO:0030163	protein ubiquitination;ubiquitin protein ligase activity;metal ion binding;transferase activity;protein binding;cytoplasm;protein catabolic process	3D-structure;Alternative splicing;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ7	negative	PECAM1	ENSG00000261371	COQ7	1	COQ7	1	0.00925593571352712					GO:0005615;GO:0001934;GO:0030335;GO:0016020;GO:0016021;GO:0007155;GO:0042803;GO:0005886;GO:0005515;GO:0030054;GO:0045121;GO:0050900;GO:0070062;GO:0043312;GO:0007165;GO:0002576;GO:0006909;GO:0030667;GO:0072672;GO:0030198;GO:0007156;GO:0031092;GO:0070830;GO:0032991;GO:0050731;GO:0005911;GO:0007159;GO:0008037;GO:0098742;GO:0001525;GO:0001886;GO:0007266;GO:0030334;GO:0035696;GO:0042060;GO:0042531;GO:0043542;GO:0050904;GO:0061028;GO:0072011;GO:0090673;GO:0098609;GO:0150107;GO:0005737;GO:0009897;GO:0030485;GO:0044291;GO:0071944	extracellular space;positive regulation of protein phosphorylation;positive regulation of cell migration;protein binding;membrane;integral component of membrane;cell adhesion;protein homodimerization activity;plasma membrane;cell junction;membrane raft;leukocyte migration;extracellular exosome;neutrophil degranulation;signal transduction;platelet degranulation;phagocytosis;secretory granule membrane;neutrophil extravasation;extracellular matrix organization;cell-cell junction;homophilic cell adhesion via plasma membrane adhesion molecules;platelet alpha granule membrane;bicellular tight junction assembly;protein-containing complex;positive regulation of peptidyl-tyrosine phosphorylation;leukocyte cell-cell adhesion;cell recognition;cell-cell adhesion via plasma-membrane adhesion molecules;angiogenesis;endothelial cell morphogenesis;Rho protein signal transduction;regulation of cell migration;monocyte extravasation;wound healing;positive regulation of tyrosine phosphorylation of STAT protein;endothelial cell migration;diapedesis;establishment of endothelial barrier;glomerular endothelium development;endothelial cell-matrix adhesion;cell-cell adhesion;positive regulation of protein localization to cell-cell junction;cytoplasm;external side of plasma membrane;smooth muscle contractile fiber;cell-cell contact zone;cell periphery	3D-structure;Alternative splicing;Cell adhesion;Cell junction;Cell membrane;Disulfide bond;Glycoprotein;Immunoglobulin domain;Lipoprotein;Membrane;Palmitate;Phagocytosis;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-168249;R-HSA-168256;R-HSA-202733;R-HSA-1474244;R-HSA-216083;R-HSA-76002;R-HSA-6798695;R-HSA-76005;R-HSA-114608;R-HSA-418346;R-HSA-432142;R-HSA-210990	Hemostasis;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Extracellular matrix organization;Integrin cell surface interactions;Platelet activation, signaling and aggregation;Neutrophil degranulation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Platelet homeostasis;Platelet sensitization by LDL;PECAM1 interactions
